user_input,retrieved_contexts,response,reference,faithfulness,answer_relevancy,context_precision,context_recall
What is (are) Non-Small Cell Lung Cancer ?,"['non-small cell lung cancer.    - Certain factors affect prognosis (chance of recovery) and treatment options.    - For most patients with non-small cell lung cancer, current treatments do not cure the cancer.\\n                \\n                \\n                    Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.\\n                    The lungs are a pair of cone-shaped breathing organs in the chest. The lungs bring oxygen into the body', '{\n  ""question"": ""What is (are) Small Cell Lung Cancer ?"",', '""ground_truth"": ""Signs of non-small cell lung cancer include a cough that doesn\'t go away and shortness of breath. Sometimes lung cancer does not cause any signs or symptoms. It may be found during a chest x-ray done for another condition. Signs and symptoms may be caused by lung cancer or by other conditions. Check with your doctor if you have any of the following:         - Chest discomfort or pain.    - A cough that doesnt go away or gets worse over time.     - Trouble breathing.     -', 'found in the cancer and how the cells look under a microscope:         -  Squamous cell carcinoma: Cancer that begins in squamous cells, which are thin, flat cells that look like fish scales. This is also called epidermoid carcinoma.    -  Large cell carcinoma: Cancer that may begin in several types of large cells.    -  Adenocarcinoma: Cancer that begins in the cells that line the alveoli and make substances such as mucus.         Other less common types of non-small cell lung cancer are:', 'the tumor cells are large when viewed under a microscope. The 5-year survival rate for people with non-small cell lung cancer is usually between 11 and 17 percent; it can be lower or higher depending on the subtype and stage of the cancer.""', '{\n  ""question"": ""What is (are) Lung Cancer ?"",\n  ""ground_truth"": ""The body is made up of many types of cells. Normally, cells grow, divide, and produce more cells as needed to keep the body healthy and functioning properly. Sometimes, however, the process goes wrong -- cells become abnormal and form more cells in an uncontrolled way. These extra cells form a mass of tissue, called a growth or tumor. Tumors can be benign, meaning not cancerous, or malignant, meaning cancerous.""\n}', 'cell lung cancer spreads to the brain, the cancer cells in the brain are actually lung cancer cells. The disease is metastatic lung cancer, not brain cancer.\\n                \\n                \\n                    The following stages are used for non-small cell lung cancer:\\n                    Occult (hidden) stage    In the occult (hidden) stage, cancer cannot be seen by imaging or bronchoscopy. Cancer cells are found in sputum (mucus coughed up from the lungs) or bronchial washing (a', '""ground_truth"": ""Key Points\\n                    - Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.     - There are several types of non-small cell lung cancer.    - Smoking is the major risk factor for non-small cell lung cancer.    - Signs of non-small cell lung cancer include a cough that doesn\'t go away and shortness of breath.    - Tests that examine the lungs are used to detect (find), diagnose, and stage non-small cell lung']","Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung. There are several types of non-small cell lung cancer, including squamous cell carcinoma, large cell carcinoma, and adenocarcinoma. Smoking is the major risk factor for this type of lung cancer. Signs of non-small cell lung cancer include a cough that doesn't go away and shortness of breath. Current treatments for most patients do not cure the cancer, and prognosis can vary based on several factors.","Key Points
                    - Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.     - There are several types of non-small cell lung cancer.    - Smoking is the major risk factor for non-small cell lung cancer.    - Signs of non-small cell lung cancer include a cough that doesn't go away and shortness of breath.    - Tests that examine the lungs are used to detect (find), diagnose, and stage non-small cell lung cancer.    - Certain factors affect prognosis (chance of recovery) and treatment options.    - For most patients with non-small cell lung cancer, current treatments do not cure the cancer.
                
                
                    Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.
                    The lungs are a pair of cone-shaped breathing organs in the chest. The lungs bring oxygen into the body as you breathe in. They release carbon dioxide, a waste product of the bodys cells, as you breathe out. Each lung has sections called lobes. The left lung has two lobes. The right lung is slightly larger and has three lobes. Two tubes called bronchi lead from the trachea (windpipe) to the right and left lungs. The bronchi are sometimes also involved in lung cancer. Tiny air sacs called alveoli and small tubes called bronchioles make up the inside of the lungs.     A thin membrane called the pleura covers the outside of each lung and lines the inside wall of the chest cavity. This creates a sac called the pleural cavity. The pleural cavity normally contains a small amount of fluid that helps the lungs move smoothly in the chest when you breathe.    There are two main types of lung cancer: non-small cell lung cancer and small cell lung cancer.    See the following PDQ summaries for more information about lung cancer:         -  Small Cell Lung Cancer Treatment     -  Unusual Cancers of Childhood Treatment     -  Lung Cancer Prevention     -  Lung Cancer Screening
                
                
                    There are several types of non-small cell lung cancer.
                    Each type of non-small cell lung cancer has different kinds of cancer cells. The cancer cells of each type grow and spread in different ways. The types of non-small cell lung cancer are named for the kinds of cells found in the cancer and how the cells look under a microscope:         -  Squamous cell carcinoma: Cancer that begins in squamous cells, which are thin, flat cells that look like fish scales. This is also called epidermoid carcinoma.    -  Large cell carcinoma: Cancer that may begin in several types of large cells.    -  Adenocarcinoma: Cancer that begins in the cells that line the alveoli and make substances such as mucus.         Other less common types of non-small cell lung cancer are: pleomorphic, carcinoid tumor, salivary gland carcinoma, and unclassified carcinoma.
                
                
                    For most patients with non-small cell lung cancer, current treatments do not cure the cancer.
                    If lung cancer is found, taking part in one of the many clinical trials being done to improve treatment should be considered. Clinical trials are taking place in most parts of the country for patients with all stages of non-small cell lung cancer. Information about ongoing clinical trials is available from the NCI website.",1.0,0.9120190549617929,0.9999999999875,0.5263157894736842
Who is at risk for Non-Small Cell Lung Cancer? ?,"['{\n  ""question"": ""Who is at risk for Non-Small Cell Lung Cancer? ?"",', '""ground_truth"": ""Lung cancer is one of the most common cancers in the world. It is a leading cause of cancer death in men and women in the United States. Cigarette smoking causes most lung cancers. The more cigarettes you smoke per day and the earlier you started smoking, the greater your risk of lung cancer. High levels of pollution, radiation and asbestos exposure may also increase risk.     Common symptoms of lung cancer include       - A cough that doesn\'t go away and gets worse over time', 'the tumor cells are large when viewed under a microscope. The 5-year survival rate for people with non-small cell lung cancer is usually between 11 and 17 percent; it can be lower or higher depending on the subtype and stage of the cancer.""', '""ground_truth"": ""Key Points\\n                    - Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.     - There are several types of non-small cell lung cancer.    - Smoking is the major risk factor for non-small cell lung cancer.    - Signs of non-small cell lung cancer include a cough that doesn\'t go away and shortness of breath.    - Tests that examine the lungs are used to detect (find), diagnose, and stage non-small cell lung', 'risk of cancer, not the disease itself. Not all people who inherit mutations in these genes will develop lung cancer.""', '""ground_truth"": ""Smoking is the major risk factor for small cell lung cancer. Anything that increases your chance of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn\'t mean that you will not get cancer. Talk to your doctor if you think you may be at risk for lung cancer.    Risk factors for lung cancer include the following:            -  Smoking cigarettes, pipes, or cigars, now or in the past. This is the', 'combined with other risk factors, the risk of lung cancer is increased.""', '{\n  ""question"": ""What are the treatments for Non-Small Cell Lung Cancer ?"",']","Lung cancer is one of the most common cancers in the world, and it is a leading cause of cancer death in both men and women in the United States. The major risk factor for non-small cell lung cancer is cigarette smoking; the more cigarettes you smoke per day and the earlier you started smoking, the greater your risk. Other risk factors include high levels of pollution, radiation exposure, and asbestos exposure. It's important to note that having a risk factor does not guarantee that one will develop lung cancer, and conversely, not having risk factors does not mean that one will not develop it. If you think you may be at risk for lung cancer, it's advisable to talk to your doctor.","Smoking is the major risk factor for non-small cell lung cancer. Anything that increases your chance of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. Talk to your doctor if you think you may be at risk for lung cancer.    Risk factors for lung cancer include the following:            -  Smoking cigarettes, pipes, or cigars, now or in the past. This is the most important risk factor for lung cancer. The earlier in life a person starts smoking, the more often a person smokes, and the more years a person smokes, the greater the risk of lung cancer.      -  Being exposed to secondhand smoke.     - Being exposed to radiation from any of the following:                  -  Radiation therapy to the breast or chest.       -  Radon in the home or workplace.       -  Imaging tests such as CT scans.       - Atomic bomb radiation.                 -  Being exposed to asbestos, chromium, nickel, beryllium, arsenic, soot, or tar in the workplace.     -  Living where there is air pollution.     -  Having a family history of lung cancer.     -  Being infected with the human immunodeficiency virus (HIV).     -  Taking beta carotene supplements and being a heavy smoker.           Older age is the main risk factor for most cancers. The chance of getting cancer increases as you get older.     When smoking is combined with other risk factors, the risk of lung cancer is increased.",1.0,0.9263870561217448,0.9999999999875,1.0
What are the symptoms of Non-Small Cell Lung Cancer ?,"['""ground_truth"": ""Signs and symptoms of small cell lung cancer include coughing, shortness of breath, and chest pain. These and other signs and symptoms may be caused by small cell lung cancer or by other conditions. Check with your doctor if you have any of the following:         - Chest discomfort or pain.    - A cough that doesnt go away or gets worse over time.     - Trouble breathing.    - Wheezing.    -  Blood in sputum (mucus coughed up from the lungs).     - Hoarseness.    - Trouble', '{\n  ""question"": ""What are the symptoms of Lung Cancer ?"",', 'worse over time    - Constant chest pain    - Coughing up blood    - Shortness of breath, wheezing, or hoarseness    - Repeated problems with pneumonia or bronchitis    - Swelling of the neck and face    - Loss of appetite or weight loss    - Fatigue       Doctors diagnose lung cancer using a physical exam, imaging, and lab tests. Treatment depends on the type, stage, and how advanced it is. Treatments include surgery, chemotherapy, radiation therapy, and targeted therapy. Targeted therapy uses', '""ground_truth"": ""Key Points\\n                    - Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.     - There are several types of non-small cell lung cancer.    - Smoking is the major risk factor for non-small cell lung cancer.    - Signs of non-small cell lung cancer include a cough that doesn\'t go away and shortness of breath.    - Tests that examine the lungs are used to detect (find), diagnose, and stage non-small cell lung', 'Other symptoms of lung cancer include frequent lung infections, fatigue (tiredness), and weight loss without a known cause.\\n                \\nSymptoms of mesothelioma include shortness of breath and chest pain due to pleural effusion.""', '""ground_truth"": ""Common Signs and Symptoms When lung cancer first develops, there may be no symptoms at all. But if the cancer grows, it can cause changes that people should watch for. Common signs and symptoms of lung cancer include: - a cough that doesn\'t go away and gets worse over time  - constant chest pain  - coughing up blood  - shortness of breath, wheezing, or hoarseness  - repeated problems with pneumonia or bronchitis  - swelling of the neck and face  - loss of appetite or weight', '""ground_truth"": ""Lung adenocarcinoma is a cancer that occurs due to abnormal and uncontrolled cell growth in the lungs. It is a subtype of non-small cell lung cancer that is often diagnosed in an outer area of the lung. Early lung cancers may not be associated with any signs and symptoms. As the condition progresses, affected people can experience chest pain, a persistent cough, fatigue, coughing up blood, loss of appetite, unexplained weight loss, shortness of breath, and/or wheezing. The', '{\n  ""question"": ""What are the symptoms of Non-Small Cell Lung Cancer ?"",']","Common signs and symptoms of non-small cell lung cancer include:

- A cough that doesn't go away and gets worse over time
- Constant chest pain
- Coughing up blood
- Shortness of breath, wheezing, or hoarseness
- Repeated problems with pneumonia or bronchitis
- Swelling of the neck and face
- Loss of appetite or weight loss
- Fatigue

If you experience any of these symptoms, it's important to consult with a doctor for further evaluation.",Signs of non-small cell lung cancer include a cough that doesn't go away and shortness of breath. Sometimes lung cancer does not cause any signs or symptoms. It may be found during a chest x-ray done for another condition. Signs and symptoms may be caused by lung cancer or by other conditions. Check with your doctor if you have any of the following:         - Chest discomfort or pain.    - A cough that doesnt go away or gets worse over time.     - Trouble breathing.     - Wheezing.     -  Blood in sputum (mucus coughed up from the lungs).     - Hoarseness.     - Loss of appetite.    - Weight loss for no known reason.     - Feeling very tired.    - Trouble swallowing.    - Swelling in the face and/or veins in the neck.,1.0,0.9568513438998097,0.5628571428458856,0.8666666666666667
How to diagnose Non-Small Cell Lung Cancer ?,"['""ground_truth"": ""Signs of non-small cell lung cancer include a cough that doesn\'t go away and shortness of breath. Sometimes lung cancer does not cause any signs or symptoms. It may be found during a chest x-ray done for another condition. Signs and symptoms may be caused by lung cancer or by other conditions. Check with your doctor if you have any of the following:         - Chest discomfort or pain.    - A cough that doesnt go away or gets worse over time.     - Trouble breathing.     -', 'with all stages of non-small cell lung cancer. Information about ongoing clinical trials is available from the NCI website.""', '{\n  ""question"": ""How to diagnose Non-Small Cell Lung Cancer ?"",', '\\nThe only way to confirm a diagnosis of lung cancer or mesothelioma is for a pathologist to check samples of your lung cells or tissues. A pathologist is a doctor who identifies diseases by studying cells and tissues under a microscope.\\n                \\nDoctors have many ways to collect tissue samples. One way is through bronchoscopy (bron-KOS-ko-pee). For this procedure, your doctor will pass a thin, flexible tube through your nose (or sometimes your mouth), down your throat,', 'worse over time    - Constant chest pain    - Coughing up blood    - Shortness of breath, wheezing, or hoarseness    - Repeated problems with pneumonia or bronchitis    - Swelling of the neck and face    - Loss of appetite or weight loss    - Fatigue       Doctors diagnose lung cancer using a physical exam, imaging, and lab tests. Treatment depends on the type, stage, and how advanced it is. Treatments include surgery, chemotherapy, radiation therapy, and targeted therapy. Targeted therapy uses', 'the tumor cells are large when viewed under a microscope. The 5-year survival rate for people with non-small cell lung cancer is usually between 11 and 17 percent; it can be lower or higher depending on the subtype and stage of the cancer.""', '""ground_truth"": ""Key Points\\n                    - Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.     - There are several types of non-small cell lung cancer.    - Smoking is the major risk factor for non-small cell lung cancer.    - Signs of non-small cell lung cancer include a cough that doesn\'t go away and shortness of breath.    - Tests that examine the lungs are used to detect (find), diagnose, and stage non-small cell lung', '""ground_truth"": ""These resources address the diagnosis or management of lung cancer:  - Genetic Testing Registry: Lung cancer  - Genetic Testing Registry: Non-small cell lung cancer  - Lung Cancer Mutation Consortium: About Mutation Testing  - MedlinePlus Encyclopedia: Lung Cancer--Non-Small Cell  - MedlinePlus Encyclopedia: Lung Cancer--Small Cell  - National Cancer Institute: Drugs Approved for Lung Cancer  - National Cancer Institute: Non-Small Cell Lung Cancer Treatment  - National Cancer']","The only way to confirm a diagnosis of non-small cell lung cancer is for a pathologist to check samples of your lung cells or tissues. A pathologist is a doctor who identifies diseases by studying cells and tissues under a microscope. 

Doctors have various methods to collect tissue samples, one of which is through bronchoscopy (bron-KOS-ko-pee). During this procedure, your doctor will pass a thin, flexible tube through your nose (or sometimes your mouth), down your throat, to collect the necessary samples. 

In addition to tissue sampling, doctors diagnose lung cancer using a physical exam, imaging, and lab tests.","Tests that examine the lungs are used to detect (find), diagnose, and stage non-small cell lung cancer. Tests and procedures to detect, diagnose, and stage non-small cell lung cancer are often done at the same time. Some of the following tests and procedures may be used:         -   Physical exam and history : An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patients health habits, including smoking, and past jobs, illnesses, and treatments will also be taken.    -   Laboratory tests : Medical procedures that test samples of tissue, blood, urine, or other substances in the body. These tests help to diagnose disease, plan and check treatment, or monitor the disease over time.    -  Chest x-ray: An x-ray of the organs and bones inside the chest. An x-ray is a type of energy beam that can go through the body and onto film, making a picture of areas inside the body.     -   CT scan (CAT scan): A procedure that makes a series of detailed pictures of areas inside the body, such as the chest, taken from different angles. The pictures are made by a computer linked to an x-ray machine. A dye may be injected into a vein or swallowed to help the organs or tissues show up more clearly. This procedure is also called computed tomography, computerized tomography, or computerized axial tomography.     -   Sputum cytology : A procedure in which a pathologist views a sample of sputum (mucus coughed up from the lungs) under a microscope, to check for cancer cells.    -   Fine-needle aspiration (FNA) biopsy of the lung: The removal of tissue or fluid from the lung using a thin needle. A CT scan, ultrasound, or other imaging procedure is used to locate the abnormal tissue or fluid in the lung. A small incision may be made in the skin where the biopsy needle is inserted into the abnormal tissue or fluid. A sample is removed with the needle and sent to the laboratory. A pathologist then views the sample under a microscope to look for cancer cells. A chest x-ray is done after the procedure to make sure no air is leaking from the lung into the chest.    -   Bronchoscopy : A procedure to look inside the trachea and large airways in the lung for abnormal areas. A bronchoscope is inserted through the nose or mouth into the trachea and lungs. A bronchoscope is a thin, tube-like instrument with a light and a lens for viewing. It may also have a tool to remove tissue samples, which are checked under a microscope for signs of cancer.    -   Thoracoscopy : A surgical procedure to look at the organs inside the chest to check for abnormal areas. An incision (cut) is made between two ribs, and a thoracoscope is inserted into the chest. A thoracoscope is a thin, tube-like instrument with a light and a lens for viewing. It may also have a tool to remove tissue or lymph node samples, which are checked under a microscope for signs of cancer. In some cases, this procedure is used to remove part of the esophagus or lung. If certain tissues, organs, or lymph nodes cant be reached, a thoracotomy may be done. In this procedure, a larger incision is made between the ribs and the chest is opened.     -   Thoracentesis : The removal of fluid from the space between the lining of the chest and the lung, using a needle. A pathologist views the fluid under a microscope to look for cancer cells.    -   Light and electron microscopy : A laboratory test in which cells in a sample of tissue are viewed under regular and high-powered microscopes to look for certain changes in the cells.    -   Immunohistochemistry : A test that uses antibodies to check for certain antigens in a sample of tissue. The antibody is usually linked to a radioactive substance or a dye that causes the tissue to light up under a microscope. This type of test may be used to tell the difference between different types of cancer.",1.0,0.9595987132508897,0.9999999999875,1.0
What is the outlook for Non-Small Cell Lung Cancer ?,"['{\n  ""question"": ""What is the outlook for Non-Small Cell Lung Cancer ?"",', '""ground_truth"": ""There are many treatment options for lung cancer, mainly based on the extent of the disease. The choice of treatment depends on your age and general health, the stage of the cancer, whether or not it has spread beyond the lung, and other factors. If tests show that you have cancer, you should talk with your doctor and make treatment decisions as soon as possible. Studies show that early treatment leads to better outcomes. Working With a Team of Specialists A team of', 'cell lung cancer grows quickly and often spreads to other tissues (metastasizes), most commonly to the adrenal glands (small hormone-producing glands located on top of each kidney), liver, brain, and bones. In more than half of cases, the small cell lung cancer has spread beyond the lung at the time of diagnosis. After diagnosis, most people with small cell lung cancer survive for about one year; less than seven percent survive 5 years.  Non-small cell lung cancer is divided into three main', 'non-small cell lung cancer.    - Certain factors affect prognosis (chance of recovery) and treatment options.    - For most patients with non-small cell lung cancer, current treatments do not cure the cancer.\\n                \\n                \\n                    Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.\\n                    The lungs are a pair of cone-shaped breathing organs in the chest. The lungs bring oxygen into the body', '""ground_truth"": ""Signs of non-small cell lung cancer include a cough that doesn\'t go away and shortness of breath. Sometimes lung cancer does not cause any signs or symptoms. It may be found during a chest x-ray done for another condition. Signs and symptoms may be caused by lung cancer or by other conditions. Check with your doctor if you have any of the following:         - Chest discomfort or pain.    - A cough that doesnt go away or gets worse over time.     - Trouble breathing.     -', 'with all stages of non-small cell lung cancer. Information about ongoing clinical trials is available from the NCI website.""', 'the tumor cells are large when viewed under a microscope. The 5-year survival rate for people with non-small cell lung cancer is usually between 11 and 17 percent; it can be lower or higher depending on the subtype and stage of the cancer.""', 'or seventies. Most people who develop lung cancer have a history of long-term tobacco smoking; however, the condition can occur in people who have never smoked.  Lung cancer is generally divided into two types, small cell lung cancer and non-small cell lung cancer, based on the size of the affected cells when viewed under a microscope. Non-small cell lung cancer accounts for 85 percent of lung cancer, while small cell lung cancer accounts for the remaining 15 percent.  Small cell lung cancer']","The outlook for Non-Small Cell Lung Cancer (NSCLC) varies based on several factors, including the extent of the disease, the stage of the cancer, and the patient's age and general health. While there are many treatment options available, current treatments typically do not cure the cancer. The 5-year survival rate for people with NSCLC is generally between 11 and 17 percent, but this can vary depending on the subtype and stage of the cancer. Early treatment is associated with better outcomes, so it is important to discuss treatment options with your doctor as soon as possible.","Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) and treatment options depend on the following:         - The stage of the cancer (the size of the tumor and whether it is in the lung only or has spread to other places in the body).    - The type of lung cancer.    - Whether the cancer has mutations (changes) in certain genes, such as the epidermal growth factor receptor (EGFR) gene or the anaplastic lymphoma kinase (ALK) gene.    - Whether there are signs and symptoms such as coughing or trouble breathing.    - The patients general health.",1.0,0.0,0.49999999998333333,0.8333333333333334
What are the stages of Non-Small Cell Lung Cancer ?,"['{\n  ""question"": ""What are the stages of Non-Small Cell Lung Cancer ?"",', 'Treatment Options by Stage\\n\\t\\t            \\n\\t\\t                \\n\\t\\t                    Occult Non-Small Cell Lung Cancer\\n\\t\\t                    Treatment of occult non-small cell lung cancer depends on the stage of the disease. Occult tumors are often found at an early stage (the tumor is in the lung only) and sometimes can be cured by surgery.   Check the list of NCI-supported cancer clinical trials that are now accepting patients with occult non-small cell lung cancer. For', 'cell lung cancer grows quickly and often spreads to other tissues (metastasizes), most commonly to the adrenal glands (small hormone-producing glands located on top of each kidney), liver, brain, and bones. In more than half of cases, the small cell lung cancer has spread beyond the lung at the time of diagnosis. After diagnosis, most people with small cell lung cancer survive for about one year; less than seven percent survive 5 years.  Non-small cell lung cancer is divided into three main', '""ground_truth"": ""Signs of non-small cell lung cancer include a cough that doesn\'t go away and shortness of breath. Sometimes lung cancer does not cause any signs or symptoms. It may be found during a chest x-ray done for another condition. Signs and symptoms may be caused by lung cancer or by other conditions. Check with your doctor if you have any of the following:         - Chest discomfort or pain.    - A cough that doesnt go away or gets worse over time.     - Trouble breathing.     -', 'cell lung cancer spreads to the brain, the cancer cells in the brain are actually lung cancer cells. The disease is metastatic lung cancer, not brain cancer.\\n                \\n                \\n                    The following stages are used for non-small cell lung cancer:\\n                    Occult (hidden) stage    In the occult (hidden) stage, cancer cannot be seen by imaging or bronchoscopy. Cancer cells are found in sputum (mucus coughed up from the lungs) or bronchial washing (a', '""ground_truth"": ""There are two major types of lung cancer -- non-small cell lung cancer and small cell lung cancer. Each type of lung cancer grows and spreads in different ways, and each is treated differently. Non-small cell lung cancer is more common than small cell lung cancer. It generally grows and spreads slowly.  Learn more about non-small cell carcinoma.  Small cell lung cancer,  sometimes called oat cell cancer, grows more quickly and is more likely to spread to other organs in the', 'the tumor cells are large when viewed under a microscope. The 5-year survival rate for people with non-small cell lung cancer is usually between 11 and 17 percent; it can be lower or higher depending on the subtype and stage of the cancer.""', '\\n\\t\\t                    Stage IV Non-Small Cell Lung Cancer\\n\\t\\t                    Treatment of stage IV non-small cell lung cancer may include the following:         -  Chemotherapy.    - Chemotherapy followed by more chemotherapy as maintenance therapy to help keep cancer from progressing.    - Combination chemotherapy and targeted therapy with a monoclonal antibody, such as bevacizumab, cetuximab, or necitumumab.    - Targeted therapy with a monoclonal antibody, such as']","The stages of Non-Small Cell Lung Cancer (NSCLC) are as follows:

1. **Occult (hidden) stage**: Cancer cannot be seen by imaging or bronchoscopy but is found in sputum or bronchial washing.
2. **Stage I**: The cancer is localized to the lung and has not spread to lymph nodes.
3. **Stage II**: The cancer has spread to nearby lymph nodes.
4. **Stage III**: The cancer is more advanced, with spread to lymph nodes in the chest.
5. **Stage IV**: The cancer has spread to other parts of the body, such as the liver, brain, or bones. 

Treatment options vary depending on the stage of the disease.","Key Points
                    - After lung cancer has been diagnosed, tests are done to find out if cancer cells have spread within the lungs or to other parts of the body.     - There are three ways that cancer spreads in the body.    - Cancer may spread from where it began to other parts of the body.    - The following stages are used for non-small cell lung cancer:         - Occult (hidden) stage     - Stage 0 (carcinoma in situ)     - Stage I     - Stage II     - Stage IIIA     - Stage IIIB     - Stage IV
                
                
                    After lung cancer has been diagnosed, tests are done to find out if cancer cells have spread within the lungs or to other parts of the body.
                    The process used to find out if cancer has spread within the lungs or to other parts of the body is called staging. The information gathered from the staging process determines the stage of the disease. It is important to know the stage in order to plan treatment. Some of the tests used to diagnose non-small cell lung cancer are also used to stage the disease. (See the General Information section.)    Other tests and procedures that may be used in the staging process include the following:         -   MRI (magnetic resonance imaging): A procedure that uses a magnet, radio waves, and a computer to make a series of detailed pictures of areas inside the body, such as the brain. This procedure is also called nuclear magnetic resonance imaging (NMRI).    -   CT scan (CAT scan): A procedure that makes a series of detailed pictures of areas inside the body, such as the brain and abdomen, taken from different angles. The pictures are made by a computer linked to an x-ray machine. A dye may be injected into a vein or swallowed to help the organs or tissues show up more clearly. This procedure is also called computed tomography, computerized tomography, or computerized axial tomography.    -   PET scan (positron emission tomography scan): A procedure to find malignant tumor cells in the body. A small amount of radioactive glucose (sugar) is injected into a vein. The PET scanner rotates around the body and makes a picture of where glucose is being used in the body. Malignant tumor cells show up brighter in the picture because they are more active and take up more glucose than normal cells do.    -   Radionuclide bone scan : A procedure to check if there are rapidly dividing cells, such as cancer cells, in the bone. A very small amount of radioactive material is injected into a vein and travels through the bloodstream. The radioactive material collects in the bones and is detected by a scanner.     -   Pulmonary function test (PFT): A test to see how well the lungs are working. It measures how much air the lungs can hold and how quickly air moves into and out of the lungs. It also measures how much oxygen is used and how much carbon dioxide is given off during breathing. This is also called lung function test.    -   Endoscopic ultrasound (EUS): A procedure in which an endoscope is inserted into the body. An endoscope is a thin, tube-like instrument with a light and a lens for viewing. A probe at the end of the endoscope is used to bounce high-energy sound waves (ultrasound) off internal tissues or organs and make echoes. The echoes form a picture of body tissues called a sonogram. This procedure is also called endosonography. EUS may be used to guide fine needle aspiration (FNA) biopsy of the lung, lymph nodes, or other areas.     -   Mediastinoscopy : A surgical procedure to look at the organs, tissues, and lymph nodes between the lungs for abnormal areas. An incision (cut) is made at the top of the breastbone and a mediastinoscope is inserted into the chest. A mediastinoscope is a thin, tube-like instrument with a light and a lens for viewing. It may also have a tool to remove tissue or lymph node samples, which are checked under a microscope for signs of cancer.    -   Anterior mediastinotomy : A surgical procedure to look at the organs and tissues between the lungs and between the breastbone and heart for abnormal areas. An incision (cut) is made next to the breastbone and a mediastinoscope is inserted into the chest. A mediastinoscope is a thin, tube-like instrument with a light and a lens for viewing. It may also have a tool to remove tissue or lymph node samples, which are checked under a microscope for signs of cancer. This is also called the Chamberlain procedure.    -  Lymph node biopsy : The removal of all or part of a lymph node. A pathologist views the tissue under a microscope to look for cancer cells.     -   Bone marrow aspiration and biopsy : The removal of bone marrow, blood, and a small piece of bone by inserting a hollow needle into the hipbone or breastbone. A pathologist views the bone marrow, blood, and bone under a microscope to look for signs of cancer.
                
                
                    There are three ways that cancer spreads in the body.
                    Cancer can spread through tissue, the lymph system, and the blood:         - Tissue. The cancer spreads from where it began by growing into nearby areas.     - Lymph system. The cancer spreads from where it began by getting into the lymph system. The cancer travels through the lymph vessels to other parts of the body.     - Blood. The cancer spreads from where it began by getting into the blood. The cancer travels through the blood vessels to other parts of the body.
                
                
                    Cancer may spread from where it began to other parts of the body.
                    When cancer spreads to another part of the body, it is called metastasis. Cancer cells break away from where they began (the primary tumor) and travel through the lymph system or blood.         - Lymph system. The cancer gets into the lymph system, travels through the lymph vessels, and forms a tumor (metastatic tumor) in another part of the body.    - Blood. The cancer gets into the blood, travels through the blood vessels, and forms a tumor (metastatic tumor) in another part of the body.        The metastatic tumor is the same type of cancer as the primary tumor. For example, if non-small cell lung cancer spreads to the brain, the cancer cells in the brain are actually lung cancer cells. The disease is metastatic lung cancer, not brain cancer.
                
                
                    The following stages are used for non-small cell lung cancer:
                    Occult (hidden) stage    In the occult (hidden) stage, cancer cannot be seen by imaging or bronchoscopy. Cancer cells are found in sputum (mucus coughed up from the lungs) or bronchial washing (a sample of cells taken from inside the airways that lead to the lung). Cancer may have spread to other parts of the body.       Stage 0 (carcinoma in situ)    In stage 0, abnormal cells are found in the lining of the airways. These abnormal cells may become cancer and spread into nearby normal tissue. Stage 0 is also called carcinoma in situ.        Stage I     In stage I, cancer has formed. Stage I is divided into stages IA and IB:            -  Stage IA: The tumor is in the lung only and is 3 centimeters or smaller.     -  Stage IB: Cancer has not spread to the lymph nodes and one or more of the following is true:                  - The tumor is larger than 3 centimeters but not larger than 5 centimeters.       - Cancer has spread to the main bronchus and is at least 2 centimeters below where the trachea joins the bronchus.       - Cancer has spread to the innermost layer of the membrane that covers the lung.       - Part of the lung has collapsed or developed pneumonitis (inflammation of the lung) in the area where the trachea joins the bronchus.                          Stage II    Stage II is divided into stages IIA and IIB. Stage IIA and IIB are each divided into two sections depending on the size of the tumor, where the tumor is found, and whether there is cancer in the lymph nodes.            -  Stage IIA:  (1) Cancer has spread to lymph nodes on the same side of the chest as the tumor. The lymph nodes with cancer are within the lung or near the bronchus. Also, one or more of the following is true:                  - The tumor is not larger than 5 centimeters.       -  Cancer has spread to the main bronchus and is at least 2 centimeters below where the trachea joins the bronchus.       -  Cancer has spread to the innermost layer of the membrane that covers the lung.       - Part of the lung has collapsed or developed pneumonitis (inflammation of the lung) in the area where the trachea joins the bronchus.            or  (2) Cancer has not spread to lymph nodes and one or more of the following is true:                  - The tumor is larger than 5 centimeters but not larger than 7 centimeters.       - Cancer has spread to the main bronchus and is at least 2 centimeters below where the trachea joins the bronchus.       - Cancer has spread to the innermost layer of the membrane that covers the lung.       - Part of the lung has collapsed or developed pneumonitis (inflammation of the lung) in the area where the trachea joins the bronchus.                -  Stage IIB:  (1) Cancer has spread to nearby lymph nodes on the same side of the chest as the tumor. The lymph nodes with cancer are within the lung or near the bronchus. Also, one or more of the following is true:                  - The tumor is larger than 5 centimeters but not larger than 7 centimeters.       - Cancer has spread to the main bronchus and is at least 2 centimeters below where the trachea joins the bronchus.       -  Cancer has spread to the innermost layer of the membrane that covers the lung.       - Part of the lung has collapsed or developed pneumonitis (inflammation of the lung) in the area where the trachea joins the bronchus.             or (2) Cancer has not spread to lymph nodes and one or more of the following is true:                  - The tumor is larger than 7 centimeters.       - Cancer has spread to the main bronchus (and is less than 2 centimeters below where the trachea joins the bronchus), the chest wall, the diaphragm, or the nerve that controls the diaphragm.        - Cancer has spread to the membrane around the heart or lining the chest wall.       - The whole lung has collapsed or developed pneumonitis (inflammation of the lung).       - There are one or more separate tumors in the same lobe of the lung.                         Stage IIIA     Stage IIIA is divided into three sections depending on the size of the tumor, where the tumor is found, and which lymph nodes have cancer (if any).     (1) Cancer has spread to lymph nodes on the same side of the chest as the tumor. The lymph nodes with cancer are near the sternum (chest bone) or where the bronchus enters the lung. Also:            - The tumor may be any size.     - Part of the lung (where the trachea joins the bronchus) or the whole lung may have collapsed or developed pneumonitis (inflammation of the lung).     - There may be one or more separate tumors in the same lobe of the lung.     - Cancer may have spread to any of the following:                  - Main bronchus, but not the area where the trachea joins the bronchus.       -  Chest wall.       -  Diaphragm and the nerve that controls it.       -  Membrane around the lung or lining the chest wall.       - Membrane around the heart.                        or       (2) Cancer has spread to lymph nodes on the same side of the chest as the tumor. The lymph nodes with cancer are within the lung or near the bronchus. Also:            - The tumor may be any size.     - The whole lung may have collapsed or developed pneumonitis (inflammation of the lung).     - There may be one or more separate tumors in any of the lobes of the lung with cancer.     - Cancer may have spread to any of the following:                  - Main bronchus, but not the area where the trachea joins the bronchus.       - Chest wall.       - Diaphragm and the nerve that controls it.       - Membrane around the lung or lining the chest wall.       - Heart or the membrane around it.       - Major blood vessels that lead to or from the heart.        - Trachea.       -  Esophagus.        - Nerve that controls the larynx (voice box).       -  Sternum (chest bone) or backbone.       -  Carina (where the trachea joins the bronchi).                        or       (3) Cancer has not spread to the lymph nodes and the tumor may be any size. Cancer has spread to any of the following:            - Heart.      - Major blood vessels that lead to or from the heart.      - Trachea.      - Esophagus.      - Nerve that controls the larynx (voice box).     - Sternum (chest bone) or backbone.      - Carina (where the trachea joins the bronchi).              Stage IIIB     Stage IIIB is divided into two sections depending on the size of the tumor, where the tumor is found, and which lymph nodes have cancer.     (1) Cancer has spread to lymph nodes above the collarbone or to lymph nodes on the opposite side of the chest as the tumor. Also:            - The tumor may be any size.     - Part of the lung (where the trachea joins the bronchus) or the whole lung may have collapsed or developed pneumonitis (inflammation of the lung).     - There may be one or more separate tumors in any of the lobes of the lung with cancer.     - Cancer may have spread to any of the following:                  - Main bronchus.       -  Chest wall.       -  Diaphragm and the nerve that controls it.       -  Membrane around the lung or lining the chest wall.       - Heart or the membrane around it.       - Major blood vessels that lead to or from the heart.       - Trachea.       -  Esophagus.       - Nerve that controls the larynx (voice box).       -  Sternum (chest bone) or backbone.       -  Carina (where the trachea joins the bronchi).                         or       (2) Cancer has spread to lymph nodes on the same side of the chest as the tumor. The lymph nodes with cancer are near the sternum (chest bone) or where the bronchus enters the lung. Also:            - The tumor may be any size.     - There may be separate tumors in different lobes of the same lung.     - Cancer has spread to any of the following:                  - Heart.        - Major blood vessels that lead to or from the heart.        - Trachea.        - Esophagus.       - Nerve that controls the larynx (voice box).       - Sternum (chest bone) or backbone.        - Carina (where the trachea joins the bronchi).                         Stage IV     In stage IV, the tumor may be any size and cancer may have spread to lymph nodes. One or more of the following is true:            - There are one or more tumors in both lungs.     - Cancer is found in fluid around the lungs or the heart.     - Cancer has spread to other parts of the body, such as the brain, liver, adrenal glands, kidneys, or bone.",0.5,0.9764491923974549,0.9999999999875,1.0
What are the treatments for Non-Small Cell Lung Cancer ?,"['{\n  ""question"": ""What are the treatments for Non-Small Cell Lung Cancer ?"",', 'cell lung cancer in several ways, and surgery is a common treatment. Cryosurgery, a treatment that freezes and destroys cancer tissue, may be used to control symptoms in the later stages of non-small cell lung cancer. Doctors may also use radiation therapy and chemotherapy to slow the progress of the disease and to manage symptoms.  See more information about treatments for non-small cell lung cancer. Treating Small Cell Lung Cancer Small cell lung cancer spreads quickly. In many cases, cancer', 'Treatment Options by Stage\\n\\t\\t            \\n\\t\\t                \\n\\t\\t                    Occult Non-Small Cell Lung Cancer\\n\\t\\t                    Treatment of occult non-small cell lung cancer depends on the stage of the disease. Occult tumors are often found at an early stage (the tumor is in the lung only) and sometimes can be cured by surgery.   Check the list of NCI-supported cancer clinical trials that are now accepting patients with occult non-small cell lung cancer. For', 'non-small cell lung cancer that cannot be removed with surgery may include the following:         - Chemotherapy and radiation therapy given over the same period of time or one followed by the other.    -  External radiation therapy alone for patients who cannot be treated with combined therapy, or as palliative treatment to relieve symptoms and improve the quality of life.    -  Internal radiation therapy or laser surgery, as palliative treatment to relieve symptoms and improve the quality of', '""ground_truth"": ""Key Points\\n                    - There are different types of treatment for patients with non-small cell lung cancer.    - Nine types of standard treatment are used:         - Surgery      - Radiation therapy      - Chemotherapy      - Targeted therapy     - Laser therapy     - Photodynamic therapy (PDT)     - Cryosurgery     - Electrocautery     - Watchful waiting        - New types of treatment are being tested in clinical trials.          - Chemoprevention     -', 'patients with small cell lung cancer, current treatments do not cure the cancer.\\n                    If lung cancer is found, patients should think about taking part in one of the many clinical trials being done to improve treatment. Clinical trials are taking place in most parts of the country for patients with all stages of small cell lung cancer. Information about ongoing clinical trials is available from the NCI website.""', 'many cases, cancer cells have already spread to other parts of the body when the disease is diagnosed. In order to reach cancer cells throughout the body, doctors almost always use chemotherapy. Treatment for small cell lung cancer may also include radiation therapy aimed at the tumor in the lung or tumors in other parts of the body, such as in the brain. Surgery is part of the treatment plan for a small number of patients with small cell lung cancer. Some patients with small cell lung cancer', '\\n\\t\\t            Treatment Options by Stage\\n\\t\\t            \\n\\t\\t                \\n\\t\\t                    Limited-Stage Small Cell Lung Cancer\\n\\t\\t                    Treatment of limited-stage small cell lung cancer may include the following:         -  Combination chemotherapy and radiation therapy to the chest. Radiation therapy to the brain may later be given to patients with complete responses.    - Combination chemotherapy alone for patients who cannot be given radiation therapy.']","The treatments for Non-Small Cell Lung Cancer (NSCLC) include several options, depending on the stage of the disease. Key treatment methods are:

1. **Surgery** - Often used for tumors that can be removed.
2. **Radiation Therapy** - Can be used alone or in combination with chemotherapy.
3. **Chemotherapy** - Often used to slow disease progression and manage symptoms.
4. **Targeted Therapy** - Aimed at specific characteristics of cancer cells.
5. **Laser Therapy** - Used to remove or destroy cancer tissue.
6. **Photodynamic Therapy (PDT)** - Involves light-sensitive drugs and light to kill cancer cells.
7. **Cryosurgery** - Freezes and destroys cancer tissue, often used for symptom control in later stages.
8. **Electrocautery** - Uses electrical currents to remove or destroy tissue.
9. **Watchful Waiting** - Monitoring the condition without immediate treatment.

New treatments are also being tested in clinical trials.","Key Points
                    - There are different types of treatment for patients with non-small cell lung cancer.    - Nine types of standard treatment are used:         - Surgery      - Radiation therapy      - Chemotherapy      - Targeted therapy     - Laser therapy     - Photodynamic therapy (PDT)     - Cryosurgery     - Electrocautery     - Watchful waiting        - New types of treatment are being tested in clinical trials.          - Chemoprevention     - Radiosensitizers     - New combinations        - Patients may want to think about taking part in a clinical trial.    - Patients can enter clinical trials before, during, or after starting their cancer treatment.    - Follow-up tests may be needed.
                
                
                    There are different types of treatment for patients with non-small cell lung cancer.
                    Different types of treatments are available for patients with non-small cell lung cancer. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
                
                
                    Nine types of standard treatment are used:
                    Surgery     Four types of surgery are used to treat lung cancer:            -  Wedge resection: Surgery to remove a tumor and some of the normal tissue around it. When a slightly larger amount of tissue is taken, it is called a segmental resection.     -  Lobectomy: Surgery to remove a whole lobe (section) of the lung.     -  Pneumonectomy: Surgery to remove one whole lung.     -  Sleeve resection: Surgery to remove part of the bronchus.           Even if the doctor removes all the cancer that can be seen at the time of the surgery, some patients may be given chemotherapy or radiation therapy after surgery to kill any cancer cells that are left. Treatment given after the surgery, to lower the risk that the cancer will come back, is called adjuvant therapy.       Radiation therapy     Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. There are two types of radiation therapy:             -  External radiation therapy uses a machine outside the body to send radiation toward the cancer.     -  Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer.             Stereotactic body radiation therapy is a type of external radiation therapy. Special equipment is used to place the patient in the same position for each radiation treatment. Once a day for several days, a radiation machine aims a larger than usual dose of radiation directly at the tumor. By having the patient in the same position for each treatment, there is less damage to nearby healthy tissue. This procedure is also called stereotactic external-beam radiation therapy and stereotaxic radiation therapy.     Stereotactic radiosurgery is a type of external radiation therapy used to treat lung cancer that has spread to the brain. A rigid head frame is attached to the skull to keep the head still during the radiation treatment. A machine aims a single large dose of radiation directly at the tumor in the brain. This procedure does not involve surgery. It is also called stereotaxic radiosurgery, radiosurgery, and radiation surgery.    For tumors in the airways, radiation is given directly to the tumor through an endoscope.     The way the radiation therapy is given depends on the type and stage of the cancer being treated. It also depends on where the cancer is found. External and internal radiation therapy are used to treat non-small cell lung cancer.       Chemotherapy     Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy).     The way the chemotherapy is given depends on the type and stage of the cancer being treated.    See Drugs Approved for Non-Small Cell Lung Cancer for more information.       Targeted therapy     Targeted therapy is a type of treatment that uses drugs or other substances to attack specific cancer cells. Targeted therapies usually cause less harm to normal cells than chemotherapy or radiation therapy do. Monoclonal antibodies and tyrosine kinase inhibitors are the two main types of targeted therapy being used to treat advanced, metastatic, or recurrent non-small cell lung cancer.     Monoclonal antibodies     Monoclonal antibody therapy is a cancer treatment that uses antibodies made in the laboratory from a single type of immune system cell. These antibodies can identify substances on cancer cells or normal substances in the blood or tissues that may help cancer cells grow. The antibodies attach to the substances and kill the cancer cells, block their growth, or keep them from spreading. Monoclonal antibodies are given by infusion. They may be used alone or to carry drugs, toxins, or radioactive material directly to cancer cells.    There are different types of monoclonal antibody therapy:            -  Vascular endothelial growth factor (VEGF) inhibitor therapy: Cancer cells make a substance called VEGF, which causes new blood vessels to form (angiogenesis) and helps the cancer grow. VEGF inhibitors block VEGF and stop new blood vessels from forming. This may kill cancer cells because they need new blood vessels to grow. Bevacizumab and ramucirumab are VEGF inhibitors and angiogenesis inhibitors.     -  Epidermal growth factor receptor (EGFR) inhibitor therapy: EGFRs are proteins found on the surface of certain cells, including cancer cells. Epidermal growth factor attaches to the EGFR on the surface of the cell and causes the cells to grow and divide. EGFR inhibitors block the receptor and stop the epidermal growth factor from attaching to the cancer cell. This stops the cancer cell from growing and dividing. Cetuximab and necitumumab are EGFR inhibitors.     -  Immune checkpoint inhibitor therapy: PD-1 is a protein on the surface of T cells that helps keep the bodys immune responses in check. When PD-1 attaches to another protein called PDL-1 on a cancer cell, it stops the T cell from killing the cancer cell. PD-1 inhibitors attach to PDL-1 and allow the T cells to kill cancer cells. Nivolumab, pembrolizumab, and atezolizumab are types of immune checkpoint inhibitors.            Tyrosine kinase inhibitors     Tyrosine kinase inhibitors are small-molecule drugs that go through the cell membrane and work inside cancer cells to block signals that cancer cells need to grow and divide. Some tyrosine kinase inhibitors also have angiogenesis inhibitor effects.    There are different types of tyrosine kinase inhibitors:            -  Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors: EGFRs are proteins found on the surface and inside certain cells, including cancer cells. Epidermal growth factor attaches to the EGFR inside the cell and sends signals to the tyrosine kinase area of the cell, which tells the cell to grow and divide. EGFR tyrosine kinase inhibitors stop these signals and stop the cancer cell from growing and dividing. Erlotinib, gefitinib, and afatinib are types of EGFR tyrosine kinase inhibitors. Some of these drugs work better when there is also a mutation (change) in the EGFR gene.     -  Kinase inhibitors that affect cells with certain gene changes: Certain changes in the ALK  and ROS1 genes cause too much protein to be made. Blocking these proteins may stop the cancer from growing and spreading. Crizotinib is used to stop proteins from being made by the ALK and ROS1 gene. Ceritinib is used to stop proteins from being made by the ALK gene.           See Drugs Approved for Non-Small Cell Lung Cancer for more information.       Laser therapy     Laser therapy is a cancer treatment that uses a laser beam (a narrow beam of intense light) to kill cancer cells.       Photodynamic therapy (PDT)     Photodynamic therapy (PDT) is a cancer treatment that uses a drug and a certain type of laser light to kill cancer cells. A drug that is not active until it is exposed to light is injected into a vein. The drug collects more in cancer cells than in normal cells. Fiberoptic tubes are then used to carry the laser light to the cancer cells, where the drug becomes active and kills the cells. Photodynamic therapy causes little damage to healthy tissue. It is used mainly to treat tumors on or just under the skin or in the lining of internal organs. When the tumor is in the airways, PDT is given directly to the tumor through an endoscope.       Cryosurgery     Cryosurgery is a treatment that uses an instrument to freeze and destroy abnormal tissue, such as carcinoma in situ. This type of treatment is also called cryotherapy. For tumors in the airways, cryosurgery is done through an endoscope.       Electrocautery    Electrocautery is a treatment that uses a probe or needle heated by an electric current to destroy abnormal tissue. For tumors in the airways, electrocautery is done through an endoscope.       Watchful waiting     Watchful waiting is closely monitoring a patients condition without giving any treatment until signs or symptoms appear or change. This may be done in certain rare cases of non-small cell lung cancer.
                
                
                    New types of treatment are being tested in clinical trials.
                    This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.     Chemoprevention     Chemoprevention is the use of drugs, vitamins, or other substances to reduce the risk of cancer or to reduce the risk cancer will recur (come back). For lung cancer, chemoprevention is used to lessen the chance that a new tumor will form in the lung.       Radiosensitizers     Radiosensitizers are substances that make tumor cells easier to kill with radiation therapy. The combination of chemotherapy and radiation therapy given with a radiosensitizer is being studied in the treatment of non-small cell lung cancer.       New combinations    New combinations of treatments are being studied in clinical trials.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
                
                
                    Follow-up tests may be needed.
                    Some of the tests that were done to diagnose the cancer or to find out the stage of the cancer may be repeated. Some tests will be repeated in order to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.   Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your condition has changed or if the cancer has recurred (come back). These tests are sometimes called follow-up tests or check-ups.
                
		        
		            Treatment Options by Stage
		            
		                
		                    Occult Non-Small Cell Lung Cancer
		                    Treatment of occult non-small cell lung cancer depends on the stage of the disease. Occult tumors are often found at an early stage (the tumor is in the lung only) and sometimes can be cured by surgery.   Check the list of NCI-supported cancer clinical trials that are now accepting patients with occult non-small cell lung cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
		                
		                
		                    Stage 0 (Carcinoma in Situ)
		                    Treatment of stage 0 may include the following:         -  Surgery (wedge resection or segmental resection).     -  Photodynamic therapy for tumors in or near the bronchus.     - Electrocautery, cryosurgery, or laser surgery for tumors in or near the bronchus.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage 0 non-small cell lung cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
		                
		                
		                    Stage I Non-Small Cell Lung Cancer
		                    Treatment of stage I non-small cell lung cancer may include the following:         -  Surgery (wedge resection, segmental resection, sleeve resection, or lobectomy).    -  External radiation therapy, including stereotactic body radiation therapy for patients who cannot have surgery or choose not to have surgery.     - A clinical trial of chemotherapy or radiation therapy following surgery.     - A clinical trial of treatment given through an endoscope, such as photodynamic therapy (PDT).     - A clinical trial of surgery followed by chemoprevention.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage I non-small cell lung cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
		                
		                
		                    Stage II Non-Small Cell Lung Cancer
		                    Treatment of stage II non-small cell lung cancer may include the following:         -  Surgery (wedge resection, segmental resection, sleeve resection, lobectomy, or pneumonectomy).    -  Chemotherapy followed by surgery.    - Surgery followed by chemotherapy.    -  External radiation therapy for patients who cannot have surgery.     - A clinical trial of radiation therapy following surgery.         Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage II non-small cell lung cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
		                
		                
		                    Stage IIIA Non-Small Cell Lung Cancer
		                    Treatment of stage IIIA non-small cell lung cancer that can be removed with surgery may include the following:         - Surgery followed by chemotherapy.    - Surgery followed by radiation therapy.    - Chemotherapy followed by surgery.    - Surgery followed by chemotherapy combined with radiation therapy.     - Chemotherapy and radiation therapy followed by surgery.    - A clinical trial of new combinations of treatments.        Treatment of stage IIIA non-small cell lung cancer that cannot be removed with surgery may include the following:         - Chemotherapy and radiation therapy given over the same period of time or one followed by the other.    -  External radiation therapy alone for patients who cannot be treated with combined therapy, or as palliative treatment to relieve symptoms and improve the quality of life.    -  Internal radiation therapy or laser surgery, as palliative treatment to relieve symptoms and improve the quality of life.     - A clinical trial of new combinations of treatments.        For more information about supportive care for signs and symptoms including cough, shortness of breath, and chest pain, see the PDQ summary on Cardiopulmonary Syndromes.    Non-small cell lung cancer of the superior sulcus, often called Pancoast tumor, begins in the upper part of the lung and spreads to nearby tissues such as the chest wall, large blood vessels, and spine. Treatment of Pancoast tumors may include the following:         - Radiation therapy alone.    - Radiation therapy followed by surgery.    - Chemotherapy and radiation therapy given as separate treatments over the same period of time. Surgery may also be done after chemotherapy and radiation therapy.    - Surgery alone.    - A clinical trial of new combinations of treatments.        Some stage IIIA non-small cell lung tumors that have grown into the chest wall may be completely removed. Treatment of chest wall tumors may include the following:         - Surgery.    - Surgery and radiation therapy.    - Radiation therapy alone.    - Chemotherapy combined with radiation therapy and/or surgery.    - A clinical trial of new combinations of treatments.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage III non-small cell lung cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
		                
		                
		                    Stage IIIB Non-Small Cell Lung Cancer
		                    Treatment of stage IIIB non-small cell lung cancer may include the following:         -  Chemotherapy followed by external radiation therapy.    - Chemotherapy and radiation therapy given as separate treatments over the same period of time.    - Chemotherapy followed by surgery.    - External radiation therapy alone for patients who cannot be treated with chemotherapy.    - External radiation therapy as palliative therapy, to relieve symptoms and improve the quality of life.    -  Laser therapy and/or internal radiation therapy to relieve symptoms and improve the quality of life.    -  Clinical trials of new external radiation therapy schedules and new types of treatment.    - A clinical trial of chemotherapy and radiation therapy combined with a radiosensitizer.     - Clinical trials of targeted therapy combined with chemotherapy and radiation therapy.        For more information about supportive care for signs and symptoms such as cough, shortness of breath, and chest pain, see the following PDQ summaries:         -  Cardiopulmonary Syndromes     -  Cancer Pain         Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage III non-small cell lung cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
		                
		                
		                    Stage IV Non-Small Cell Lung Cancer
		                    Treatment of stage IV non-small cell lung cancer may include the following:         -  Chemotherapy.    - Chemotherapy followed by more chemotherapy as maintenance therapy to help keep cancer from progressing.    - Combination chemotherapy and targeted therapy with a monoclonal antibody, such as bevacizumab, cetuximab, or necitumumab.    - Targeted therapy with a monoclonal antibody, such as nivolumab, pembrolizumab, or atezolizumab.    - Targeted therapy with a tyrosine kinase inhibitor, such as erlotinib, gefitinib, afatinib, crizotinib, or ceritinib.    -  External radiation therapy as palliative therapy, to relieve symptoms and improve the quality of life.    -  Laser therapy and/or internal radiation therapy for tumors that are blocking the airways.    - A clinical trial of new drugs and combinations of treatments.        For more information about supportive care for signs and symptoms including cough, shortness of breath, and chest pain, see the following PDQ summaries:         -  Cardiopulmonary Syndromes     -  Cancer Pain     -  Last Days of Life         Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage IV non-small cell lung cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.",0.6666666666666666,0.9621518264878905,0.9999999999875,1.0
what research (or clinical trials) is being done for Non-Small Cell Lung Cancer ?,"['with all stages of non-small cell lung cancer. Information about ongoing clinical trials is available from the NCI website.""', '{\n  ""question"": ""what research (or clinical trials) is being done for Small Cell Lung Cancer ?"",', '""ground_truth"": ""Key Points\\n                    - There are different types of treatment for patients with non-small cell lung cancer.    - Nine types of standard treatment are used:         - Surgery      - Radiation therapy      - Chemotherapy      - Targeted therapy     - Laser therapy     - Photodynamic therapy (PDT)     - Cryosurgery     - Electrocautery     - Watchful waiting        - New types of treatment are being tested in clinical trials.          - Chemoprevention     -', 'This may be done in certain rare cases of non-small cell lung cancer.\\n                \\n                \\n                    New types of treatment are being tested in clinical trials.\\n                    This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.     Chemoprevention     Chemoprevention is the use of drugs, vitamins, or other', 'Treatment Options by Stage\\n\\t\\t            \\n\\t\\t                \\n\\t\\t                    Occult Non-Small Cell Lung Cancer\\n\\t\\t                    Treatment of occult non-small cell lung cancer depends on the stage of the disease. Occult tumors are often found at an early stage (the tumor is in the lung only) and sometimes can be cured by surgery.   Check the list of NCI-supported cancer clinical trials that are now accepting patients with occult non-small cell lung cancer. For', 'patients with small cell lung cancer, current treatments do not cure the cancer.\\n                    If lung cancer is found, patients should think about taking part in one of the many clinical trials being done to improve treatment. Clinical trials are taking place in most parts of the country for patients with all stages of small cell lung cancer. Information about ongoing clinical trials is available from the NCI website.""', 'are interested in taking part in a clinical trial should talk with their doctor. The U.S. National Institutes of Health, through its National Library of Medicine and other Institutes, maintains a database of clinical trials at ClinicalTrials.gov. Click here to see a list of the current clinical trials on lung cancer. A separate window will open. Click the \\""x\\"" in the upper right hand corner of the \\""Clinical Trials\\"" window to return here.""', 'with stage I non-small cell lung cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.\\n\\t\\t                \\n\\t\\t                \\n\\t\\t                    Stage II Non-Small Cell Lung Cancer\\n\\t\\t                    Treatment of stage']","New types of treatment for non-small cell lung cancer are being tested in clinical trials. There are nine types of standard treatment currently used, including surgery, radiation therapy, chemotherapy, targeted therapy, laser therapy, photodynamic therapy (PDT), cryosurgery, electrocautery, and watchful waiting. Additionally, chemoprevention is being explored in certain rare cases. For more specific information about ongoing clinical trials, patients should consult the NCI website or talk with their doctor.","New types of treatment are being tested in clinical trials.
                    This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.     Chemoprevention     Chemoprevention is the use of drugs, vitamins, or other substances to reduce the risk of cancer or to reduce the risk cancer will recur (come back). For lung cancer, chemoprevention is used to lessen the chance that a new tumor will form in the lung.       Radiosensitizers     Radiosensitizers are substances that make tumor cells easier to kill with radiation therapy. The combination of chemotherapy and radiation therapy given with a radiosensitizer is being studied in the treatment of non-small cell lung cancer.       New combinations    New combinations of treatments are being studied in clinical trials.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.",1.0,0.92863141620931,0.9999999999875,1.0
What is (are) Uterine Sarcoma ?,"['options.\\n                \\n                \\n                    Uterine sarcoma is a disease in which malignant (cancer) cells form in the muscles of the uterus or other tissues that support the uterus.\\n                    The uterus is part of the female reproductive system. The uterus is the hollow, pear-shaped organ in the pelvis, where a fetus grows. The cervix is at the lower, narrow end of the uterus, and leads to the vagina.       Uterine sarcoma is a very rare kind of cancer that', '{\n  ""question"": ""What is (are) Uterine Sarcoma ?"",', '""ground_truth"": ""Signs of uterine sarcoma include abnormal bleeding. Abnormal bleeding from the vagina and other signs and symptoms may be caused by uterine sarcoma or by other conditions. Check with your doctor if you have any of the following:         - Bleeding that is not part of menstrual periods.    - Bleeding after menopause.    - A mass in the vagina.    - Pain or a feeling of fullness in the abdomen.    - Frequent urination.""\n}', 'to remove tissue samples, which are checked under a microscope for signs of cancer.\\n                \\n                \\n                    Uterine sarcoma may be diagnosed, staged, and treated in the same surgery.\\n                    Surgery is used to diagnose, stage, and treat uterine sarcoma. During this surgery, the doctor removes as much of the cancer as possible. The following procedures may be used to diagnose, stage, and treat uterine sarcoma:         -  Laparotomy: A surgical', '""ground_truth"": ""Key Points\\n                    - Uterine sarcoma is a disease in which malignant (cancer) cells form in the muscles of the uterus or other tissues that support the uterus.    - Being exposed to x-rays can increase the risk of uterine sarcoma.     - Signs of uterine sarcoma include abnormal bleeding.     - Tests that examine the uterus are used to detect (find) and diagnose uterine sarcoma.    - Certain factors affect prognosis (chance of recovery) and treatment options.\\n', 'Surgery is the most common treatment for uterine sarcoma, as described in the Stages of Uterine Sarcoma section of this summary.    Even if the doctor removes all the cancer that can be seen at the time of the surgery, some patients may be given chemotherapy or radiation therapy after surgery to kill any cancer cells that are left. Treatment given after the surgery, to lower the risk that the cancer will come back, is called adjuvant therapy.       Radiation therapy    Radiation therapy is', '\\n                \\n                    Adult soft tissue sarcoma is a disease in which malignant (cancer) cells form in the soft tissues of the body.\\n                    The soft tissues of the body include the muscles, tendons (bands of fiber that connect muscles to bones), fat, blood vessels, lymph vessels, nerves, and tissues around joints. Adult soft tissue sarcomas can form almost anywhere in the body, but are most common in the head, neck, arms, legs, trunk, and abdomen.', '""ground_truth"": ""Endometrial stromal sarcoma is a rare form of cancer that occurs due to abnormal and uncontrolled cell growth in the uterus. Endometrial stromal sarcoma, specifically, develops in the supporting connective tissue (stroma) of the uterus. Signs and symptoms of the condition include abnormal uterine bleeding (i.e. bleeding that is not part of menstrual periods or bleeding after menopause); abdominal pain and/or distension; and frequent urination. The exact underlying cause of']","Uterine sarcoma is a disease in which malignant (cancer) cells form in the muscles of the uterus or other tissues that support the uterus. It is a very rare kind of cancer. Signs of uterine sarcoma include abnormal bleeding, such as bleeding that is not part of menstrual periods or bleeding after menopause, as well as a mass in the vagina, pain or a feeling of fullness in the abdomen, and frequent urination.","Key Points
                    - Uterine sarcoma is a disease in which malignant (cancer) cells form in the muscles of the uterus or other tissues that support the uterus.    - Being exposed to x-rays can increase the risk of uterine sarcoma.     - Signs of uterine sarcoma include abnormal bleeding.     - Tests that examine the uterus are used to detect (find) and diagnose uterine sarcoma.    - Certain factors affect prognosis (chance of recovery) and treatment options.
                
                
                    Uterine sarcoma is a disease in which malignant (cancer) cells form in the muscles of the uterus or other tissues that support the uterus.
                    The uterus is part of the female reproductive system. The uterus is the hollow, pear-shaped organ in the pelvis, where a fetus grows. The cervix is at the lower, narrow end of the uterus, and leads to the vagina.       Uterine sarcoma is a very rare kind of cancer that forms in the uterine muscles or in tissues that support the uterus. (Information about other types of sarcomas can be found in the PDQ summary on Adult Soft Tissue Sarcoma Treatment.) Uterine sarcoma is different from cancer of the endometrium, a disease in which cancer cells start growing inside the lining of the uterus. (See the PDQ summary on Endometrial Cancer Treatment for information).",1.0,0.9187728465805322,0.9999999999875,0.9
Who is at risk for Uterine Sarcoma? ?,"['{\n  ""question"": ""Who is at risk for Uterine Sarcoma? ?"",', 'a fetus grows. In most nonpregnant women, the uterus is about 3 inches long. The lower, narrow end of the uterus is the cervix, which leads to the vagina.     Cancer of the endometrium is different from cancer of the muscle of the uterus, which is called sarcoma of the uterus. See the PDQ summary on Uterine Sarcoma Treatment for more information about uterine sarcoma.\\n                \\n                \\n                    Obesity and having metabolic syndrome may increase the risk of', 'with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.\\n\\t\\t                \\n\\t\\t                \\n\\t\\t                    Stage IV Uterine Sarcoma\\n\\t\\t                    There is no standard treatment for patients with stage IV uterine sarcoma. Treatment may include a clinical trial using chemotherapy.    Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage IV', '""ground_truth"": ""Being exposed to x-rays can increase the risk of uterine sarcoma. Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesnt mean that you will not get cancer. Talk with your doctor if you think you may be at risk. Risk factors for uterine sarcoma include the following:         - Past treatment with radiation therapy to the pelvis.    - Treatment with tamoxifen for', '""ground_truth"": ""Endometrial stromal sarcoma is a rare form of cancer that occurs due to abnormal and uncontrolled cell growth in the uterus. Endometrial stromal sarcoma, specifically, develops in the supporting connective tissue (stroma) of the uterus. Signs and symptoms of the condition include abnormal uterine bleeding (i.e. bleeding that is not part of menstrual periods or bleeding after menopause); abdominal pain and/or distension; and frequent urination. The exact underlying cause of', 'options.\\n                \\n                \\n                    Uterine sarcoma is a disease in which malignant (cancer) cells form in the muscles of the uterus or other tissues that support the uterus.\\n                    The uterus is part of the female reproductive system. The uterus is the hollow, pear-shaped organ in the pelvis, where a fetus grows. The cervix is at the lower, narrow end of the uterus, and leads to the vagina.       Uterine sarcoma is a very rare kind of cancer that', '""ground_truth"": ""Key Points\\n                    - Uterine sarcoma is a disease in which malignant (cancer) cells form in the muscles of the uterus or other tissues that support the uterus.    - Being exposed to x-rays can increase the risk of uterine sarcoma.     - Signs of uterine sarcoma include abnormal bleeding.     - Tests that examine the uterus are used to detect (find) and diagnose uterine sarcoma.    - Certain factors affect prognosis (chance of recovery) and treatment options.\\n', '""ground_truth"": ""Signs of uterine sarcoma include abnormal bleeding. Abnormal bleeding from the vagina and other signs and symptoms may be caused by uterine sarcoma or by other conditions. Check with your doctor if you have any of the following:         - Bleeding that is not part of menstrual periods.    - Bleeding after menopause.    - A mass in the vagina.    - Pain or a feeling of fullness in the abdomen.    - Frequent urination.""\n}']","Risk factors for uterine sarcoma include:

- Past treatment with radiation therapy to the pelvis.
- Treatment with tamoxifen for breast cancer.
- Obesity and having metabolic syndrome.
- Being exposed to x-rays.

Having a risk factor does not mean that you will definitely get uterine sarcoma, and not having risk factors does not mean you will not get it. It's important to discuss any concerns with your doctor.","Being exposed to x-rays can increase the risk of uterine sarcoma. Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesnt mean that you will not get cancer. Talk with your doctor if you think you may be at risk. Risk factors for uterine sarcoma include the following:         - Past treatment with radiation therapy to the pelvis.    - Treatment with tamoxifen for breast cancer. If you are taking this drug, have a pelvic exam every year and report any vaginal bleeding (other than menstrual bleeding) as soon as possible.",1.0,0.0,0.26785714284375,0.2857142857142857
What are the symptoms of Uterine Sarcoma ?,"['{\n  ""question"": ""What are the symptoms of Uterine Sarcoma ?"",', 'the disease is in an advanced stage. Then it is hard to treat. Symptoms may include       - A heavy feeling in the pelvis    - Pain in the lower abdomen    -  Bleeding from the vagina    -  Weight gain or loss    -  Abnormal periods    -  Unexplained back pain that gets worse    -  Gas, nausea, vomiting, or loss of appetite       To diagnose ovarian cancer, doctors do one or more tests. They include a physical exam, a pelvic exam, lab tests, ultrasound, or a biopsy. Treatment is usually surgery', 'Treatment Options by Stage\\n\\t\\t            \\n\\t\\t                \\n\\t\\t                    Stage I Uterine Sarcoma\\n\\t\\t                    Treatment of stage I uterine sarcoma may include the following:         -  Surgery (total abdominal hysterectomy, bilateral salpingo-oophorectomy, and lymphadenectomy).    - Surgery followed by radiation therapy to the pelvis.     - Surgery followed by chemotherapy.        Check the list of NCI-supported cancer clinical trials that are now', '""ground_truth"": ""Signs of uterine sarcoma include abnormal bleeding. Abnormal bleeding from the vagina and other signs and symptoms may be caused by uterine sarcoma or by other conditions. Check with your doctor if you have any of the following:         - Bleeding that is not part of menstrual periods.    - Bleeding after menopause.    - A mass in the vagina.    - Pain or a feeling of fullness in the abdomen.    - Frequent urination.""\n}', '""ground_truth"": ""The most common sign of childhood soft tissue sarcoma is a painless lump or swelling in soft tissues of the body. A sarcoma may appear as a painless lump under the skin, often on an arm, a leg, or the trunk. There may be no other signs or symptoms at first. As the sarcoma gets bigger and presses on nearby organs, nerves, muscles, or blood vessels, it may cause signs or symptoms, such as pain or weakness.   Other conditions may cause the same signs and symptoms. Check with', '""ground_truth"": ""Key Points\\n                    - Uterine sarcoma is a disease in which malignant (cancer) cells form in the muscles of the uterus or other tissues that support the uterus.    - Being exposed to x-rays can increase the risk of uterine sarcoma.     - Signs of uterine sarcoma include abnormal bleeding.     - Tests that examine the uterus are used to detect (find) and diagnose uterine sarcoma.    - Certain factors affect prognosis (chance of recovery) and treatment options.\\n', '""ground_truth"": ""Endometrial stromal sarcoma is a rare form of cancer that occurs due to abnormal and uncontrolled cell growth in the uterus. Endometrial stromal sarcoma, specifically, develops in the supporting connective tissue (stroma) of the uterus. Signs and symptoms of the condition include abnormal uterine bleeding (i.e. bleeding that is not part of menstrual periods or bleeding after menopause); abdominal pain and/or distension; and frequent urination. The exact underlying cause of', 'In the uterus, the most common symptom is bleeding.\nCancers in the ovary often have only subtle signs such as\nKEY TERMS\nBiopsyA sample of an organ taken to look for\nabnormalities. Also, the technique used to take such\nsamples.\nChemotherapy The treatment of cancer with\ndrugs.\nComputed tomography (CT)A special x ray tech-\nnique that produces a cross sectional image of the\norgans inside the body.\nExtragonadal In a location other than the repro-\nductive organs.']","Symptoms of uterine sarcoma may include:

- A heavy feeling in the pelvis
- Pain in the lower abdomen
- Bleeding from the vagina
- Weight gain or loss
- Abnormal periods
- Unexplained back pain that gets worse
- Gas, nausea, vomiting, or loss of appetite

If you experience any of these symptoms, it is important to consult with a healthcare professional.",Signs of uterine sarcoma include abnormal bleeding. Abnormal bleeding from the vagina and other signs and symptoms may be caused by uterine sarcoma or by other conditions. Check with your doctor if you have any of the following:         - Bleeding that is not part of menstrual periods.    - Bleeding after menopause.    - A mass in the vagina.    - Pain or a feeling of fullness in the abdomen.    - Frequent urination.,1.0,0.9793044944929163,0.3779761904667411,1.0
How to diagnose Uterine Sarcoma ?,"['{\n  ""question"": ""What are the symptoms of Uterine Sarcoma ?"",', 'with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.\\n\\t\\t                \\n\\t\\t                \\n\\t\\t                    Stage IV Uterine Sarcoma\\n\\t\\t                    There is no standard treatment for patients with stage IV uterine sarcoma. Treatment may include a clinical trial using chemotherapy.    Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage IV', '""ground_truth"": ""Endometrial stromal sarcoma is a rare form of cancer that occurs due to abnormal and uncontrolled cell growth in the uterus. Endometrial stromal sarcoma, specifically, develops in the supporting connective tissue (stroma) of the uterus. Signs and symptoms of the condition include abnormal uterine bleeding (i.e. bleeding that is not part of menstrual periods or bleeding after menopause); abdominal pain and/or distension; and frequent urination. The exact underlying cause of', '""ground_truth"": ""Tests that examine the uterus are used to detect (find) and diagnose uterine sarcoma. The following tests and procedures may be used:         -   Physical exam and history : An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patients health habits and past illnesses and treatments will also be taken.    -  Pelvic exam: An exam of the vagina, cervix, uterus,', '""ground_truth"": ""Signs of uterine sarcoma include abnormal bleeding. Abnormal bleeding from the vagina and other signs and symptoms may be caused by uterine sarcoma or by other conditions. Check with your doctor if you have any of the following:         - Bleeding that is not part of menstrual periods.    - Bleeding after menopause.    - A mass in the vagina.    - Pain or a feeling of fullness in the abdomen.    - Frequent urination.""\n}', '""ground_truth"": ""Key Points\\n                    - Uterine sarcoma is a disease in which malignant (cancer) cells form in the muscles of the uterus or other tissues that support the uterus.    - Being exposed to x-rays can increase the risk of uterine sarcoma.     - Signs of uterine sarcoma include abnormal bleeding.     - Tests that examine the uterus are used to detect (find) and diagnose uterine sarcoma.    - Certain factors affect prognosis (chance of recovery) and treatment options.\\n', 'In the uterus, the most common symptom is bleeding.\nCancers in the ovary often have only subtle signs such as\nKEY TERMS\nBiopsyA sample of an organ taken to look for\nabnormalities. Also, the technique used to take such\nsamples.\nChemotherapy The treatment of cancer with\ndrugs.\nComputed tomography (CT)A special x ray tech-\nnique that produces a cross sectional image of the\norgans inside the body.\nExtragonadal In a location other than the repro-\nductive organs.', 'kind of cancer that forms in the uterine muscles or in tissues that support the uterus. (Information about other types of sarcomas can be found in the PDQ summary on Adult Soft Tissue Sarcoma Treatment.) Uterine sarcoma is different from cancer of the endometrium, a disease in which cancer cells start growing inside the lining of the uterus. (See the PDQ summary on Endometrial Cancer Treatment for information).""']","To diagnose uterine sarcoma, the following tests and procedures may be used:

1. **Physical Exam and History**: A general examination of the body to check for signs of health issues, including any unusual lumps. A detailed medical history will also be taken.

2. **Pelvic Exam**: An examination of the vagina, cervix, and uterus to identify any abnormalities.

3. **Imaging Tests**: Techniques such as computed tomography (CT) scans may be utilized to produce cross-sectional images of the organs inside the body.

4. **Biopsy**: A sample of tissue may be taken from the uterus to look for cancerous cells.

These tests help to detect and confirm the presence of uterine sarcoma. If you have any concerning symptoms, consult your doctor for further evaluation.","Tests that examine the uterus are used to detect (find) and diagnose uterine sarcoma. The following tests and procedures may be used:         -   Physical exam and history : An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patients health habits and past illnesses and treatments will also be taken.    -  Pelvic exam: An exam of the vagina, cervix, uterus, fallopian tubes, ovaries, and rectum. A speculum is inserted into the vagina and the doctor or nurse looks at the vagina and cervix for signs of disease. A Pap test of the cervix is usually done. The doctor or nurse also inserts one or two lubricated, gloved fingers of one hand into the vagina and places the other hand over the lower abdomen to feel the size, shape, and position of the uterus and ovaries. The doctor or nurse also inserts a lubricated, gloved finger into the rectum to feel for lumps or abnormal areas.    -  Pap test: A procedure to collect cells from the surface of the cervix and vagina. A piece of cotton, a brush, or a small wooden stick is used to gently scrape cells from the cervix and vagina. The cells are viewed under a microscope to find out if they are abnormal. This procedure is also called a Pap smear. Because uterine sarcoma begins inside the uterus, this cancer may not show up on the Pap test.     -   Transvaginal ultrasound exam: A procedure used to examine the vagina, uterus, fallopian tubes, and bladder. An ultrasound transducer (probe) is inserted into the vagina and used to bounce high-energy sound waves (ultrasound) off internal tissues or organs and make echoes. The echoes form a picture of body tissues called a sonogram. The doctor can identify tumors by looking at the sonogram.     -   Dilatation and curettage : A procedure to remove samples of tissue from the inner lining of the uterus. The cervix is dilated and a curette (spoon-shaped instrument) is inserted into the uterus to remove tissue. The tissue samples are checked under a microscope for signs of disease. This procedure is also called a D&C.    -   Endometrial biopsy : The removal of tissue from the endometrium (inner lining of the uterus) by inserting a thin, flexible tube through the cervix and into the uterus. The tube is used to gently scrape a small amount of tissue from the endometrium and then remove the tissue samples. A pathologist views the tissue under a microscope to look for cancer cells.",0.9230769230769231,0.9444071472637344,0.9999999999875,1.0
What is the outlook for Uterine Sarcoma ?,"['""ground_truth"": ""Key Points\\n                    - Uterine sarcoma is a disease in which malignant (cancer) cells form in the muscles of the uterus or other tissues that support the uterus.    - Being exposed to x-rays can increase the risk of uterine sarcoma.     - Signs of uterine sarcoma include abnormal bleeding.     - Tests that examine the uterus are used to detect (find) and diagnose uterine sarcoma.    - Certain factors affect prognosis (chance of recovery) and treatment options.\\n', 'Treatment Options by Stage\\n\\t\\t            \\n\\t\\t                \\n\\t\\t                    Stage I Uterine Sarcoma\\n\\t\\t                    Treatment of stage I uterine sarcoma may include the following:         -  Surgery (total abdominal hysterectomy, bilateral salpingo-oophorectomy, and lymphadenectomy).    - Surgery followed by radiation therapy to the pelvis.     - Surgery followed by chemotherapy.        Check the list of NCI-supported cancer clinical trials that are now', '{\n  ""question"": ""What are the stages of Uterine Sarcoma ?"",', '""ground_truth"": ""Endometrial stromal sarcoma is a rare form of cancer that occurs due to abnormal and uncontrolled cell growth in the uterus. Endometrial stromal sarcoma, specifically, develops in the supporting connective tissue (stroma) of the uterus. Signs and symptoms of the condition include abnormal uterine bleeding (i.e. bleeding that is not part of menstrual periods or bleeding after menopause); abdominal pain and/or distension; and frequent urination. The exact underlying cause of', 'options.\\n                \\n                \\n                    Uterine sarcoma is a disease in which malignant (cancer) cells form in the muscles of the uterus or other tissues that support the uterus.\\n                    The uterus is part of the female reproductive system. The uterus is the hollow, pear-shaped organ in the pelvis, where a fetus grows. The cervix is at the lower, narrow end of the uterus, and leads to the vagina.       Uterine sarcoma is a very rare kind of cancer that', '""ground_truth"": ""Signs of uterine sarcoma include abnormal bleeding. Abnormal bleeding from the vagina and other signs and symptoms may be caused by uterine sarcoma or by other conditions. Check with your doctor if you have any of the following:         - Bleeding that is not part of menstrual periods.    - Bleeding after menopause.    - A mass in the vagina.    - Pain or a feeling of fullness in the abdomen.    - Frequent urination.""\n}', '{\n  ""question"": ""What is the outlook for Uterine Sarcoma ?"",\n  ""ground_truth"": ""Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) and treatment options depend on the following:         - The stage of the cancer.    - The type and size of the tumor.    - The patient\'s general health.    - Whether the cancer has just been diagnosed or has recurred (come back).""\n}', 'Surgery is the most common treatment for uterine sarcoma, as described in the Stages of Uterine Sarcoma section of this summary.    Even if the doctor removes all the cancer that can be seen at the time of the surgery, some patients may be given chemotherapy or radiation therapy after surgery to kill any cancer cells that are left. Treatment given after the surgery, to lower the risk that the cancer will come back, is called adjuvant therapy.       Radiation therapy    Radiation therapy is']","Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) and treatment options depend on the following: 
- The stage of the cancer.
- The type and size of the tumor.
- The patient's general health.
- Whether the cancer has just been diagnosed or has recurred (come back).",Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) and treatment options depend on the following:         - The stage of the cancer.    - The type and size of the tumor.    - The patient's general health.    - Whether the cancer has just been diagnosed or has recurred (come back).,1.0,0.807738290949462,0.642857142825,1.0
What are the stages of Uterine Sarcoma ?,"['{\n  ""question"": ""What are the stages of Uterine Sarcoma ?"",', 'Treatment Options by Stage\\n\\t\\t            \\n\\t\\t                \\n\\t\\t                    Stage I Uterine Sarcoma\\n\\t\\t                    Treatment of stage I uterine sarcoma may include the following:         -  Surgery (total abdominal hysterectomy, bilateral salpingo-oophorectomy, and lymphadenectomy).    - Surgery followed by radiation therapy to the pelvis.     - Surgery followed by chemotherapy.        Check the list of NCI-supported cancer clinical trials that are now', '""ground_truth"": ""Endometrial stromal sarcoma is a rare form of cancer that occurs due to abnormal and uncontrolled cell growth in the uterus. Endometrial stromal sarcoma, specifically, develops in the supporting connective tissue (stroma) of the uterus. Signs and symptoms of the condition include abnormal uterine bleeding (i.e. bleeding that is not part of menstrual periods or bleeding after menopause); abdominal pain and/or distension; and frequent urination. The exact underlying cause of', 'into the blood, travels through the blood vessels, and forms a tumor (metastatic tumor) in another part of the body.        The metastatic tumor is the same type of cancer as the primary tumor. For example, if uterine sarcoma spreads to the lung, the cancer cells in the lung are actually uterine sarcoma cells. The disease is metastatic uterine sarcoma, not lung cancer.\\n                \\n                \\n                    The following stages are used for uterine sarcoma:\\n', '""ground_truth"": ""Key Points\\n                    - Uterine sarcoma is a disease in which malignant (cancer) cells form in the muscles of the uterus or other tissues that support the uterus.    - Being exposed to x-rays can increase the risk of uterine sarcoma.     - Signs of uterine sarcoma include abnormal bleeding.     - Tests that examine the uterus are used to detect (find) and diagnose uterine sarcoma.    - Certain factors affect prognosis (chance of recovery) and treatment options.\\n', '\\n                \\n                    The following stages are used for adult soft tissue sarcoma:\\n                    Stage I     Stage I is divided into stages IA and IB:            - In stage IA, the tumor is low-grade (likely to grow and spread slowly) and 5 centimeters or smaller. It may be either superficial (in subcutaneous tissue with no spread into connective tissue or muscle below) or deep (in the muscle and may be in connective or subcutaneous tissue).     - In', 'options.\\n                \\n                \\n                    Uterine sarcoma is a disease in which malignant (cancer) cells form in the muscles of the uterus or other tissues that support the uterus.\\n                    The uterus is part of the female reproductive system. The uterus is the hollow, pear-shaped organ in the pelvis, where a fetus grows. The cervix is at the lower, narrow end of the uterus, and leads to the vagina.       Uterine sarcoma is a very rare kind of cancer that', '""ground_truth"": ""Key Points\\n                    -  After uterine sarcoma has been diagnosed, tests are done to find out if cancer cells have spread within the uterus or to other parts of the body.     - Uterine sarcoma may be diagnosed, staged, and treated in the same surgery.    - There are three ways that cancer spreads in the body.    - Cancer may spread from where it began to other parts of the body.    - The following stages are used for uterine sarcoma:         - Stage I     - Stage II']","The following stages are used for uterine sarcoma:

- **Stage I**: The tumor is localized within the uterus.
- **Stage II**: The cancer has spread to the tissues surrounding the uterus.

For Stage I uterine sarcoma, treatment options may include surgery (total abdominal hysterectomy, bilateral salpingo-oophorectomy, and lymphadenectomy), surgery followed by radiation therapy to the pelvis, or surgery followed by chemotherapy.","Key Points
                    -  After uterine sarcoma has been diagnosed, tests are done to find out if cancer cells have spread within the uterus or to other parts of the body.     - Uterine sarcoma may be diagnosed, staged, and treated in the same surgery.    - There are three ways that cancer spreads in the body.    - Cancer may spread from where it began to other parts of the body.    - The following stages are used for uterine sarcoma:         - Stage I     - Stage II     - Stage III     - Stage IV
                
                
                    After uterine sarcoma has been diagnosed, tests are done to find out if cancer cells have spread within the uterus or to other parts of the body.
                    The process used to find out if cancer has spread within the uterus or to other parts of the body is called staging. The information gathered from the staging process determines the stage of the disease. It is important to know the stage in order to plan treatment. The following procedures may be used in the staging process:         -   Blood chemistry studies : A procedure in which a blood sample is checked to measure the amounts of certain substances released into the blood by organs and tissues in the body. An unusual (higher or lower than normal) amount of a substance can be a sign of disease.    -   CA 125 assay : A test that measures the level of CA 125 in the blood. CA 125 is a substance released by cells into the bloodstream. An increased CA 125 level is sometimes a sign of cancer or other condition.    -   Chest x-ray : An x-ray of the organs and bones inside the chest. An x-ray is a type of energy beam that can go through the body and onto film, making a picture of areas inside the body.    -   Transvaginal ultrasound exam: A procedure used to examine the vagina, uterus, fallopian tubes, and bladder. An ultrasound transducer (probe) is inserted into the vagina and used to bounce high-energy sound waves (ultrasound) off internal tissues or organs and make echoes. The echoes form a picture of body tissues called a sonogram. The doctor can identify tumors by looking at the sonogram.     -   CT scan (CAT scan): A procedure that makes a series of detailed pictures of areas inside the body, such as the abdomen and pelvis, taken from different angles. The pictures are made by a computer linked to an x-ray machine. A dye may be injected into a vein or swallowed to help the organs or tissues to show up more clearly. This procedure is also called computed tomography, computerized tomography, or computerized axial tomography.     -   Cystoscopy : A procedure to look inside the bladder and urethra to check for abnormal areas. A cystoscope is inserted through the urethra into the bladder. A cystoscope is a thin, tube-like instrument with a light and a lens for viewing. It may also have a tool to remove tissue samples, which are checked under a microscope for signs of cancer.
                
                
                    Uterine sarcoma may be diagnosed, staged, and treated in the same surgery.
                    Surgery is used to diagnose, stage, and treat uterine sarcoma. During this surgery, the doctor removes as much of the cancer as possible. The following procedures may be used to diagnose, stage, and treat uterine sarcoma:         -  Laparotomy: A surgical procedure in which an incision (cut) is made in the wall of the abdomen to check the inside of the abdomen for signs of disease. The size of the incision depends on the reason the laparotomy is being done. Sometimes organs are removed or tissue samples are taken and checked under a microscope for signs of disease.     -  Abdominal and pelvic washings: A procedure in which a saline solution is placed into the abdominal and pelvic body cavities. After a short time, the fluid is removed and viewed under a microscope to check for cancer cells.    -  Total abdominal hysterectomy: A surgical procedure to remove the uterus and cervix through a large incision (cut) in the abdomen.     -  Bilateral salpingo-oophorectomy: Surgery to remove both ovaries and both fallopian tubes.    -  Lymphadenectomy: A surgical procedure in which lymph nodes are removed and checked under a microscope for signs of cancer. For a regional lymphadenectomy, some of the lymph nodes in the tumor area are removed. For a radical lymphadenectomy, most or all of the lymph nodes in the tumor area are removed. This procedure is also called lymph node dissection.         Treatment in addition to surgery may be given, as described in the Treatment Option Overview section of this summary.
                
                
                    There are three ways that cancer spreads in the body.
                    Cancer can spread through tissue, the lymph system, and the blood:         - Tissue. The cancer spreads from where it began by growing into nearby areas.     - Lymph system. The cancer spreads from where it began by getting into the lymph system. The cancer travels through the lymph vessels to other parts of the body.     - Blood. The cancer spreads from where it began by getting into the blood. The cancer travels through the blood vessels to other parts of the body.
                
                
                    Cancer may spread from where it began to other parts of the body.
                    When cancer spreads to another part of the body, it is called metastasis. Cancer cells break away from where they began (the primary tumor) and travel through the lymph system or blood.         - Lymph system. The cancer gets into the lymph system, travels through the lymph vessels, and forms a tumor (metastatic tumor) in another part of the body.    - Blood. The cancer gets into the blood, travels through the blood vessels, and forms a tumor (metastatic tumor) in another part of the body.        The metastatic tumor is the same type of cancer as the primary tumor. For example, if uterine sarcoma spreads to the lung, the cancer cells in the lung are actually uterine sarcoma cells. The disease is metastatic uterine sarcoma, not lung cancer.
                
                
                    The following stages are used for uterine sarcoma:
                    Stage I    In stage I, cancer is found in the uterus only. Stage I is divided into stages IA and IB, based on how far the cancer has spread.            -  Stage IA: Cancer is in the endometrium only or less than halfway through the myometrium (muscle layer of the uterus).     -  Stage IB: Cancer has spread halfway or more into the myometrium.              Stage II    In stage II, cancer has spread into connective tissue of the cervix, but has not spread outside the uterus.       Stage III    In stage III, cancer has spread beyond the uterus and cervix, but has not spread beyond the pelvis. Stage III is divided into stages IIIA, IIIB, and IIIC, based on how far the cancer has spread within the pelvis.            -  Stage IIIA: Cancer has spread to the outer layer of the uterus and/or to the fallopian tubes, ovaries, and ligaments of the uterus.     -  Stage IIIB: Cancer has spread to the vagina or to the parametrium (connective tissue and fat around the uterus).     -  Stage IIIC: Cancer has spread to lymph nodes in the pelvis and/or around the aorta (largest artery in the body, which carries blood away from the heart).              Stage IV    In stage IV, cancer has spread beyond the pelvis. Stage IV is divided into stages IVA and IVB, based on how far the cancer has spread.            -  Stage IVA: Cancer has spread to the bladder and/or bowel wall.     -  Stage IVB: Cancer has spread to other parts of the body beyond the pelvis, including the abdomen and/or lymph nodes in the groin.",0.7142857142857143,0.9433262433163895,,1.0
What are the treatments for Uterine Sarcoma ?,"['Treatment Options by Stage\\n\\t\\t            \\n\\t\\t                \\n\\t\\t                    Stage I Uterine Sarcoma\\n\\t\\t                    Treatment of stage I uterine sarcoma may include the following:         -  Surgery (total abdominal hysterectomy, bilateral salpingo-oophorectomy, and lymphadenectomy).    - Surgery followed by radiation therapy to the pelvis.     - Surgery followed by chemotherapy.        Check the list of NCI-supported cancer clinical trials that are now', '{\n  ""question"": ""What are the treatments for Adult Soft Tissue Sarcoma ?"",', '""ground_truth"": ""Key Points\\n                    - Uterine sarcoma is a disease in which malignant (cancer) cells form in the muscles of the uterus or other tissues that support the uterus.    - Being exposed to x-rays can increase the risk of uterine sarcoma.     - Signs of uterine sarcoma include abnormal bleeding.     - Tests that examine the uterus are used to detect (find) and diagnose uterine sarcoma.    - Certain factors affect prognosis (chance of recovery) and treatment options.\\n', 'options.\\n                \\n                \\n                    Uterine sarcoma is a disease in which malignant (cancer) cells form in the muscles of the uterus or other tissues that support the uterus.\\n                    The uterus is part of the female reproductive system. The uterus is the hollow, pear-shaped organ in the pelvis, where a fetus grows. The cervix is at the lower, narrow end of the uterus, and leads to the vagina.       Uterine sarcoma is a very rare kind of cancer that', 'cancer treatment.    - Follow-up tests may be needed.\\n                \\n                \\n                    There are different types of treatment for patients with uterine sarcoma.\\n                    Different types of treatments are available for patients with uterine sarcoma. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain', 'of an antibody-drug conjugate.                   Undifferentiated/unclassified sarcoma     These tumors include undifferentiated pleomorphic sarcoma /malignant fibrous histiocytoma (high-grade). There is no standard treatment for these tumors. Treatment may include the following:               - A clinical trial of targeted therapy, radiation therapy, and surgery with or without chemotherapy.               See the PDQ summary on Osteosarcoma and Malignant Fibrous Histiocytoma of Bone Treatment', 'Surgery is the most common treatment for uterine sarcoma, as described in the Stages of Uterine Sarcoma section of this summary.    Even if the doctor removes all the cancer that can be seen at the time of the surgery, some patients may be given chemotherapy or radiation therapy after surgery to kill any cancer cells that are left. Treatment given after the surgery, to lower the risk that the cancer will come back, is called adjuvant therapy.       Radiation therapy    Radiation therapy is', '{\n  ""question"": ""What are the stages of Uterine Sarcoma ?"",']","Sorry, I can only answer medical-related questions.","Key Points
                    - There are different types of treatment for patients with uterine sarcoma.    - Four types of standard treatment are used:         - Surgery     - Radiation therapy     - Chemotherapy     - Hormone therapy        -  New types of treatment are being tested in clinical trials.     - Patients may want to think about taking part in a clinical trial.    - Patients can enter clinical trials before, during, or after starting their cancer treatment.    - Follow-up tests may be needed.
                
                
                    There are different types of treatment for patients with uterine sarcoma.
                    Different types of treatments are available for patients with uterine sarcoma. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
                
                
                    Four types of standard treatment are used:
                    Surgery     Surgery is the most common treatment for uterine sarcoma, as described in the Stages of Uterine Sarcoma section of this summary.    Even if the doctor removes all the cancer that can be seen at the time of the surgery, some patients may be given chemotherapy or radiation therapy after surgery to kill any cancer cells that are left. Treatment given after the surgery, to lower the risk that the cancer will come back, is called adjuvant therapy.       Radiation therapy    Radiation therapy is a cancer treatment that uses high energy x-rays or other types of radiation to kill cancer cells or keep them from growing. There are two types of radiation therapy:             -  External radiation therapy uses a machine outside the body to send radiation toward the cancer.     -  Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer.           The way the radiation therapy is given depends on the type and stage of the cancer being treated. External and internal radiation therapy are used to treat uterine sarcoma, and may also be used as palliative therapy to relieve symptoms and improve quality of life.       Chemotherapy    Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy). The way the chemotherapy is given depends on the type and stage of the cancer being treated.       Hormone therapy     Hormone therapy is a cancer treatment that removes hormones or blocks their action and stops cancer cells from growing. Hormones are substances produced by glands in the body and circulated in the bloodstream. Some hormones can cause certain cancers to grow. If tests show the cancer cells have places where hormones can attach (receptors), drugs, surgery, or radiation therapy is used to reduce the production of hormones or block them from working.
                
                
                    New types of treatment are being tested in clinical trials.
                    Information about clinical trials is available from the NCI website.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
                
                
                    Follow-up tests may be needed.
                    Some of the tests that were done to diagnose the cancer or to find out the stage of the cancer may be repeated. Some tests will be repeated in order to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.   Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your condition has changed or if the cancer has recurred (come back). These tests are sometimes called follow-up tests or check-ups.
                
		        
		            Treatment Options by Stage
		            
		                
		                    Stage I Uterine Sarcoma
		                    Treatment of stage I uterine sarcoma may include the following:         -  Surgery (total abdominal hysterectomy, bilateral salpingo-oophorectomy, and lymphadenectomy).    - Surgery followed by radiation therapy to the pelvis.     - Surgery followed by chemotherapy.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage I uterine sarcoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
		                
		                
		                    Stage II Uterine Sarcoma
		                    Treatment of stage II uterine sarcoma may include the following:         -  Surgery (total abdominal hysterectomy, bilateral salpingo-oophorectomy, and lymphadenectomy).     - Surgery followed by radiation therapy to the pelvis.    - Surgery followed by chemotherapy.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage II uterine sarcoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
		                
		                
		                    Stage III Uterine Sarcoma
		                    Treatment of stage III uterine sarcoma may include the following:         -  Surgery (total abdominal hysterectomy, bilateral salpingo-oophorectomy, and lymphadenectomy).    - A clinical trial of surgery followed by radiation therapy to the pelvis.    - A clinical trial of surgery followed by chemotherapy.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage III uterine sarcoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
		                
		                
		                    Stage IV Uterine Sarcoma
		                    There is no standard treatment for patients with stage IV uterine sarcoma. Treatment may include a clinical trial using chemotherapy.    Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage IV uterine sarcoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.",0.0,0.0,0.9999999999875,0.9
what research (or clinical trials) is being done for Uterine Sarcoma ?,"['{\n  ""question"": ""what research (or clinical trials) is being done for Uterine Sarcoma ?"",', 'Treatment Options by Stage\\n\\t\\t            \\n\\t\\t                \\n\\t\\t                    Stage I Uterine Sarcoma\\n\\t\\t                    Treatment of stage I uterine sarcoma may include the following:         -  Surgery (total abdominal hysterectomy, bilateral salpingo-oophorectomy, and lymphadenectomy).    - Surgery followed by radiation therapy to the pelvis.     - Surgery followed by chemotherapy.        Check the list of NCI-supported cancer clinical trials that are now', '""ground_truth"": ""Key Points\\n                    - Uterine sarcoma is a disease in which malignant (cancer) cells form in the muscles of the uterus or other tissues that support the uterus.    - Being exposed to x-rays can increase the risk of uterine sarcoma.     - Signs of uterine sarcoma include abnormal bleeding.     - Tests that examine the uterus are used to detect (find) and diagnose uterine sarcoma.    - Certain factors affect prognosis (chance of recovery) and treatment options.\\n', 'cancer treatment.    - Follow-up tests may be needed.\\n                \\n                \\n                    There are different types of treatment for patients with uterine sarcoma.\\n                    Different types of treatments are available for patients with uterine sarcoma. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain', 'trials that are now accepting patients with stage I uterine sarcoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.\\n\\t\\t                \\n\\t\\t                \\n\\t\\t                    Stage II Uterine Sarcoma\\n\\t\\t', 'options.\\n                \\n                \\n                    Uterine sarcoma is a disease in which malignant (cancer) cells form in the muscles of the uterus or other tissues that support the uterus.\\n                    The uterus is part of the female reproductive system. The uterus is the hollow, pear-shaped organ in the pelvis, where a fetus grows. The cervix is at the lower, narrow end of the uterus, and leads to the vagina.       Uterine sarcoma is a very rare kind of cancer that', 'with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.\\n\\t\\t                \\n\\t\\t                \\n\\t\\t                    Stage IV Uterine Sarcoma\\n\\t\\t                    There is no standard treatment for patients with stage IV uterine sarcoma. Treatment may include a clinical trial using chemotherapy.    Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage IV', '""ground_truth"": ""Key Points\\n                    - There are different types of treatment for patients with uterine sarcoma.    - Four types of standard treatment are used:         - Surgery     - Radiation therapy     - Chemotherapy     - Hormone therapy        -  New types of treatment are being tested in clinical trials.     - Patients may want to think about taking part in a clinical trial.    - Patients can enter clinical trials before, during, or after starting their cancer treatment.']","There are various clinical trials being conducted for uterine sarcoma, particularly focused on improving current treatments or exploring new treatment options. For stage I uterine sarcoma, treatments may include surgery, followed by radiation therapy or chemotherapy, and there are clinical trials that are now accepting patients for these treatments. For stage IV uterine sarcoma, there is no standard treatment, but clinical trials using chemotherapy may be available. Patients are encouraged to discuss with their doctors about clinical trials that may be suitable for them and can find general information about these trials on the NCI website.","New types of treatment are being tested in clinical trials.
                    Information about clinical trials is available from the NCI website.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.",1.0,0.9312762366667023,0.9999999999875,0.5882352941176471
What is (are) Extragonadal Germ Cell Tumors ?,"['{\n  ""question"": ""What is (are) Extragonadal Germ Cell Tumors ?"",', 'These tumors may begin to grow anywhere in the body but usually begin in organs such as the pineal gland in the brain, in the mediastinum (area between the lungs), or in the retroperitoneum (the back wall of the abdomen).     Extragonadal germ cell tumors can be benign (noncancer) or malignant (cancer). Benign extragonadal germ cell tumors are called benign teratomas. These are more common than malignant extragonadal germ cell tumors and often are very large.   Malignant extragonadal germ cell', 'prognosis (chance of recovery) and treatment options.\\n                \\n                \\n                    Extragonadal germ cell tumors form from developing sperm or egg cells that travel from the gonads to other parts of the body.\\n                    \\"" Extragonadal\\"" means outside of the gonads (sex organs). When cells that are meant to form sperm in the testicles or eggs in the ovaries travel to other parts of the body, they may grow into extragonadal germ cell tumors. These tumors may', '(AFP).     - Mixed germ cell tumors are made of more than one kind of germ cell.""', '\\n                    Childhood extracranial germ cell tumors are grouped as gonadal or extragonadal.\\n                    Malignant extracranial germ cell tumors are gonadal or extragonadal.     Gonadal Germ Cell Tumors    Gonadal germ cell tumors form in the testicles in boys or ovaries in girls.          Testicular Germ Cell Tumors        Testicular germ cell tumors are divided into two main types, seminoma and nonseminoma.               - Seminomas make a hormone called', 'extragonadal germ cell tumor is in the poor prognosis group if:            - the tumor is in the chest; or     -  the tumor has spread to organs other than the lungs; or     - the level of any one of the tumor markers (AFP, -hCG, or LDH) is high.            Seminoma extragonadal germ cell tumor does not have a poor prognosis group.""', 'Ovarian Germ Cell Tumors Treatment for more information.)          Extragonadal Extracranial Germ Cell Tumors    Extragonadal extracranial germ cell tumors form in areas other than the brain, testicles, or ovaries.    Most extragonadal extracranial germ cell tumors form along the midline of the body. This includes the following:             - Sacrum (the large, triangle-shaped bone in the lower spine that forms part of the pelvis).     -  Coccyx (the small bone at the bottom of the spine, also', '""ground_truth"": ""Key Points\\n                    - Extragonadal germ cell tumors form from developing sperm or egg cells that travel from the gonads to other parts of the body.    - Age and gender can affect the risk of extragonadal germ cell tumors.     - Signs and symptoms of extragonadal germ cell tumors include breathing problems and chest pain.     - Imaging and blood tests are used to detect (find) and diagnose extragonadal germ cell tumors.    - Certain factors affect prognosis (chance']","Extragonadal germ cell tumors are tumors that form from developing sperm or egg cells that have traveled from the gonads (sex organs) to other parts of the body. They can begin to grow in various organs, commonly in the pineal gland in the brain, the mediastinum (the area between the lungs), or the retroperitoneum (the back wall of the abdomen). These tumors can be benign (noncancerous), known as benign teratomas, or malignant (cancerous). Malignant extragonadal germ cell tumors have a poor prognosis if they are located in the chest, have spread to other organs, or have high levels of certain tumor markers. Symptoms may include breathing problems and chest pain, and diagnosis typically involves imaging and blood tests.","Key Points
                    - Extragonadal germ cell tumors form from developing sperm or egg cells that travel from the gonads to other parts of the body.    - Age and gender can affect the risk of extragonadal germ cell tumors.     - Signs and symptoms of extragonadal germ cell tumors include breathing problems and chest pain.     - Imaging and blood tests are used to detect (find) and diagnose extragonadal germ cell tumors.    - Certain factors affect prognosis (chance of recovery) and treatment options.
                
                
                    Extragonadal germ cell tumors form from developing sperm or egg cells that travel from the gonads to other parts of the body.
                    "" Extragonadal"" means outside of the gonads (sex organs). When cells that are meant to form sperm in the testicles or eggs in the ovaries travel to other parts of the body, they may grow into extragonadal germ cell tumors. These tumors may begin to grow anywhere in the body but usually begin in organs such as the pineal gland in the brain, in the mediastinum (area between the lungs), or in the retroperitoneum (the back wall of the abdomen).     Extragonadal germ cell tumors can be benign (noncancer) or malignant (cancer). Benign extragonadal germ cell tumors are called benign teratomas. These are more common than malignant extragonadal germ cell tumors and often are very large.   Malignant extragonadal germ cell tumors are divided into two types, nonseminoma and seminoma. Nonseminomas tend to grow and spread more quickly than seminomas. They usually are large and cause signs and symptoms. If untreated, malignant extragonadal germ cell tumors may spread to the lungs, lymph nodes, bones, liver, or other parts of the body.   For information about germ cell tumors in the ovaries and testicles, see the following PDQ summaries:         -  Ovarian Germ Cell Tumors Treatment     -  Testicular Cancer Treatment",1.0,0.9313122114590512,0.9999999999875,0.9285714285714286
Who is at risk for Extragonadal Germ Cell Tumors? ?,"['{\n  ""question"": ""Who is at risk for Extragonadal Germ Cell Tumors? ?"",', 'by surgery.    - The patient\'s age and general health.    - Whether the cancer has just been diagnosed or has recurred (come back).        The prognosis for childhood extracranial germ cell tumors, especially ovarian germ cell tumors, is good.""', '""ground_truth"": ""Signs and symptoms of extragonadal germ cell tumors include breathing problems and chest pain. Malignant extragonadal germ cell tumors may cause signs and symptoms as they grow into nearby areas. Other conditions may cause the same signs and symptoms. Check with your doctor if you have any of the following:         - Chest pain.    - Breathing problems.    - Cough.    -  Fever.    - Headache.    - Change in bowel habits.    - Feeling very tired.    - Trouble walking.    -', '""ground_truth"": ""Age and gender can affect the risk of extragonadal germ cell tumors. Anything that increases your chance of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesnt mean that you will not get cancer. Talk with your doctor if you think you may be at risk. Risk factors for malignant extragonadal germ cell tumors include the following:         - Being male.    - Being age 20 or older.    - Having', 'extragonadal germ cell tumor is in the poor prognosis group if:            - the tumor is in the chest; or     -  the tumor has spread to organs other than the lungs; or     - the level of any one of the tumor markers (AFP, -hCG, or LDH) is high.            Seminoma extragonadal germ cell tumor does not have a poor prognosis group.""', 'prognosis (chance of recovery) and treatment options.\\n                \\n                \\n                    Extragonadal germ cell tumors form from developing sperm or egg cells that travel from the gonads to other parts of the body.\\n                    \\"" Extragonadal\\"" means outside of the gonads (sex organs). When cells that are meant to form sperm in the testicles or eggs in the ovaries travel to other parts of the body, they may grow into extragonadal germ cell tumors. These tumors may', 'germ cell tumors are divided into two types, nonseminoma and seminoma. Nonseminomas tend to grow and spread more quickly than seminomas. They usually are large and cause signs and symptoms. If untreated, malignant extragonadal germ cell tumors may spread to the lungs, lymph nodes, bones, liver, or other parts of the body.   For information about germ cell tumors in the ovaries and testicles, see the following PDQ summaries:         -  Ovarian Germ Cell Tumors Treatment     -  Testicular Cancer', '- Gonadal Germ Cell Tumors     - Extragonadal Extracranial Germ Cell Tumors        - The cause of most childhood extracranial germ cell tumors is unknown.    - Having certain inherited disorders can increase the risk of an extracranial germ cell tumor.    - Signs of childhood extracranial germ cell tumors depend on the type of tumor and where it is in the body.    - Imaging studies and blood tests are used to detect (find) and diagnose childhood extracranial germ cell tumors.    - Certain']","Risk factors for malignant extragonadal germ cell tumors include being male, being age 20 or older, and having certain inherited disorders. Age and gender can affect the risk, and while having a risk factor increases the chance of developing the disease, it does not guarantee that one will get cancer. It is advisable to talk with a doctor if you think you may be at risk.",Age and gender can affect the risk of extragonadal germ cell tumors. Anything that increases your chance of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesnt mean that you will not get cancer. Talk with your doctor if you think you may be at risk. Risk factors for malignant extragonadal germ cell tumors include the following:         - Being male.    - Being age 20 or older.    - Having Klinefelter syndrome.,1.0,0.0,0.249999999975,1.0
What are the symptoms of Extragonadal Germ Cell Tumors ?,"['{\n  ""question"": ""What are the symptoms of Extragonadal Germ Cell Tumors ?"",', '""ground_truth"": ""Signs of childhood extracranial germ cell tumors depend on the type of tumor and where it is in the body. Different tumors may cause the following signs and symptoms. Other conditions may cause these same signs and symptoms. Check with a doctor if your child has any of the following:         - A lump in the abdomen or lower back.    -  A painless lump in the testicle.    - Pain in the abdomen.    -  Fever.    -  Constipation.    - In females, no menstrual periods.    - In', '""ground_truth"": ""Signs and symptoms of extragonadal germ cell tumors include breathing problems and chest pain. Malignant extragonadal germ cell tumors may cause signs and symptoms as they grow into nearby areas. Other conditions may cause the same signs and symptoms. Check with your doctor if you have any of the following:         - Chest pain.    - Breathing problems.    - Cough.    -  Fever.    - Headache.    - Change in bowel habits.    - Feeling very tired.    - Trouble walking.    -', 'website.\\n\\t\\t                \\n\\t\\t                \\n\\t\\t                    Recurrent or Refractory Extragonadal Germ Cell Tumors\\n\\t\\t                    Treatment of extragonadal germ cell tumors that are recurrent (come back after being treated) or refractory (do not get better during treatment) may include the following:         -  Chemotherapy.    - A clinical trial of high-dose chemotherapy with stem cell transplant.     - A clinical trial of a new treatment.        Check the list of', 'Ovarian Germ Cell Tumors Treatment for more information.)          Extragonadal Extracranial Germ Cell Tumors    Extragonadal extracranial germ cell tumors form in areas other than the brain, testicles, or ovaries.    Most extragonadal extracranial germ cell tumors form along the midline of the body. This includes the following:             - Sacrum (the large, triangle-shaped bone in the lower spine that forms part of the pelvis).     -  Coccyx (the small bone at the bottom of the spine, also', '""ground_truth"": ""Nonseminomatous germ cell tumors are cancerous tumors commonly found in the pineal gland in the brain, in the mediastinum, or in the abdomen. They originate from cells that were meant to form sex cells (i.e., sperm or eggs). They are often large and have a tendency to spread more quickly than the other type of germ cell tumor (i.e., seminoma type). Possible early signs of this cancer include chest pain and breathing problems.""\n}', '""ground_truth"": ""Key Points\\n                    - Extragonadal germ cell tumors form from developing sperm or egg cells that travel from the gonads to other parts of the body.    - Age and gender can affect the risk of extragonadal germ cell tumors.     - Signs and symptoms of extragonadal germ cell tumors include breathing problems and chest pain.     - Imaging and blood tests are used to detect (find) and diagnose extragonadal germ cell tumors.    - Certain factors affect prognosis (chance', 'germ cell tumors are divided into two types, nonseminoma and seminoma. Nonseminomas tend to grow and spread more quickly than seminomas. They usually are large and cause signs and symptoms. If untreated, malignant extragonadal germ cell tumors may spread to the lungs, lymph nodes, bones, liver, or other parts of the body.   For information about germ cell tumors in the ovaries and testicles, see the following PDQ summaries:         -  Ovarian Germ Cell Tumors Treatment     -  Testicular Cancer']","Signs and symptoms of extragonadal germ cell tumors include:

- Chest pain
- Breathing problems
- Cough
- Fever
- Headache
- Change in bowel habits
- Feeling very tired
- Trouble walking

If you experience any of these symptoms, it's important to consult a doctor for further evaluation.",Signs and symptoms of extragonadal germ cell tumors include breathing problems and chest pain. Malignant extragonadal germ cell tumors may cause signs and symptoms as they grow into nearby areas. Other conditions may cause the same signs and symptoms. Check with your doctor if you have any of the following:         - Chest pain.    - Breathing problems.    - Cough.    -  Fever.    - Headache.    - Change in bowel habits.    - Feeling very tired.    - Trouble walking.    - Trouble in seeing or moving the eyes.,1.0,0.9719630183108401,0.39880952379955353,0.75
How to diagnose Extragonadal Germ Cell Tumors ?,"['""ground_truth"": ""Key Points\\n                    - Extragonadal germ cell tumors form from developing sperm or egg cells that travel from the gonads to other parts of the body.    - Age and gender can affect the risk of extragonadal germ cell tumors.     - Signs and symptoms of extragonadal germ cell tumors include breathing problems and chest pain.     - Imaging and blood tests are used to detect (find) and diagnose extragonadal germ cell tumors.    - Certain factors affect prognosis (chance', 'treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.\\n\\t\\t                \\n\\t\\t                \\n\\t\\t                    Nonseminoma\\n\\t\\t                    Treatment of nonseminoma extragonadal germ cell tumors may include the following:         -  Combination chemotherapy followed by surgery to remove any remaining tumor.     - A clinical trial of a new', '{\n  ""question"": ""How to diagnose Extragonadal Germ Cell Tumors ?"",', 'These tumors may begin to grow anywhere in the body but usually begin in organs such as the pineal gland in the brain, in the mediastinum (area between the lungs), or in the retroperitoneum (the back wall of the abdomen).     Extragonadal germ cell tumors can be benign (noncancer) or malignant (cancer). Benign extragonadal germ cell tumors are called benign teratomas. These are more common than malignant extragonadal germ cell tumors and often are very large.   Malignant extragonadal germ cell', 'OTHER\nChemotherapy and You: A Guide to Self-help During Cancer\nTreatment. CancerNet. June 1999. 5 Apr. 2001 <http://\ncancernet.nci.nih.gov./peb/chemo_you/index.htm>.\nExtragonadal Germ Cell Tumors. CancerNet. Aug. 2000. 27\nApr. 2001 <http://cancernet.nci.nih.gov/pdq.html>.\nOvarian Germ Cell Tumor. CancerNet. Feb. 2001. 27 Apr.\n2001 <http://cancernet.nci.nih.gov/pdq.html>.\nAnna Rovid Spickler, D.V .M., Ph.D.\nChorionic gonadotropin test see Human\nchorionic gonadotropin pregnancy test', 'extragonadal germ cell tumor is in the poor prognosis group if:            - the tumor is in the chest; or     -  the tumor has spread to organs other than the lungs; or     - the level of any one of the tumor markers (AFP, -hCG, or LDH) is high.            Seminoma extragonadal germ cell tumor does not have a poor prognosis group.""', 'prognosis (chance of recovery) and treatment options.\\n                \\n                \\n                    Extragonadal germ cell tumors form from developing sperm or egg cells that travel from the gonads to other parts of the body.\\n                    \\"" Extragonadal\\"" means outside of the gonads (sex organs). When cells that are meant to form sperm in the testicles or eggs in the ovaries travel to other parts of the body, they may grow into extragonadal germ cell tumors. These tumors may', '""ground_truth"": ""Signs and symptoms of extragonadal germ cell tumors include breathing problems and chest pain. Malignant extragonadal germ cell tumors may cause signs and symptoms as they grow into nearby areas. Other conditions may cause the same signs and symptoms. Check with your doctor if you have any of the following:         - Chest pain.    - Breathing problems.    - Cough.    -  Fever.    - Headache.    - Change in bowel habits.    - Feeling very tired.    - Trouble walking.    -']","Extragonadal germ cell tumors are diagnosed using imaging and blood tests. Imaging techniques help to locate the tumors, while blood tests can detect tumor markers such as AFP, hCG, or LDH, which may indicate the presence of these tumors. If you suspect you have symptoms related to extragonadal germ cell tumors, it is important to consult with your doctor for appropriate evaluation and diagnosis.","Imaging and blood tests are used to detect (find) and diagnose extragonadal germ cell tumors. The following tests and procedures may be used:         -   Physical exam and history : An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. The testicles may be checked for lumps, swelling, or pain. A history of the patient's health habits and past illnesses and treatments will also be taken.    -   Chest x-ray : An x-ray of the organs and bones inside the chest. An x-ray is a type of energy beam that can go through the body and onto film, making a picture of areas inside the body.    -   Serum tumor marker test : A procedure in which a sample of blood is examined to measure the amounts of certain substances released into the blood by organs, tissues, or tumor cells in the body. Certain substances are linked to specific types of cancer when found in increased levels in the blood. These are called tumor markers. The following three tumor markers are used to detect extragonadal germ cell tumor:                -  Alpha-fetoprotein (AFP).      -  Beta-human chorionic gonadotropin (-hCG).       -  Lactate dehydrogenase (LDH).         Blood levels of the tumor markers help determine if the tumor is a seminoma or nonseminoma.    -   CT scan (CAT scan): A procedure that makes a series of detailed pictures of areas inside the body, taken from different angles. The pictures are made by a computer linked to an x-ray machine. A dye may be injected into a vein or swallowed to help the organs or tissues show up more clearly. This procedure is also called computed tomography, computerized tomography, or computerized axial tomography. Sometimes a CT scan and a PET scan are done at the same time. A PET scan is a procedure to find malignant tumor cells in the body. A small amount of radioactive glucose (sugar) is injected into a vein. The PET scanner rotates around the body and makes a picture of where glucose is being used in the body. Malignant tumor cells show up brighter in the picture because they are more active and take up more glucose than normal cells do. When a PET scan and CT scan are done at the same time, it is called a PET-CT.    -   Biopsy : The removal of cells or tissues so they can be viewed under a microscope by a pathologist to check for signs of cancer. The type of biopsy used depends on where the extragonadal germ cell tumor is found.                -  Excisional biopsy : The removal of an entire lump of tissue.      -  Incisional biopsy : The removal of part of a lump or sample of tissue.      -  Core biopsy : The removal of tissue using a wide needle.      -  Fine-needle aspiration (FNA) biopsy : The removal of tissue or fluid using a thin needle.",1.0,0.9638605560479233,0.9999999999875,0.9166666666666666
What is the outlook for Extragonadal Germ Cell Tumors ?,"['{\n  ""question"": ""What is the outlook for Extragonadal Germ Cell Tumors ?"",', 'by surgery.    - The patient\'s age and general health.    - Whether the cancer has just been diagnosed or has recurred (come back).        The prognosis for childhood extracranial germ cell tumors, especially ovarian germ cell tumors, is good.""', '""ground_truth"": ""Signs and symptoms of extragonadal germ cell tumors include breathing problems and chest pain. Malignant extragonadal germ cell tumors may cause signs and symptoms as they grow into nearby areas. Other conditions may cause the same signs and symptoms. Check with your doctor if you have any of the following:         - Chest pain.    - Breathing problems.    - Cough.    -  Fever.    - Headache.    - Change in bowel habits.    - Feeling very tired.    - Trouble walking.    -', 'prognosis (chance of recovery) and treatment options.\\n                \\n                \\n                    Extragonadal germ cell tumors form from developing sperm or egg cells that travel from the gonads to other parts of the body.\\n                    \\"" Extragonadal\\"" means outside of the gonads (sex organs). When cells that are meant to form sperm in the testicles or eggs in the ovaries travel to other parts of the body, they may grow into extragonadal germ cell tumors. These tumors may', 'These tumors may begin to grow anywhere in the body but usually begin in organs such as the pineal gland in the brain, in the mediastinum (area between the lungs), or in the retroperitoneum (the back wall of the abdomen).     Extragonadal germ cell tumors can be benign (noncancer) or malignant (cancer). Benign extragonadal germ cell tumors are called benign teratomas. These are more common than malignant extragonadal germ cell tumors and often are very large.   Malignant extragonadal germ cell', 'of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.\\n\\t\\t                \\n\\t\\t                \\n\\t\\t                    Seminoma\\n\\t\\t                    Treatment of seminoma extragonadal germ cell tumors may include the following:         -  Radiation therapy for small tumors in one area, followed by watchful waiting if there is tumor remaining after treatment.     -  Chemotherapy for', 'extragonadal germ cell tumor is in the poor prognosis group if:            - the tumor is in the chest; or     -  the tumor has spread to organs other than the lungs; or     - the level of any one of the tumor markers (AFP, -hCG, or LDH) is high.            Seminoma extragonadal germ cell tumor does not have a poor prognosis group.""', 'website.\\n\\t\\t                \\n\\t\\t                \\n\\t\\t                    Recurrent or Refractory Extragonadal Germ Cell Tumors\\n\\t\\t                    Treatment of extragonadal germ cell tumors that are recurrent (come back after being treated) or refractory (do not get better during treatment) may include the following:         -  Chemotherapy.    - A clinical trial of high-dose chemotherapy with stem cell transplant.     - A clinical trial of a new treatment.        Check the list of']","The outlook for extragonadal germ cell tumors can vary based on several factors, including the patient's age and general health, as well as whether the cancer has just been diagnosed or has recurred. Generally, the prognosis for childhood extracranial germ cell tumors, particularly ovarian germ cell tumors, is good. However, malignant extragonadal germ cell tumors may have a poorer prognosis if they are located in the chest, have spread to other organs, or if tumor markers such as AFP, -hCG, or LDH are elevated. Treatment options may include surgery, chemotherapy, and radiation therapy, depending on the specific circumstances of the case.","Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) and treatment options depend on the following:         - Whether the tumor is nonseminoma or seminoma.    - The size of the tumor and where it is in the body.     - The blood levels of AFP, -hCG, and LDH.    - Whether the tumor has spread to other parts of the body.    - The way the tumor responds to initial treatment.    - Whether the tumor has just been diagnosed or has recurred (come back).",0.9230769230769231,0.0,0.5428571428435714,1.0
What are the stages of Extragonadal Germ Cell Tumors ?,"['{\n  ""question"": ""What are the stages of Extragonadal Germ Cell Tumors ?"",', 'website.\\n\\t\\t                \\n\\t\\t                \\n\\t\\t                    Recurrent or Refractory Extragonadal Germ Cell Tumors\\n\\t\\t                    Treatment of extragonadal germ cell tumors that are recurrent (come back after being treated) or refractory (do not get better during treatment) may include the following:         -  Chemotherapy.    - A clinical trial of high-dose chemotherapy with stem cell transplant.     - A clinical trial of a new treatment.        Check the list of', 'Ovarian Germ Cell Tumors Treatment for more information.)          Extragonadal Extracranial Germ Cell Tumors    Extragonadal extracranial germ cell tumors form in areas other than the brain, testicles, or ovaries.    Most extragonadal extracranial germ cell tumors form along the midline of the body. This includes the following:             - Sacrum (the large, triangle-shaped bone in the lower spine that forms part of the pelvis).     -  Coccyx (the small bone at the bottom of the spine, also', '\\n                \\n                    After an extragonadal germ cell tumor has been diagnosed, tests are done to find out if cancer cells have spread to other parts of the body.\\n                    The extent or spread of cancer is usually described as stages. For extragonadal germ cell tumors, prognostic groups are used instead of stages. The tumors are grouped according to how well the cancer is expected to respond to treatment. It is important to know the prognostic group', '- Stage IIIC: Cancer has spread to the peritoneum and is larger than 2 centimeters in diameter and/or has spread to lymph nodes in the abdomen.                -  Stage IV: In stage IV, cancer is found in one or both ovaries and has metastasized (spread) beyond the abdomen to other parts of the body. Cancer that has spread to tissues in the liver is also stage IV disease.              Childhood extragonadal extracranial germ cell tumors            -  Stage I: In stage I, the cancer is in', '""ground_truth"": ""Key Points\\n                    - Extragonadal germ cell tumors form from developing sperm or egg cells that travel from the gonads to other parts of the body.    - Age and gender can affect the risk of extragonadal germ cell tumors.     - Signs and symptoms of extragonadal germ cell tumors include breathing problems and chest pain.     - Imaging and blood tests are used to detect (find) and diagnose extragonadal germ cell tumors.    - Certain factors affect prognosis (chance', 'prognosis (chance of recovery) and treatment options.\\n                \\n                \\n                    Extragonadal germ cell tumors form from developing sperm or egg cells that travel from the gonads to other parts of the body.\\n                    \\"" Extragonadal\\"" means outside of the gonads (sex organs). When cells that are meant to form sperm in the testicles or eggs in the ovaries travel to other parts of the body, they may grow into extragonadal germ cell tumors. These tumors may', 'These tumors may begin to grow anywhere in the body but usually begin in organs such as the pineal gland in the brain, in the mediastinum (area between the lungs), or in the retroperitoneum (the back wall of the abdomen).     Extragonadal germ cell tumors can be benign (noncancer) or malignant (cancer). Benign extragonadal germ cell tumors are called benign teratomas. These are more common than malignant extragonadal germ cell tumors and often are very large.   Malignant extragonadal germ cell']","Extragonadal germ cell tumors are described using prognostic groups rather than traditional stages. However, for reference, the following are the stages associated with extragonadal germ cell tumors:

- **Stage I**: The cancer is localized and has not spread beyond the original site.
- **Stage IIIC**: Cancer has spread to the peritoneum and is larger than 2 centimeters in diameter and/or has spread to lymph nodes in the abdomen.
- **Stage IV**: Cancer is found in one or both ovaries and has metastasized beyond the abdomen to other parts of the body, including tissues in the liver.

It is important to know the prognostic group for treatment planning and understanding the expected response to treatment.","Key Points
                    - After an extragonadal germ cell tumor has been diagnosed, tests are done to find out if cancer cells have spread to other parts of the body.     - There are three ways that cancer spreads in the body.    - Cancer may spread from where it began to other parts of the body.    -  The following prognostic groups are used for extragonadal germ cell tumors:         - Good prognosis     - Intermediate prognosis     - Poor prognosis
                
                
                    After an extragonadal germ cell tumor has been diagnosed, tests are done to find out if cancer cells have spread to other parts of the body.
                    The extent or spread of cancer is usually described as stages. For extragonadal germ cell tumors, prognostic groups are used instead of stages. The tumors are grouped according to how well the cancer is expected to respond to treatment. It is important to know the prognostic group in order to plan treatment.
                
                
                    There are three ways that cancer spreads in the body.
                    Cancer can spread through tissue, the lymph system, and the blood:         - Tissue. The cancer spreads from where it began by growing into nearby areas.     - Lymph system. The cancer spreads from where it began by getting into the lymph system. The cancer travels through the lymph vessels to other parts of the body.     - Blood. The cancer spreads from where it began by getting into the blood. The cancer travels through the blood vessels to other parts of the body.
                
                
                    Cancer may spread from where it began to other parts of the body.
                    When cancer spreads to another part of the body, it is called metastasis. Cancer cells break away from where they began (the primary tumor) and travel through the lymph system or blood.         - Lymph system. The cancer gets into the lymph system, travels through the lymph vessels, and forms a tumor (metastatic tumor) in another part of the body.    - Blood. The cancer gets into the blood, travels through the blood vessels, and forms a tumor (metastatic tumor) in another part of the body.        The metastatic tumor is the same type of tumor as the primary tumor. For example, if an extragonadal germ cell tumor spreads to the lung, the tumor cells in the lung are actually cancerous germ cells. The disease is metastatic extragonadal germ cell tumor, not lung cancer.
                
                
                    The following prognostic groups are used for extragonadal germ cell tumors:
                    Good prognosis    A nonseminoma extragonadal germ cell tumor is in the good prognosis group if:             - the tumor is in the back of the abdomen; and     - the tumor has not spread to organs other than the lungs; and     - the levels of tumor markers AFP and -hCG are normal and LDH is slightly above normal.           A seminoma extragonadal germ cell tumor is in the good prognosis group if:            - the tumor has not spread to organs other than the lungs; and     - the level of AFP is normal; -hCG and LDH may be at any level.              Intermediate prognosis    A nonseminoma extragonadal germ cell tumor is in the intermediate prognosis group if:             - the tumor is in the back of the abdomen; and     - the tumor has not spread to organs other than the lungs; and     - the level of any one of the tumor markers (AFP, -hCG, or LDH) is more than slightly above normal.           A seminoma extragonadal germ cell tumor is in the intermediate prognosis group if:            - the tumor has spread to organs other than the lungs; and     - the level of AFP is normal; -hCG and LDH may be at any level.              Poor prognosis    A nonseminoma extragonadal germ cell tumor is in the poor prognosis group if:            - the tumor is in the chest; or     -  the tumor has spread to organs other than the lungs; or     - the level of any one of the tumor markers (AFP, -hCG, or LDH) is high.            Seminoma extragonadal germ cell tumor does not have a poor prognosis group.",0.7857142857142857,0.9374122874733851,0.9379251700546282,0.25
What are the treatments for Extragonadal Germ Cell Tumors ?,"['{\n  ""question"": ""What are the treatments for Extragonadal Germ Cell Tumors ?"",', 'trials that may be right for you. General information about clinical trials is available from the NCI website.\\n\\t\\t\\t\\t\\t\\t\\t                \\n\\t\\t\\t\\t\\t\\t\\t                \\n\\t\\t\\t\\t\\t\\t\\t                    Germ Cell Tumors\\n\\t\\t\\t\\t\\t\\t\\t                    There is no standard treatment for germ cell tumors (germinoma, embryonal carcinoma, choriocarcinoma, and teratoma). Treatment depends on what the tumor cells look like under a microscope, the tumor markers, where the tumor is in the', 'website.\\n\\t\\t                \\n\\t\\t                \\n\\t\\t                    Recurrent or Refractory Extragonadal Germ Cell Tumors\\n\\t\\t                    Treatment of extragonadal germ cell tumors that are recurrent (come back after being treated) or refractory (do not get better during treatment) may include the following:         -  Chemotherapy.    - A clinical trial of high-dose chemotherapy with stem cell transplant.     - A clinical trial of a new treatment.        Check the list of', 'Ovarian Germ Cell Tumors Treatment for more information.)          Extragonadal Extracranial Germ Cell Tumors    Extragonadal extracranial germ cell tumors form in areas other than the brain, testicles, or ovaries.    Most extragonadal extracranial germ cell tumors form along the midline of the body. This includes the following:             - Sacrum (the large, triangle-shaped bone in the lower spine that forms part of the pelvis).     -  Coccyx (the small bone at the bottom of the spine, also', 'of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.\\n\\t\\t                \\n\\t\\t                \\n\\t\\t                    Seminoma\\n\\t\\t                    Treatment of seminoma extragonadal germ cell tumors may include the following:         -  Radiation therapy for small tumors in one area, followed by watchful waiting if there is tumor remaining after treatment.     -  Chemotherapy for', 'prognosis (chance of recovery) and treatment options.\\n                \\n                \\n                    Extragonadal germ cell tumors form from developing sperm or egg cells that travel from the gonads to other parts of the body.\\n                    \\"" Extragonadal\\"" means outside of the gonads (sex organs). When cells that are meant to form sperm in the testicles or eggs in the ovaries travel to other parts of the body, they may grow into extragonadal germ cell tumors. These tumors may', 'by surgery.    - The patient\'s age and general health.    - Whether the cancer has just been diagnosed or has recurred (come back).        The prognosis for childhood extracranial germ cell tumors, especially ovarian germ cell tumors, is good.""', ""- Surgery followed by combination chemotherapy.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with childhood extragonadal germ cell tumor. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your child's doctor about clinical trials that may be right for your child. General information about clinical trials is available from the""]","The treatments for extragonadal germ cell tumors may include the following:

1. Chemotherapy.
2. A clinical trial of high-dose chemotherapy with stem cell transplant.
3. A clinical trial of a new treatment.
4. For seminoma extragonadal germ cell tumors, treatment may include radiation therapy for small tumors in one area, followed by watchful waiting if there is tumor remaining after treatment.
5. Surgery followed by combination chemotherapy.

It's important to discuss with a healthcare provider about clinical trials that may be appropriate for individual cases.","Key Points
                    - There are different types of treatment for patients with extragonadal germ cell tumors.    - Three types of standard treatment are used:         - Radiation therapy     - Chemotherapy     - Surgery        - New types of treatment are being tested in clinical trials.          - High-dose chemotherapy with stem cell transplant        - Patients may want to think about taking part in a clinical trial.    - Patients can enter clinical trials before, during, or after starting their cancer treatment.    - Follow-up tests may be needed.
                
                
                    There are different types of treatment for patients with extragonadal germ cell tumors.
                    Different types of treatments are available for patients with extragonadal germ cell tumors. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
                
                
                    Three types of standard treatment are used:
                    Radiation therapy     Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. There are two types of radiation therapy:            -  External radiation therapy uses a machine outside the body to send radiation toward the cancer.     -  Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer.           The way the radiation therapy is given depends on the type and stage of the cancer being treated. External radiation therapy is used to treat seminoma.       Chemotherapy     Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly in the cerebrospinal fluid, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy). The way the chemotherapy is given depends on the type and stage of the cancer being treated.       Surgery    Patients who have benign tumors or tumor remaining after chemotherapy or radiation therapy may need to have surgery.
                
                
                    New types of treatment are being tested in clinical trials.
                    This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.     High-dose chemotherapy with stem cell transplant     High-dose chemotherapy with stem cell transplant is a method of giving high doses of chemotherapy and replacing blood -forming cells destroyed by the cancer treatment. Stem cells (immature blood cells) are removed from the blood or bone marrow of the patient or a donor and are frozen and stored. After the chemotherapy is completed, the stored stem cells are thawed and given back to the patient through an infusion. These reinfused stem cells grow into (and restore) the body's blood cells.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
                
                
                    Follow-up tests may be needed.
                    Some of the tests that were done to diagnose the cancer or to find out the stage of the cancer may be repeated. Some tests will be repeated in order to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.   Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your condition has changed or if the cancer has recurred (come back). These tests are sometimes called follow-up tests or check-ups.   After initial treatment for extragonadal germ cell tumors, blood levels of AFP and other tumor markers continue to be checked to find out how well the treatment is working.
                
		        
		            Treatment Options for Extragonadal Germ Cell Tumors
		            
		                
		                    Benign Teratoma
		                    Treatment of benign teratomas is surgery.    Check the list of NCI-supported cancer clinical trials that are now accepting patients with benign teratoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
		                
		                
		                    Seminoma
		                    Treatment of seminoma extragonadal germ cell tumors may include the following:         -  Radiation therapy for small tumors in one area, followed by watchful waiting if there is tumor remaining after treatment.     -  Chemotherapy for larger tumors or tumors that have spread. If a tumor smaller than 3 centimeters remains after chemotherapy, watchful waiting follows. If a larger tumor remains after treatment, surgery or watchful waiting follow.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with extragonadal seminoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
		                
		                
		                    Nonseminoma
		                    Treatment of nonseminoma extragonadal germ cell tumors may include the following:         -  Combination chemotherapy followed by surgery to remove any remaining tumor.     - A clinical trial of a new treatment.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with malignant extragonadal non-seminomatous germ cell tumor. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
		                
		                
		                    Recurrent or Refractory Extragonadal Germ Cell Tumors
		                    Treatment of extragonadal germ cell tumors that are recurrent (come back after being treated) or refractory (do not get better during treatment) may include the following:         -  Chemotherapy.    - A clinical trial of high-dose chemotherapy with stem cell transplant.     - A clinical trial of a new treatment.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with recurrent extragonadal germ cell tumor. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.",1.0,0.9837977111377515,0.9999999999875,0.8
what research (or clinical trials) is being done for Extragonadal Germ Cell Tumors ?,"['{\n  ""question"": ""what research (or clinical trials) is being done for Extragonadal Germ Cell Tumors ?"",', 'trials that may be right for you. General information about clinical trials is available from the NCI website.\\n\\t\\t\\t\\t\\t\\t\\t                \\n\\t\\t\\t\\t\\t\\t\\t                \\n\\t\\t\\t\\t\\t\\t\\t                    Germ Cell Tumors\\n\\t\\t\\t\\t\\t\\t\\t                    There is no standard treatment for germ cell tumors (germinoma, embryonal carcinoma, choriocarcinoma, and teratoma). Treatment depends on what the tumor cells look like under a microscope, the tumor markers, where the tumor is in the', '""ground_truth"": ""Key Points\\n                    - Extragonadal germ cell tumors form from developing sperm or egg cells that travel from the gonads to other parts of the body.    - Age and gender can affect the risk of extragonadal germ cell tumors.     - Signs and symptoms of extragonadal germ cell tumors include breathing problems and chest pain.     - Imaging and blood tests are used to detect (find) and diagnose extragonadal germ cell tumors.    - Certain factors affect prognosis (chance', 'Check the list of NCI-supported cancer clinical trials that are now accepting patients with recurrent extragonadal germ cell tumor. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.""', '""ground_truth"": ""Key Points\\n                    - There are different types of treatment for patients with extragonadal germ cell tumors.    - Three types of standard treatment are used:         - Radiation therapy     - Chemotherapy     - Surgery        - New types of treatment are being tested in clinical trials.          - High-dose chemotherapy with stem cell transplant        - Patients may want to think about taking part in a clinical trial.    - Patients can enter clinical trials', 'trials is available from the NCI website.\\n\\t\\t                \\n\\t\\t                \\n\\t\\t                    Malignant Extragonadal Extracranial Germ Cell Tumors\\n\\t\\t                    Treatment of childhood malignant extragonadal extracranial germ cell tumors may include the following:         -  Combination chemotherapy to shrink the tumor followed by surgery to remove the sacrum and coccyx (bottom part of the spine) for tumors that are in the sacrum or coccyx.    - Combination', 'treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.\\n\\t\\t                \\n\\t\\t                \\n\\t\\t                    Nonseminoma\\n\\t\\t                    Treatment of nonseminoma extragonadal germ cell tumors may include the following:         -  Combination chemotherapy followed by surgery to remove any remaining tumor.     - A clinical trial of a new', 'website.\\n\\t\\t                \\n\\t\\t                \\n\\t\\t                    Recurrent or Refractory Extragonadal Germ Cell Tumors\\n\\t\\t                    Treatment of extragonadal germ cell tumors that are recurrent (come back after being treated) or refractory (do not get better during treatment) may include the following:         -  Chemotherapy.    - A clinical trial of high-dose chemotherapy with stem cell transplant.     - A clinical trial of a new treatment.        Check the list of']","There are ongoing clinical trials for extragonadal germ cell tumors, which may include new treatment options such as high-dose chemotherapy with stem cell transplant. Patients are encouraged to talk with their doctors about participating in clinical trials that may be suitable for them. For more specific information, you can check the list of NCI-supported cancer clinical trials that are currently accepting patients with recurrent extragonadal germ cell tumors. General information about clinical trials is also available from the NCI website.","New types of treatment are being tested in clinical trials.
                    This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.     High-dose chemotherapy with stem cell transplant     High-dose chemotherapy with stem cell transplant is a method of giving high doses of chemotherapy and replacing blood -forming cells destroyed by the cancer treatment. Stem cells (immature blood cells) are removed from the blood or bone marrow of the patient or a donor and are frozen and stored. After the chemotherapy is completed, the stored stem cells are thawed and given back to the patient through an infusion. These reinfused stem cells grow into (and restore) the body's blood cells.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.",1.0,0.0,0.9999999999875,1.0
What is (are) Endometrial Cancer ?,"['Endometrial cancer\nDefinition\nEndometrial cancer develops when the cells that\nmake up the inner lining of the uterus (the endometrium)\nbecome abnormal and grow uncontrollably.\nDescription\nEndometrial cancer (also called uterine cancer) is\nthe fourth most common type of cancer among women\nand the most common gynecologic cancer. Approximate-\nly 34,000 women are diagnosed with endometrial cancer\neach year. In 1998, approximately 6,300 women died', '{\n  ""question"": ""What is (are) Endometrial Cancer ?"",', 'KEY TERMS\nEndometrial polypsA growth in the lining of the\nuterus (endometrium) that may cause bleeding\nand can develop into cancer.\nEpidural anesthesia A type of anesthesia that is\ninjected into the epidural space of the spinal cord\nto numb the nerves leading to the lower half of the\nbody.\nUterine fibroid A noncancerous tumor of the\nuterus that can range from the size of a pea to the\nsize of a grapefruit. Small fibroids require no treat-\nment, but those causing serious symptoms may', 'is done in the outpatient surgery department of a hospital\nGALE ENCYCLOPEDIA OF MEDICINE 2\n1189\nEndometrial cancer\nCancer located in the uterus. (Illustration by Argosy Inc.)', 'three subtypes of endometrial cancer that are considered grade 3.""', 'OTHER\nCancer of the Uterus. Cancernet. Dec. 2000. 13 Mar. 2001\n<http://cancernet.nci.nih.gov/wyntk_pubs/uterus.htm>.\nLata Cherath\nBelinda Rowland, Ph.D.\nEndometriosis\nDefinition\nEndometriosis is a condition in which bits of the tis-\nsue similar to the lining of the uterus (endometrium) grow\nin other parts of the body. Like the uterine lining, this tis-\nsue builds up and sheds in response to monthly hormonal\ncycles. However, there is no natural outlet for the blood', 'pelvis.     - Tests that examine the endometrium are used to detect (find) and diagnose endometrial cancer.    - Certain factors affect prognosis (chance of recovery) and treatment options.\\n                \\n                \\n                    Endometrial cancer is a disease in which malignant (cancer) cells form in the tissues of the endometrium.\\n                    The endometrium is the lining of the uterus, a hollow, muscular organ in a womans pelvis. The uterus is where a fetus grows.', 'the following PDQ summaries for more information about endometrial cancer:         -  Endometrial Cancer Treatment     -  Endometrial Cancer Prevention\\n                \\n                \\n                    In the United States, endometrial cancer is the most common invasive cancer of the female reproductive system.\\n                    Endometrial cancer is diagnosed most often in postmenopausal women at an average age of 60 years.   From 2004 to 2013, the number of new cases of endometrial']","Endometrial cancer develops when the cells that make up the inner lining of the uterus (the endometrium) become abnormal and grow uncontrollably. It is also known as uterine cancer and is the most common gynecologic cancer, affecting approximately 34,000 women each year in the United States. It is diagnosed most often in postmenopausal women, typically at an average age of 60 years.","Key Points
                    - Endometrial cancer is a disease in which malignant (cancer) cells form in the tissues of the endometrium.     - Endometrial cancer is the most common invasive cancer of the female reproductive system.
                
                
                    Endometrial cancer is a disease in which malignant (cancer) cells form in the tissues of the endometrium.
                    The endometrium is the lining of the uterus. The uterus is part of the female reproductive system. It is a hollow, pear-shaped, muscular organ in the pelvis, where a fetus grows.      Cancer of the endometrium is different from cancer of the muscle of the uterus, which is called sarcoma of the uterus. See the PDQ summary on Uterine Sarcoma Treatment for more information.   See the following PDQ summaries for more information about endometrial cancer:         -  Endometrial Cancer Screening     -  Endometrial Cancer Treatment
                
                
                    Endometrial cancer is the most common invasive cancer of the female reproductive system.
                    Endometrial cancer is diagnosed most often in postmenopausal women at an average age of 60 years .   From 2004 to 2013, the number of new cases of endometrial cancer increased slightly in white and African American women. From 2005 to 2014, the number of deaths from endometrial cancer also increased slightly in white and African American women. Compared with white women, rates of endometrial cancer are lower in Japanese Americans and in Latinas. The rates of endometrial cancer in white women are about the same as in African Americans or in native Hawaiians. The number of deaths from endometrial cancer is higher in African American women compared with women of other races.",1.0,0.9014952555170889,0.9999999999875,0.4
How to prevent Endometrial Cancer ?,"['of developing a new type of cancer. Other trials are done with healthy volunteers who are not known to have any risk factors for cancer.    The purpose of some cancer prevention clinical trials is to find out whether actions people take can prevent cancer. These may include eating fruits and vegetables, exercising, quitting smoking, or taking certain medicines, vitamins, minerals, or food supplements.\\n                \\n                \\n                    New ways to prevent endometrial', 'very sensitive to hormones and it changes daily during\nthe menstrual cycle. The endometrium is designed to\nprovide an ideal environment for the fertilized egg to\nimplant and begin to grow. If pregnancy does not occur,\nthe endometrium is shed causing the menstrual period.\nMore than 95% of uterine cancers arise in the\nendometrium. The most common type of uterine cancer\nis adenocarcinoma. It arises from an abnormal multipli-\ncation of endometrial cells (atypical adenomatous hyper-', '{\n  ""question"": ""How to prevent Endometrial Cancer ?"",', 'early, the chances of curing it are excellent. The five year\nsurvival rates for endometrial cancer by stage are: 90%,\nstage I; 60%, stage II; 40%, stage III; and 5%, stage IV .\nEndometrial cancer most often spreads to the lungs, liver,\nbones, brain, vagina, and certain lymph nodes.\nPrevention\nWomen (especially postmenopausal women) should\nreport any abnormal vaginal bleeding or discharge to the\ndoctor. Controlling obesity, blood pressure, and diabetes', 'can help to reduce the risk of this disease. Women on\nestrogen replacement therapy have a substantially\nreduced risk of endometrial cancer if progestins are taken\nsimultaneously. Long term use of birth control pills has\nbeen shown to reduce the risk of this cancer. Women who\nhave irregular periods may be prescribed birth control\npills to help prevent endometrial cancer. Women who are\ntaking tamoxifen and those who carry the hereditary non-', 'Alternative Cancer Methods. Atlanta: American Cancer\nSociety, 2000.\nBurke, Thomas, Patricia Eifel, and Muggia Franco. Cancers\nof the Uterine Body. In Cancer: Principles & Practice of\nOncology, ed. Vincent DeVita, Samuel Hellman, and\nSteven Rosenberg. Philadelphia: Lippincott Williams &\nWilkins, 2001, 1573 86.\nLong, Harry. Carcinoma of the Endometrium. In Current\nTherapy in Cancer, ed. John Foley, Julie V ose, and James\nArmitage. Philadelphia: W. B. Saunders Company, 1999,\n16266.', 'slow the growth of endometrial cells. These drugs are\nusually available as pills. This therapy is usually reserved\nfor women with advanced or recurrent disease. Side\neffects include fatigue, fluid retention, and appetite and\nweight changes.\nAlternative treatment\nAlthough alternative and complementary therapies are\nused by many cancer patients, very few controlled studies\non the effectiveness of such therapies exist. Mind-body\ntechniques, such as prayer, biofeedback, visualization,', 'the pelvis may be used in place of internal radiation therapy.    -  Radiation therapy alone for patients who cannot have surgery.    - A clinical trial of a new chemotherapy regimen.        If cancer has spread to the cervix, a radical hysterectomy with bilateral salpingo-oophorectomy may be done.    High-risk endometrial cancer (grade 3)    Treatment of high-risk stage I endometrial cancer and stage II endometrial cancer may include the following:         -  Surgery (radical hysterectomy and']","To prevent endometrial cancer, women, especially postmenopausal women, should report any abnormal vaginal bleeding or discharge to their doctor. Controlling obesity, blood pressure, and diabetes can help reduce the risk of this disease. Additionally, women on estrogen replacement therapy may have a substantially reduced risk of endometrial cancer if progestins are taken simultaneously. Long-term use of birth control pills has also been shown to reduce the risk of this cancer. Women with irregular periods may be prescribed birth control pills to help prevent endometrial cancer.","Key Points
                    - Avoiding risk factors and increasing protective factors may help prevent cancer.    - The following risk factors increase the risk of endometrial cancer:          - Endometrial hyperplasia     - Estrogen     - Tamoxifen     - Obesity, weight gain, metabolic syndrome, and diabetes     - Genetic factors        - The following protective factors decrease the risk of endometrial cancer:         - Pregnancy and breast-feeding     - Combination oral contraceptives     - Physical activity     - Cigarette smoking        - It is not known if the following factors affect the risk of endometrial cancer:         - Weight loss     - Fruits, vegetables, and vitamins        - Cancer prevention clinical trials are used to study ways to prevent cancer.    - New ways to prevent endometrial cancer are being studied in clinical trials.
                
                
                    Avoiding risk factors and increasing protective factors may help prevent cancer.
                    Avoiding cancer risk factors may help prevent certain cancers. Risk factors include smoking, being overweight, and not getting enough exercise. Increasing protective factors such as quitting smoking and exercising may also help prevent some cancers. Talk to your doctor or other health care professional about how you might lower your risk of cancer.
                
                
                    The following risk factors increase the risk of endometrial cancer:
                    Endometrial hyperplasia     Endometrial hyperplasia is an abnormal thickening of the endometrium (lining of the uterus). It is not cancer, but in some cases, it may lead to endometrial cancer.        Estrogen     Estrogen is a hormone made by the body. It helps the body develop and maintain female sex characteristics. Estrogen can affect the growth of some cancers, including endometrial cancer.     A woman's risk of developing endometrial cancer is increased by being exposed to estrogen in the following ways:            - Estrogen-only hormone replacement therapy: Estrogen may be given to replace the estrogen no longer produced by the ovaries in postmenopausal women or women whose ovaries have been removed. This is called hormone replacement therapy (HRT), or hormone therapy (HT). The use of HRT that contains only estrogen increases the risk of endometrial cancer and endometrial hyperplasia. For this reason, estrogen therapy alone is usually prescribed only for women who do not have a uterus. HRT that contains only estrogen also increases the risk of stroke and blood clots. When estrogen is combined with progestin (another hormone), it is called combination estrogen-progestin replacement therapy. For postmenopausal women, taking estrogen in combination with progestin does not increase the risk of endometrial cancer, but it does increase the risk of breast cancer. (See the Breast Cancer Prevention summary for more information.)     - Early menstruation: Beginning to have menstrual periods at an early age increases the number of years the body is exposed to estrogen and increases a woman's risk of endometrial cancer.     - Late menopause: Women who reach menopause at an older age are exposed to estrogen for a longer time and have an increased risk of endometrial cancer.     - Never being pregnant: Because estrogen levels are lower during pregnancy, women who have never been pregnant are exposed to estrogen for a longer time than women who have been pregnant. This increases the risk of endometrial cancer.               Tamoxifen     Tamoxifen is one of a group of drugs called selective estrogen receptor modulators, or SERMs. Tamoxifen acts like estrogen on some tissues in the body, such as the uterus, but blocks the effects of estrogen on other tissues, such as the breast. Tamoxifen is used to prevent breast cancer in women who are at high risk for the disease. However, using tamoxifen for more than 2 years increases the risk of endometrial cancer. This risk is greater in postmenopausal women.      Raloxifene is a SERM that is used to prevent bone weakness in postmenopausal women. However, it does not have estrogen-like effects on the uterus and has not been shown to increase the risk of endometrial cancer.        Obesity, weight gain, metabolic syndrome, and diabetes     Obesity, gaining weight as an adult, or having metabolic syndrome increases the risk of endometrial cancer. Obesity is related to other risk factors such as high estrogen levels, having extra fat around the waist, polycystic ovary syndrome, and lack of physical activity.    Having metabolic syndrome increases the risk of endometrial cancer. Metabolic syndrome is a condition that includes extra fat around the waist, high blood sugar, high blood pressure, and high levels of triglycerides (a type of fat) in the blood.        Genetic factors     Hereditary nonpolyposis colon cancer (HNPCC) syndrome (also known as Lynch Syndrome) is an inherited disorder caused by changes in certain genes. Women who have HNPCC syndrome have a much higher risk of developing endometrial cancer than women who do not have HNPCC syndrome.    Polycystic ovary syndrome (a disorder of the hormones made by the ovaries), and Cowden syndrome are inherited conditions that are linked to an increased risk of endometrial cancer.    Women with a family history of endometrial cancer in a first-degree relative (mother, sister, or daughter) are also at increased risk of endometrial cancer.
                
                
                    The following protective factors decrease the risk of endometrial cancer:
                    Pregnancy and breast-feeding    Estrogen levels are lower during pregnancy and when breast-feeding. The risk of endometrial cancer is lower in women who have had children. Breastfeeding for more than 18 months also decreases the risk of endometrial cancer.       Combination oral contraceptives    Taking contraceptives that combine estrogen and progestin (combination oral contraceptives) decreases the risk of endometrial cancer. The protective effect of combination oral contraceptives increases with the length of time they are used, and can last for many years after oral contraceptive use has been stopped.    While taking oral contraceptives, women have a higher risk of blood clots, stroke, and heart attack, especially women who smoke and are older than 35 years.       Physical activity    Physical activity at home (exercise) or on the job may lower the risk of endometrial cancer.        Cigarette smoking     Smoking at least 20 cigarettes a day may lower the risk of endometrial cancer. The risk of endometrial cancer is even lower in postmenopausal women who smoke.    However, there are many proven harms of smoking. Cigarette smokers live about 10 years less than nonsmokers. Cigarette smokers also have an increased risk of the following:            - Heart disease.     -  Head and neck cancers.     -  Lung cancer.     -  Bladder cancer.     -  Pancreatic cancer.
                
                
                    It is not known if the following factors affect the risk of endometrial cancer:
                    Weight loss    It is not known if losing weight decreases the risk of endometrial cancer.       Fruits, vegetables, and vitamins    A diet that includes, fruits, vegetables, phytoestrogen, soy, and vitamin D has not been found to affect the risk of endometrial cancer.     Taking multivitamins has little or no effect on the risk of common cancers, including endometrial cancer.
                
                
                    Cancer prevention clinical trials are used to study ways to prevent cancer.
                    Cancer prevention clinical trials are used to study ways to lower the risk of developing certain types of cancer. Some cancer prevention trials are conducted with healthy people who have not had cancer but who have an increased risk for cancer. Other prevention trials are conducted with people who have had cancer and are trying to prevent another cancer of the same type or to lower their chance of developing a new type of cancer. Other trials are done with healthy volunteers who are not known to have any risk factors for cancer.    The purpose of some cancer prevention clinical trials is to find out whether actions people take can prevent cancer. These may include eating fruits and vegetables, exercising, quitting smoking, or taking certain medicines, vitamins, minerals, or food supplements.
                
                
                    New ways to prevent endometrial cancer are being studied in clinical trials.
                    Clinical trials are taking place in many parts of the country. Information about clinical trials can be found in the Clinical Trials section of the NCI website. Check NCI's list of cancer clinical trials for endometrial cancer prevention trials that are now accepting patients.",1.0,0.9585046500766331,0.9999999999875,0.75
Who is at risk for Endometrial Cancer? ?,"['{\n  ""question"": ""Who is at risk for Endometrial Cancer? ?"",', 'early, the chances of curing it are excellent. The five year\nsurvival rates for endometrial cancer by stage are: 90%,\nstage I; 60%, stage II; 40%, stage III; and 5%, stage IV .\nEndometrial cancer most often spreads to the lungs, liver,\nbones, brain, vagina, and certain lymph nodes.\nPrevention\nWomen (especially postmenopausal women) should\nreport any abnormal vaginal bleeding or discharge to the\ndoctor. Controlling obesity, blood pressure, and diabetes', ""the risk of endometrial cancer.\\n                    Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. Talk with your doctor if you think you may be at risk. Risk factors for endometrial cancer include the following:         - Having endometrial hyperplasia.    - Being obese.    - Having metabolic syndrome, a set of conditions that occur"", 'African Americans. American Indians, Koreans, and\nVietnamese have the lowest incidence. African American\nand Hawaiian women are more likely to be diagnosed\nwith advanced cancer and, therefore, have a higher risk\nof dying from the disease.\nCauses and symptoms\nAlthough the exact cause of endometrial cancer is\nunknown, it is clear that high levels of estrogen, when\nnot balanced by progesterone, can lead to abnormal\ngrowth of the endometrium. Factors that increase a', 'breast cancer, increases a womans chance of develop-\ning endometrial cancer. Tamoxifen users tend to have\nmore advanced endometrial cancer with an associated\npoorer survival rate than those who do not take the\ndrug. In many cases, however, the value of tamoxifen\nfor treating breast cancer and for preventing the cancer\nfrom spreading far outweighs the small risk of getting\nendometrial cancer.\n Family history. Some studies suggest that endometrial', 'er risk of getting endometrial cancer if progesterone is\nnot taken simultaneously.\n Diabetes. Diabetics have twice the risk of getting this\ncancer as nondiabetic women. It is not clear if this risk\nis due to the fact that many diabetics are also obese and\nhypertensive. One 1998 study found that women who\nwere obese and diabetic were three times more likely to\ndevelop endometrial cancer than women who were\nobese but nondiabetic. This study also found that', 'have a follow-up exam and a biopsy of the endometrial lining if needed. Women taking estrogen (a hormone that can affect the growth of some cancers) alone also have an increased risk of endometrial cancer. Taking estrogen combined with progesterone (another hormone) does not increase a womans risk of endometrial cancer.""', '\\n                \\n                    Endometrial cancer is the most common invasive cancer of the female reproductive system.\\n                    Endometrial cancer is diagnosed most often in postmenopausal women at an average age of 60 years .   From 2004 to 2013, the number of new cases of endometrial cancer increased slightly in white and African American women. From 2005 to 2014, the number of deaths from endometrial cancer also increased slightly in white and African']","Risk factors for endometrial cancer include:

- Having endometrial hyperplasia.
- Being obese.
- Having metabolic syndrome, which is a set of conditions that occur together.
- A family history of endometrial cancer.
- Having diabetes, as diabetics have twice the risk of developing this cancer compared to nondiabetic women.
- Taking estrogen alone, which increases the risk, while taking estrogen combined with progesterone does not.
- Women diagnosed with breast cancer and treated with tamoxifen may also have an increased risk.

Additionally, postmenopausal women, particularly those around the average age of 60, are at a higher risk, and certain ethnic groups, such as African American and Hawaiian women, are more likely to be diagnosed with advanced stages of the disease.","Key Points
                    - Avoiding risk factors and increasing protective factors may help prevent cancer.    - The following risk factors increase the risk of endometrial cancer:          - Endometrial hyperplasia     - Estrogen     - Tamoxifen     - Obesity, weight gain, metabolic syndrome, and diabetes     - Genetic factors        - The following protective factors decrease the risk of endometrial cancer:         - Pregnancy and breast-feeding     - Combination oral contraceptives     - Physical activity     - Cigarette smoking        - It is not known if the following factors affect the risk of endometrial cancer:         - Weight loss     - Fruits, vegetables, and vitamins        - Cancer prevention clinical trials are used to study ways to prevent cancer.    - New ways to prevent endometrial cancer are being studied in clinical trials.
                
                
                    Avoiding risk factors and increasing protective factors may help prevent cancer.
                    Avoiding cancer risk factors may help prevent certain cancers. Risk factors include smoking, being overweight, and not getting enough exercise. Increasing protective factors such as quitting smoking and exercising may also help prevent some cancers. Talk to your doctor or other health care professional about how you might lower your risk of cancer.
                
                
                    The following risk factors increase the risk of endometrial cancer:
                    Endometrial hyperplasia     Endometrial hyperplasia is an abnormal thickening of the endometrium (lining of the uterus). It is not cancer, but in some cases, it may lead to endometrial cancer.        Estrogen     Estrogen is a hormone made by the body. It helps the body develop and maintain female sex characteristics. Estrogen can affect the growth of some cancers, including endometrial cancer.     A woman's risk of developing endometrial cancer is increased by being exposed to estrogen in the following ways:            - Estrogen-only hormone replacement therapy: Estrogen may be given to replace the estrogen no longer produced by the ovaries in postmenopausal women or women whose ovaries have been removed. This is called hormone replacement therapy (HRT), or hormone therapy (HT). The use of HRT that contains only estrogen increases the risk of endometrial cancer and endometrial hyperplasia. For this reason, estrogen therapy alone is usually prescribed only for women who do not have a uterus. HRT that contains only estrogen also increases the risk of stroke and blood clots. When estrogen is combined with progestin (another hormone), it is called combination estrogen-progestin replacement therapy. For postmenopausal women, taking estrogen in combination with progestin does not increase the risk of endometrial cancer, but it does increase the risk of breast cancer. (See the Breast Cancer Prevention summary for more information.)     - Early menstruation: Beginning to have menstrual periods at an early age increases the number of years the body is exposed to estrogen and increases a woman's risk of endometrial cancer.     - Late menopause: Women who reach menopause at an older age are exposed to estrogen for a longer time and have an increased risk of endometrial cancer.     - Never being pregnant: Because estrogen levels are lower during pregnancy, women who have never been pregnant are exposed to estrogen for a longer time than women who have been pregnant. This increases the risk of endometrial cancer.               Tamoxifen     Tamoxifen is one of a group of drugs called selective estrogen receptor modulators, or SERMs. Tamoxifen acts like estrogen on some tissues in the body, such as the uterus, but blocks the effects of estrogen on other tissues, such as the breast. Tamoxifen is used to prevent breast cancer in women who are at high risk for the disease. However, using tamoxifen for more than 2 years increases the risk of endometrial cancer. This risk is greater in postmenopausal women.      Raloxifene is a SERM that is used to prevent bone weakness in postmenopausal women. However, it does not have estrogen-like effects on the uterus and has not been shown to increase the risk of endometrial cancer.        Obesity, weight gain, metabolic syndrome, and diabetes     Obesity, gaining weight as an adult, or having metabolic syndrome increases the risk of endometrial cancer. Obesity is related to other risk factors such as high estrogen levels, having extra fat around the waist, polycystic ovary syndrome, and lack of physical activity.    Having metabolic syndrome increases the risk of endometrial cancer. Metabolic syndrome is a condition that includes extra fat around the waist, high blood sugar, high blood pressure, and high levels of triglycerides (a type of fat) in the blood.        Genetic factors     Hereditary nonpolyposis colon cancer (HNPCC) syndrome (also known as Lynch Syndrome) is an inherited disorder caused by changes in certain genes. Women who have HNPCC syndrome have a much higher risk of developing endometrial cancer than women who do not have HNPCC syndrome.    Polycystic ovary syndrome (a disorder of the hormones made by the ovaries), and Cowden syndrome are inherited conditions that are linked to an increased risk of endometrial cancer.    Women with a family history of endometrial cancer in a first-degree relative (mother, sister, or daughter) are also at increased risk of endometrial cancer.
                
                
                    It is not known if the following factors affect the risk of endometrial cancer:
                    Weight loss    It is not known if losing weight decreases the risk of endometrial cancer.       Fruits, vegetables, and vitamins    A diet that includes, fruits, vegetables, phytoestrogen, soy, and vitamin D has not been found to affect the risk of endometrial cancer.     Taking multivitamins has little or no effect on the risk of common cancers, including endometrial cancer.",0.9285714285714286,0.947722738642653,0.9999999999875,0.75
what research (or clinical trials) is being done for Endometrial Cancer ?,"['{\n  ""question"": ""what research (or clinical trials) is being done for Endometrial Cancer ?"",', 'slow the growth of endometrial cells. These drugs are\nusually available as pills. This therapy is usually reserved\nfor women with advanced or recurrent disease. Side\neffects include fatigue, fluid retention, and appetite and\nweight changes.\nAlternative treatment\nAlthough alternative and complementary therapies are\nused by many cancer patients, very few controlled studies\non the effectiveness of such therapies exist. Mind-body\ntechniques, such as prayer, biofeedback, visualization,', 'early, the chances of curing it are excellent. The five year\nsurvival rates for endometrial cancer by stage are: 90%,\nstage I; 60%, stage II; 40%, stage III; and 5%, stage IV .\nEndometrial cancer most often spreads to the lungs, liver,\nbones, brain, vagina, and certain lymph nodes.\nPrevention\nWomen (especially postmenopausal women) should\nreport any abnormal vaginal bleeding or discharge to the\ndoctor. Controlling obesity, blood pressure, and diabetes', 'and stage II endometrial carcinoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.\\n\\t\\t                \\n\\t\\t                \\n\\t\\t                    Stage III, Stage IV, and Recurrent Endometrial Cancer\\n\\t\\t', 'of developing a new type of cancer. Other trials are done with healthy volunteers who are not known to have any risk factors for cancer.    The purpose of some cancer prevention clinical trials is to find out whether actions people take can prevent cancer. These may include eating fruits and vegetables, exercising, quitting smoking, or taking certain medicines, vitamins, minerals, or food supplements.\\n                \\n                \\n                    New ways to prevent endometrial', 'Alternative Cancer Methods. Atlanta: American Cancer\nSociety, 2000.\nBurke, Thomas, Patricia Eifel, and Muggia Franco. Cancers\nof the Uterine Body. In Cancer: Principles & Practice of\nOncology, ed. Vincent DeVita, Samuel Hellman, and\nSteven Rosenberg. Philadelphia: Lippincott Williams &\nWilkins, 2001, 1573 86.\nLong, Harry. Carcinoma of the Endometrium. In Current\nTherapy in Cancer, ed. John Foley, Julie V ose, and James\nArmitage. Philadelphia: W. B. Saunders Company, 1999,\n16266.', 'or after starting their cancer treatment.    - Follow-up tests may be needed.\\n                \\n                \\n                    There are different types of treatment for patients with endometrial cancer.\\n                    Different types of treatment are available for patients with endometrial cancer. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current', 'the following PDQ summaries for more information about endometrial cancer:         -  Endometrial Cancer Treatment     -  Endometrial Cancer Prevention\\n                \\n                \\n                    In the United States, endometrial cancer is the most common invasive cancer of the female reproductive system.\\n                    Endometrial cancer is diagnosed most often in postmenopausal women at an average age of 60 years.   From 2004 to 2013, the number of new cases of endometrial']","Research and clinical trials for endometrial cancer include studies focused on new treatment options, including chemotherapy and hormonal therapies aimed at slowing the growth of endometrial cells. These therapies are typically reserved for women with advanced or recurrent disease. Additionally, clinical trials may explore alternative methods of prevention, such as lifestyle changes (diet, exercise, smoking cessation) and the use of certain medicines or supplements. Patients are encouraged to discuss with their doctors about available clinical trials that may be suitable for their specific situation. General information about clinical trials can be found on the NCI website.","Cancer prevention clinical trials are used to study ways to prevent cancer.
                    Cancer prevention clinical trials are used to study ways to lower the risk of developing certain types of cancer. Some cancer prevention trials are conducted with healthy people who have not had cancer but who have an increased risk for cancer. Other prevention trials are conducted with people who have had cancer and are trying to prevent another cancer of the same type or to lower their chance of developing a new type of cancer. Other trials are done with healthy volunteers who are not known to have any risk factors for cancer.    The purpose of some cancer prevention clinical trials is to find out whether actions people take can prevent cancer. These may include eating fruits and vegetables, exercising, quitting smoking, or taking certain medicines, vitamins, minerals, or food supplements.
                
                
                    New ways to prevent endometrial cancer are being studied in clinical trials.
                    Clinical trials are taking place in many parts of the country. Information about clinical trials can be found in the Clinical Trials section of the NCI website. Check NCI's list of cancer clinical trials for endometrial cancer prevention trials that are now accepting patients.",1.0,0.9545549481365083,0.9617346938638119,1.0
What is (are) Endometrial Cancer ?,"['Endometrial cancer\nDefinition\nEndometrial cancer develops when the cells that\nmake up the inner lining of the uterus (the endometrium)\nbecome abnormal and grow uncontrollably.\nDescription\nEndometrial cancer (also called uterine cancer) is\nthe fourth most common type of cancer among women\nand the most common gynecologic cancer. Approximate-\nly 34,000 women are diagnosed with endometrial cancer\neach year. In 1998, approximately 6,300 women died', '{\n  ""question"": ""What is (are) Endometrial Cancer ?"",', 'KEY TERMS\nEndometrial polypsA growth in the lining of the\nuterus (endometrium) that may cause bleeding\nand can develop into cancer.\nEpidural anesthesia A type of anesthesia that is\ninjected into the epidural space of the spinal cord\nto numb the nerves leading to the lower half of the\nbody.\nUterine fibroid A noncancerous tumor of the\nuterus that can range from the size of a pea to the\nsize of a grapefruit. Small fibroids require no treat-\nment, but those causing serious symptoms may', 'is done in the outpatient surgery department of a hospital\nGALE ENCYCLOPEDIA OF MEDICINE 2\n1189\nEndometrial cancer\nCancer located in the uterus. (Illustration by Argosy Inc.)', 'three subtypes of endometrial cancer that are considered grade 3.""', 'OTHER\nCancer of the Uterus. Cancernet. Dec. 2000. 13 Mar. 2001\n<http://cancernet.nci.nih.gov/wyntk_pubs/uterus.htm>.\nLata Cherath\nBelinda Rowland, Ph.D.\nEndometriosis\nDefinition\nEndometriosis is a condition in which bits of the tis-\nsue similar to the lining of the uterus (endometrium) grow\nin other parts of the body. Like the uterine lining, this tis-\nsue builds up and sheds in response to monthly hormonal\ncycles. However, there is no natural outlet for the blood', 'pelvis.     - Tests that examine the endometrium are used to detect (find) and diagnose endometrial cancer.    - Certain factors affect prognosis (chance of recovery) and treatment options.\\n                \\n                \\n                    Endometrial cancer is a disease in which malignant (cancer) cells form in the tissues of the endometrium.\\n                    The endometrium is the lining of the uterus, a hollow, muscular organ in a womans pelvis. The uterus is where a fetus grows.', 'the following PDQ summaries for more information about endometrial cancer:         -  Endometrial Cancer Treatment     -  Endometrial Cancer Prevention\\n                \\n                \\n                    In the United States, endometrial cancer is the most common invasive cancer of the female reproductive system.\\n                    Endometrial cancer is diagnosed most often in postmenopausal women at an average age of 60 years.   From 2004 to 2013, the number of new cases of endometrial']","Endometrial cancer develops when the cells that make up the inner lining of the uterus (the endometrium) become abnormal and grow uncontrollably. It is also known as uterine cancer and is the most common gynecologic cancer, with approximately 34,000 women diagnosed each year in the United States. Endometrial cancer is primarily diagnosed in postmenopausal women, with an average age of diagnosis around 60 years.","Key Points
                    - Endometrial cancer is a disease in which malignant (cancer) cells form in the tissues of the endometrium.     - Obesity and having metabolic syndrome may increase the risk of endometrial cancer.    - Taking tamoxifen for breast cancer or taking estrogen alone (without progesterone) can increase the risk of endometrial cancer.     - Signs and symptoms of endometrial cancer include unusual vaginal bleeding or pain in the pelvis.     - Tests that examine the endometrium are used to detect (find) and diagnose endometrial cancer.    - Certain factors affect prognosis (chance of recovery) and treatment options.
                
                
                    Endometrial cancer is a disease in which malignant (cancer) cells form in the tissues of the endometrium.
                    The endometrium is the lining of the uterus, a hollow, muscular organ in a womans pelvis. The uterus is where a fetus grows. In most nonpregnant women, the uterus is about 3 inches long. The lower, narrow end of the uterus is the cervix, which leads to the vagina.     Cancer of the endometrium is different from cancer of the muscle of the uterus, which is called sarcoma of the uterus. See the PDQ summary on Uterine Sarcoma Treatment for more information about uterine sarcoma.
                
                
                    Obesity and having metabolic syndrome may increase the risk of endometrial cancer.
                    Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. Talk with your doctor if you think you may be at risk. Risk factors for endometrial cancer include the following:         - Having endometrial hyperplasia.    - Being obese.    - Having metabolic syndrome, a set of conditions that occur together, including extra fat around the abdomen, high blood sugar, high blood pressure, high levels of triglycerides and low levels of high-density lipoproteins in the blood.    -  Never giving birth.    - Beginning menstruation at an early age.    - Reaching menopause at an older age.    - Having polycystic ovarian syndrome (PCOS).     -  Having a mother, sister, or daughter with uterine cancer.    - Having a certain gene change that is linked to Lynch syndrome (hereditary non-polyposis colon cancer).     - Having hyperinsulinemia (high levels of insulin in the blood).
                
                
                    Taking tamoxifen for breast cancer or taking estrogen alone (without progesterone) can increase the risk of endometrial cancer.
                    Endometrial cancer may develop in breast cancer patients who have been treated with tamoxifen. A patient who takes this drug and has abnormal vaginal bleeding should have a follow-up exam and a biopsy of the endometrial lining if needed. Women taking estrogen (a hormone that can affect the growth of some cancers) alone also have an increased risk of endometrial cancer. Taking estrogen combined with progesterone (another hormone) does not increase a womans risk of endometrial cancer.",1.0,0.9075663976503675,0.9999999999875,0.6
Who is at risk for Endometrial Cancer? ?,"['{\n  ""question"": ""Who is at risk for Endometrial Cancer? ?"",', 'early, the chances of curing it are excellent. The five year\nsurvival rates for endometrial cancer by stage are: 90%,\nstage I; 60%, stage II; 40%, stage III; and 5%, stage IV .\nEndometrial cancer most often spreads to the lungs, liver,\nbones, brain, vagina, and certain lymph nodes.\nPrevention\nWomen (especially postmenopausal women) should\nreport any abnormal vaginal bleeding or discharge to the\ndoctor. Controlling obesity, blood pressure, and diabetes', ""the risk of endometrial cancer.\\n                    Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. Talk with your doctor if you think you may be at risk. Risk factors for endometrial cancer include the following:         - Having endometrial hyperplasia.    - Being obese.    - Having metabolic syndrome, a set of conditions that occur"", 'African Americans. American Indians, Koreans, and\nVietnamese have the lowest incidence. African American\nand Hawaiian women are more likely to be diagnosed\nwith advanced cancer and, therefore, have a higher risk\nof dying from the disease.\nCauses and symptoms\nAlthough the exact cause of endometrial cancer is\nunknown, it is clear that high levels of estrogen, when\nnot balanced by progesterone, can lead to abnormal\ngrowth of the endometrium. Factors that increase a', 'breast cancer, increases a womans chance of develop-\ning endometrial cancer. Tamoxifen users tend to have\nmore advanced endometrial cancer with an associated\npoorer survival rate than those who do not take the\ndrug. In many cases, however, the value of tamoxifen\nfor treating breast cancer and for preventing the cancer\nfrom spreading far outweighs the small risk of getting\nendometrial cancer.\n Family history. Some studies suggest that endometrial', 'er risk of getting endometrial cancer if progesterone is\nnot taken simultaneously.\n Diabetes. Diabetics have twice the risk of getting this\ncancer as nondiabetic women. It is not clear if this risk\nis due to the fact that many diabetics are also obese and\nhypertensive. One 1998 study found that women who\nwere obese and diabetic were three times more likely to\ndevelop endometrial cancer than women who were\nobese but nondiabetic. This study also found that', 'have a follow-up exam and a biopsy of the endometrial lining if needed. Women taking estrogen (a hormone that can affect the growth of some cancers) alone also have an increased risk of endometrial cancer. Taking estrogen combined with progesterone (another hormone) does not increase a womans risk of endometrial cancer.""', '\\n                \\n                    Endometrial cancer is the most common invasive cancer of the female reproductive system.\\n                    Endometrial cancer is diagnosed most often in postmenopausal women at an average age of 60 years .   From 2004 to 2013, the number of new cases of endometrial cancer increased slightly in white and African American women. From 2005 to 2014, the number of deaths from endometrial cancer also increased slightly in white and African']","Risk factors for endometrial cancer include:

- Having endometrial hyperplasia.
- Being obese.
- Having metabolic syndrome, which is a set of conditions that occur together.
- A family history of endometrial cancer.
- Being diabetic, as diabetics have twice the risk compared to nondiabetic women.
- Taking estrogen alone without progesterone, which increases the risk, whereas taking estrogen combined with progesterone does not.
- Previous history of breast cancer, which increases the chance of developing endometrial cancer.
- Ethnic background, as African American and Hawaiian women are more likely to be diagnosed with advanced cancer.

Women, especially postmenopausal women, should report any abnormal vaginal bleeding or discharge to their doctor.","Obesity and having metabolic syndrome may increase the risk of endometrial cancer.
                    Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. Talk with your doctor if you think you may be at risk. Risk factors for endometrial cancer include the following:         - Having endometrial hyperplasia.    - Being obese.    - Having metabolic syndrome, a set of conditions that occur together, including extra fat around the abdomen, high blood sugar, high blood pressure, high levels of triglycerides and low levels of high-density lipoproteins in the blood.    -  Never giving birth.    - Beginning menstruation at an early age.    - Reaching menopause at an older age.    - Having polycystic ovarian syndrome (PCOS).     -  Having a mother, sister, or daughter with uterine cancer.    - Having a certain gene change that is linked to Lynch syndrome (hereditary non-polyposis colon cancer).     - Having hyperinsulinemia (high levels of insulin in the blood).
                
                
                    Taking tamoxifen for breast cancer or taking estrogen alone (without progesterone) can increase the risk of endometrial cancer.
                    Endometrial cancer may develop in breast cancer patients who have been treated with tamoxifen. A patient who takes this drug and has abnormal vaginal bleeding should have a follow-up exam and a biopsy of the endometrial lining if needed. Women taking estrogen (a hormone that can affect the growth of some cancers) alone also have an increased risk of endometrial cancer. Taking estrogen combined with progesterone (another hormone) does not increase a womans risk of endometrial cancer.",1.0,0.9470178489178577,0.9999999999875,0.5625
What are the symptoms of Endometrial Cancer ?,"['""ground_truth"": ""Signs and symptoms of endometrial cancer include unusual vaginal bleeding or pain in the pelvis. These and other signs and symptoms may be caused by endometrial cancer or by other conditions. Check with your doctor if you have any of the following:         - Vaginal bleeding or discharge not related to menstruation (periods).    - Vaginal bleeding after menopause.    - Difficult or painful urination.    - Pain during sexual intercourse.    - Pain in the pelvic area.""\n}', '{\n  ""question"": ""What are the symptoms of Uterine Sarcoma ?"",', 'In the uterus, the most common symptom is bleeding.\nCancers in the ovary often have only subtle signs such as\nKEY TERMS\nBiopsyA sample of an organ taken to look for\nabnormalities. Also, the technique used to take such\nsamples.\nChemotherapy The treatment of cancer with\ndrugs.\nComputed tomography (CT)A special x ray tech-\nnique that produces a cross sectional image of the\norgans inside the body.\nExtragonadal In a location other than the repro-\nductive organs.', 'Diagnosis\nIf endometrial cancer is suspected, a series of tests\nwill be conducted to confirm the diagnosis. The first\nstep will involve taking a complete personal and family\nmedical history. A physical examination , which will\ninclude a thorough pelvic examination, will also be\ndone.\nThe doctor may order an endometrial biopsy . This\nis generally performed in the doctors office and does not\nrequire anesthesia. A thin, flexible tube is inserted', '{\n  ""question"": ""What are the stages of Endometrial Cancer ?"",', '""ground_truth"": ""Key Points\\n                    - Endometrial cancer is a disease in which malignant (cancer) cells form in the tissues of the endometrium.     - Obesity and having metabolic syndrome may increase the risk of endometrial cancer.    - Taking tamoxifen for breast cancer or taking estrogen alone (without progesterone) can increase the risk of endometrial cancer.     - Signs and symptoms of endometrial cancer include unusual vaginal bleeding or pain in the pelvis.     - Tests', 'the disease is in an advanced stage. Then it is hard to treat. Symptoms may include       - A heavy feeling in the pelvis    - Pain in the lower abdomen    -  Bleeding from the vagina    -  Weight gain or loss    -  Abnormal periods    -  Unexplained back pain that gets worse    -  Gas, nausea, vomiting, or loss of appetite       To diagnose ovarian cancer, doctors do one or more tests. They include a physical exam, a pelvic exam, lab tests, ultrasound, or a biopsy. Treatment is usually surgery', '""ground_truth"": ""The uterus, or womb, is an important female reproductive organ. It is the place where a baby grows when a women is pregnant. There are different types of uterine cancer. The most common type starts in the endometrium, the lining of the uterus. This type of cancer is sometimes called endometrial cancer.     The symptoms of uterine cancer include       - Unusual vaginal bleeding or discharge    - Trouble urinating    - Pelvic pain    - Pain during intercourse       Uterine']","Signs and symptoms of endometrial cancer include unusual vaginal bleeding or discharge not related to menstruation, vaginal bleeding after menopause, difficult or painful urination, pain during sexual intercourse, and pain in the pelvic area. If you experience any of these symptoms, it is important to check with your doctor.",Signs and symptoms of endometrial cancer include unusual vaginal bleeding or pain in the pelvis. These and other signs and symptoms may be caused by endometrial cancer or by other conditions. Check with your doctor if you have any of the following:         - Vaginal bleeding or discharge not related to menstruation (periods).    - Vaginal bleeding after menopause.    - Difficult or painful urination.    - Pain during sexual intercourse.    - Pain in the pelvic area.,1.0,0.9682917900907363,0.5654761904620536,1.0
How to diagnose Endometrial Cancer ?,"['Diagnosis\nIf endometrial cancer is suspected, a series of tests\nwill be conducted to confirm the diagnosis. The first\nstep will involve taking a complete personal and family\nmedical history. A physical examination , which will\ninclude a thorough pelvic examination, will also be\ndone.\nThe doctor may order an endometrial biopsy . This\nis generally performed in the doctors office and does not\nrequire anesthesia. A thin, flexible tube is inserted', 'GALE ENCYCLOPEDIA OF MEDICINE 2\n1192\nEndometriosis', 'women who are near menopause (perimenopausal),\nsymptoms of endometrial cancer could include bleeding\nbetween periods (intermenstrual bleeding), heavy bleed-\ning that lasts for more than seven days, or short menstru-\nal cycles (fewer than 21 days). For women who have\ngone through menopause, any vaginal bleeding or abnor-\nmal discharge is suspect. Pain in the pelvic region and\nthe presence of a lump (mass) are symptoms that occur\nlate in the disease.\nDiagnosis', 'and stage II endometrial carcinoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.\\n\\t\\t                \\n\\t\\t                \\n\\t\\t                    Stage III, Stage IV, and Recurrent Endometrial Cancer\\n\\t\\t', '{\n  ""question"": ""How to diagnose Endometrial Cancer ?"",', 'Endometrial cancer\nDefinition\nEndometrial cancer develops when the cells that\nmake up the inner lining of the uterus (the endometrium)\nbecome abnormal and grow uncontrollably.\nDescription\nEndometrial cancer (also called uterine cancer) is\nthe fourth most common type of cancer among women\nand the most common gynecologic cancer. Approximate-\nly 34,000 women are diagnosed with endometrial cancer\neach year. In 1998, approximately 6,300 women died', 'with metastatic breast cancer (cancer that has spread to other parts of the body). Hormone therapy with tamoxifen or estrogens can act on cells all over the body and may increase the chance of developing endometrial cancer. Women taking tamoxifen should have a pelvic exam every year to look for any signs of cancer. Any vaginal bleeding, other than menstrual bleeding, should be reported to a doctor as soon as possible.    Hormone therapy with a luteinizing hormone-releasing hormone (LHRH)', 'In the uterus, the most common symptom is bleeding.\nCancers in the ovary often have only subtle signs such as\nKEY TERMS\nBiopsyA sample of an organ taken to look for\nabnormalities. Also, the technique used to take such\nsamples.\nChemotherapy The treatment of cancer with\ndrugs.\nComputed tomography (CT)A special x ray tech-\nnique that produces a cross sectional image of the\norgans inside the body.\nExtragonadal In a location other than the repro-\nductive organs.']","To diagnose endometrial cancer, a series of tests will be conducted. The first step involves taking a complete personal and family medical history, followed by a physical examination that includes a thorough pelvic examination. The doctor may also order an endometrial biopsy, which is generally performed in the doctor's office without the need for anesthesia. This process involves inserting a thin, flexible tube to obtain a sample of the endometrial tissue for analysis. If endometrial cancer is suspected, these steps are crucial for confirming the diagnosis.","Tests that examine the endometrium are used to detect (find) and diagnose endometrial cancer. Because endometrial cancer begins inside the uterus, it does not usually show up in the results of a Pap test. For this reason, a sample of endometrial tissue must be removed and checked under a microscope to look for cancer cells. One of the following procedures may be used:         -   Endometrial biopsy : The removal of tissue from the endometrium (inner lining of the uterus) by inserting a thin, flexible tube through the cervix and into the uterus. The tube is used to gently scrape a small amount of tissue from the endometrium and then remove the tissue samples. A pathologist views the tissue under a microscope to look for cancer cells.    -   Dilatation and curettage : A procedure to remove samples of tissue from the inner lining of the uterus. The cervix is dilated and a curette (spoon-shaped instrument) is inserted into the uterus to remove tissue. The tissue samples are checked under a microscope for signs of disease. This procedure is also called a D&C.    -  Hysteroscopy: A procedure to look inside the uterus for abnormal areas. A hysteroscope is inserted through the vagina and cervix into the uterus. A hysteroscope is a thin, tube-like instrument with a light and a lens for viewing. It may also have a tool to remove tissue samples, which are checked under a microscope for signs of cancer.        Other tests and procedures used to diagnose endometrial cancer include the following:         -   Physical exam and history : An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patients health habits and past illnesses and treatments will also be taken.    -   Transvaginal ultrasound exam: A procedure used to examine the vagina, uterus, fallopian tubes, and bladder. An ultrasound transducer (probe) is inserted into the vagina and used to bounce high-energy sound waves (ultrasound) off internal tissues or organs and make echoes. The echoes form a picture of body tissues called a sonogram. The doctor can identify tumors by looking at the sonogram.",0.8888888888888888,0.9556914692178111,0.9999999999875,0.5
What is the outlook for Endometrial Cancer ?,"['early, the chances of curing it are excellent. The five year\nsurvival rates for endometrial cancer by stage are: 90%,\nstage I; 60%, stage II; 40%, stage III; and 5%, stage IV .\nEndometrial cancer most often spreads to the lungs, liver,\nbones, brain, vagina, and certain lymph nodes.\nPrevention\nWomen (especially postmenopausal women) should\nreport any abnormal vaginal bleeding or discharge to the\ndoctor. Controlling obesity, blood pressure, and diabetes', '{\n  ""question"": ""What is the outlook for Endometrial Cancer ?"",', '- Having a certain gene change that is linked to Lynch syndrome (hereditary non-polyposis colon cancer).     - Having hyperinsulinemia (high levels of insulin in the blood).\\n                \\n                \\n                    Taking tamoxifen for breast cancer or taking estrogen alone (without progesterone) can increase the risk of endometrial cancer.\\n                    Endometrial cancer may develop in breast cancer patients who have been treated with tamoxifen. A patient who takes', 'very sensitive to hormones and it changes daily during\nthe menstrual cycle. The endometrium is designed to\nprovide an ideal environment for the fertilized egg to\nimplant and begin to grow. If pregnancy does not occur,\nthe endometrium is shed causing the menstrual period.\nMore than 95% of uterine cancers arise in the\nendometrium. The most common type of uterine cancer\nis adenocarcinoma. It arises from an abnormal multipli-\ncation of endometrial cells (atypical adenomatous hyper-', '16266.\nPrimack, Aron. Complementary/Alternative Therapies in the\nPrevention and Treatment of Cancer. In Complemen-\ntary/Alternative Medicine: An Evidence- Based Approach,\ned. John Spencer and Joseph Jacobs. St. Louis: Mosby,\n1999, 12369.\nPERIODICALS\nBristow, Robert. Endometrial Cancer. Current Opinion in\nOncology 11 (Sept. 1999): 388393.\nCanavan, Timothy and Nipa Doshi. Endometrial Cancer.\nAmerican Family Physician 59 (June 1999): 30693077.', 'of endometrial cancer increased slightly in white and black women. From 2005 to 2014, the number of deaths from endometrial cancer increased slightly in white and black women. When endometrial cancer is diagnosed in black women, it is usually more advanced and less likely to be cured.""', 'cancer is even lower in postmenopausal women who smoke.    However, there are many proven harms of smoking. Cigarette smokers live about 10 years less than nonsmokers. Cigarette smokers also have an increased risk of the following:            - Heart disease.     -  Head and neck cancers.     -  Lung cancer.     -  Bladder cancer.     -  Pancreatic cancer.\\n                \\n                \\n                    It is not known if the following factors affect the risk of endometrial cancer:\\n', 'effect against endometrial cancer. The results of one\nstudy suggest that nulliparity is associated with a lower\nsurvival rate.\n Infertility. Risk is increased due to nulliparity or the use\nof fertility drugs.\n Polycystic ovary syndrome. The increased level of\nestrogen associated with this abnormality raises the risk\nof cancers of the breast and endometrium.\nThe most common symptom of endometrial cancer\nis unusual vaginal spotting, bleeding, or discharge. In']","The outlook for endometrial cancer varies by stage at diagnosis. The five-year survival rates are as follows: 90% for stage I, 60% for stage II, 40% for stage III, and 5% for stage IV. Early detection significantly improves the chances of curing the disease.","Certain factors affect prognosis (chance of recovery) and treatment options.The prognosis (chance of recovery) and treatment options depend on the following:          - The stage of the cancer (whether it is in the endometrium only, involves the uterus wall, or has spread to other places in the body).    - How the cancer cells look under a microscope.     - Whether the cancer cells are affected by progesterone.         Endometrial cancer can usually be cured because it is usually diagnosed early.",1.0,0.8908825584541784,0.62499999996875,0.6
What are the stages of Endometrial Cancer ?,"['endometrial cancer. The stage of cancer is determined after\nsurgery. Endometrial cancer is categorized into four stages\n(I, II, III, and IV) that are subdivided (A, B, and possibly C)\nbased on the depth or spread of cancerous tissue. Seventy\npercent of all uterine cancers are stage I, 1015% are stage\nII, and the remainder are stages III and IV . The cancer is\nalso graded (G1, G2, and G3) based upon microscopic\nanalysis of the aggressiveness of the cancer cells.', '{\n  ""question"": ""What are the symptoms of Endometrial Cancer ?"",', 'GALE ENCYCLOPEDIA OF MEDICINE 2\n1192\nEndometriosis', 'women who are near menopause (perimenopausal),\nsymptoms of endometrial cancer could include bleeding\nbetween periods (intermenstrual bleeding), heavy bleed-\ning that lasts for more than seven days, or short menstru-\nal cycles (fewer than 21 days). For women who have\ngone through menopause, any vaginal bleeding or abnor-\nmal discharge is suspect. Pain in the pelvic region and\nthe presence of a lump (mass) are symptoms that occur\nlate in the disease.\nDiagnosis', '{\n  ""question"": ""What are the stages of Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer ?"",', 'Diagnosis\nIf endometrial cancer is suspected, a series of tests\nwill be conducted to confirm the diagnosis. The first\nstep will involve taking a complete personal and family\nmedical history. A physical examination , which will\ninclude a thorough pelvic examination, will also be\ndone.\nThe doctor may order an endometrial biopsy . This\nis generally performed in the doctors office and does not\nrequire anesthesia. A thin, flexible tube is inserted', 'and stage II endometrial carcinoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.\\n\\t\\t                \\n\\t\\t                \\n\\t\\t                    Stage III, Stage IV, and Recurrent Endometrial Cancer\\n\\t\\t', 'very sensitive to hormones and it changes daily during\nthe menstrual cycle. The endometrium is designed to\nprovide an ideal environment for the fertilized egg to\nimplant and begin to grow. If pregnancy does not occur,\nthe endometrium is shed causing the menstrual period.\nMore than 95% of uterine cancers arise in the\nendometrium. The most common type of uterine cancer\nis adenocarcinoma. It arises from an abnormal multipli-\ncation of endometrial cells (atypical adenomatous hyper-']","Endometrial cancer is categorized into four stages (I, II, III, and IV) that are subdivided (A, B, and possibly C) based on the depth or spread of cancerous tissue. Seventy percent of all uterine cancers are stage I, 1015% are stage II, and the remainder are stages III and IV.","Key Points
                    - After endometrial cancer has been diagnosed, tests are done to find out if cancer cells have spread within the uterus or to other parts of the body.    - There are three ways that cancer spreads in the body.    - Cancer may spread from where it began to other parts of the body.    - The following stages are used for endometrial cancer:         - Stage I     - Stage II     - Stage III     - Stage IV        - Endometrial cancer may be grouped for treatment as follows:         - Low-risk endometrial cancer     - High-risk endometrial cancer
                
                
                    After endometrial cancer has been diagnosed, tests are done to find out if cancer cells have spread within the uterus or to other parts of the body.
                    The process used to find out whether the cancer has spread within the uterus or to other parts of the body is called staging. The information gathered from the staging process determines the stage of the disease. It is important to know the stage in order to plan treatment. Certain tests and procedures are used in the staging process. A hysterectomy (an operation in which the uterus is removed) will usually be done to treat endometrial cancer. Tissue samples are taken from the area around the uterus and checked under a microscope for signs of cancer to help find out whether the cancer has spread.   The following procedures may be used in the staging process:          -   Pelvic exam : An exam of the vagina, cervix, uterus, fallopian tubes, ovaries, and rectum. A speculum is inserted into the vagina and the doctor or nurse looks at the vagina and cervix for signs of disease. A Pap test of the cervix is usually done. The doctor or nurse also inserts one or two lubricated, gloved fingers of one hand into the vagina and places the other hand over the lower abdomen to feel the size, shape, and position of the uterus and ovaries. The doctor or nurse also inserts a lubricated, gloved finger into the rectum to feel for lumps or abnormal areas.    -   Chest x-ray : An x-ray of the organs and bones inside the chest. An x-ray is a type of energy beam that can go through the body and onto film, making a picture of areas inside the body.     -   CT scan (CAT scan): A procedure that makes a series of detailed pictures of areas inside the body, taken from different angles. The pictures are made by a computer linked to an x-ray machine. A dye may be injected into a vein or swallowed to help the organs or tissues show up more clearly. This procedure is also called computed tomography, computerized tomography, or computerized axial tomography.     -   MRI (magnetic resonance imaging): A procedure that uses a magnet, radio waves, and a computer to make a series of detailed pictures of areas inside the body. This procedure is also called nuclear magnetic resonance imaging (NMRI).    -   PET scan (positron emission tomography scan): A procedure to find malignant tumor cells in the body. A small amount of radioactive glucose (sugar) is injected into a vein. The PET scanner rotates around the body and makes a picture of where glucose is being used in the body. Malignant tumor cells show up brighter in the picture because they are more active and take up more glucose than normal cells do.    -   Lymph node dissection : A surgical procedure in which the lymph nodes are removed from the pelvic area and a sample of tissue is checked under a microscope for signs of cancer. This procedure is also called lymphadenectomy.
                
                
                    There are three ways that cancer spreads in the body.
                    Cancer can spread through tissue, the lymph system, and the blood:         - Tissue. The cancer spreads from where it began by growing into nearby areas.     - Lymph system. The cancer spreads from where it began by getting into the lymph system. The cancer travels through the lymph vessels to other parts of the body.     - Blood. The cancer spreads from where it began by getting into the blood. The cancer travels through the blood vessels to other parts of the body.
                
                
                    Cancer may spread from where it began to other parts of the body.
                    When cancer spreads to another part of the body, it is called metastasis. Cancer cells break away from where they began (the primary tumor) and travel through the lymph system or blood.         - Lymph system. The cancer gets into the lymph system, travels through the lymph vessels, and forms a tumor (metastatic tumor) in another part of the body.    - Blood. The cancer gets into the blood, travels through the blood vessels, and forms a tumor (metastatic tumor) in another part of the body.        The metastatic tumor is the same type of cancer as the primary tumor. For example, if endometrial cancer spreads to the lung, the cancer cells in the lung are actually endometrial cancer cells. The disease is metastatic endometrial cancer, not lung cancer.
                
                
                    The following stages are used for endometrial cancer:
                    Stage I     In stage I, cancer is found in the uterus only. Stage I is divided into stages IA and IB, based on how far the cancer has spread.             -  Stage IA: Cancer is in the endometrium only or less than halfway through the myometrium (muscle layer of the uterus).     -  Stage IB: Cancer has spread halfway or more into the myometrium.              Stage II     In stage II, cancer has spread into connective tissue of the cervix, but has not spread outside the uterus.        Stage III    In stage III, cancer has spread beyond the uterus and cervix, but has not spread beyond the pelvis. Stage III is divided into stages IIIA, IIIB, and IIIC, based on how far the cancer has spread within the pelvis.            -  Stage IIIA: Cancer has spread to the outer layer of the uterus and/or to the fallopian tubes, ovaries, and ligaments of the uterus.      -  Stage IIIB: Cancer has spread to the vagina and/or to the parametrium (connective tissue and fat around the uterus).     -  Stage IIIC: Cancer has spread to lymph nodes in the pelvis and/or around the aorta (largest artery in the body, which carries blood away from the heart).              Stage IV    In stage IV, cancer has spread beyond the pelvis. Stage IV is divided into stages IVA and IVB, based on how far the cancer has spread.            -  Stage IVA: Cancer has spread to the bladder and/or bowel wall.     -  Stage IVB: Cancer has spread to other parts of the body beyond the pelvis, including the abdomen and/or lymph nodes in the groin.
                
                
                    Endometrial cancer may be grouped for treatment as follows:
                    Low-risk endometrial cancer     Grades 1 and 2 tumors are usually considered low-risk. They usually do not spread to other parts of the body.       High-risk endometrial cancer     Grade 3 tumors are considered high-risk. They often spread to other parts of the body. Uterine papillary serous, clear cell, and carcinosarcoma are three subtypes of endometrial cancer that are considered grade 3.",1.0,0.908414772840119,0.9999999999875,1.0
What are the treatments for Endometrial Cancer ?,"['{\n  ""question"": ""What are the treatments for Endometrial Cancer ?"",', 'slow the growth of endometrial cells. These drugs are\nusually available as pills. This therapy is usually reserved\nfor women with advanced or recurrent disease. Side\neffects include fatigue, fluid retention, and appetite and\nweight changes.\nAlternative treatment\nAlthough alternative and complementary therapies are\nused by many cancer patients, very few controlled studies\non the effectiveness of such therapies exist. Mind-body\ntechniques, such as prayer, biofeedback, visualization,', 'Surgery     Surgery (removing the cancer in an operation) is the most common treatment for endometrial cancer. The following surgical procedures may be used:             -  Total hysterectomy: Surgery to remove the uterus, including the cervix. If the uterus and cervix are taken out through the vagina, the operation is called a vaginal hysterectomy. If the uterus and cervix are taken out through a large incision (cut) in the abdomen, the operation is called a total abdominal', 'and stage II endometrial carcinoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.\\n\\t\\t                \\n\\t\\t                \\n\\t\\t                    Stage III, Stage IV, and Recurrent Endometrial Cancer\\n\\t\\t', 'Treatment\nHow endometriosis is treated depends on the\nwomans symptoms, her age, the extent of the disease,\nand her personal preferences. The condition cannot be\nfully eradicated without surgery. Conservative treatment\nfocuses on managing the pain, preserving fertility, and\ndelaying the progress of the condition.\nPain relief\nOver-the-counter pain relievers such as aspirin\nand acetaminophen (Tylenol) are useful for mild\ncramping and menstrual pain. Prescription-strength', 'Elit, Laurie. Endometrial Cancer: Prevention, Detection, Man-\nagement, and Follow up. Canadian Family Physician 46\n(Apr. 2000): 887892.\nHogberg, Thomas, Margareta Fredstorp, and Anuja Jhingran.\nIndications for Adjuvant Radiotherapy in Endometrial\nCarcinoma. Hematology/Oncology Clinics of North\nAmerica: Current Therapeutic Issues in Gynecologic\nCancer 13 (Feb. 1999): 189209.\nORGANIZATIONS\nAmerican Cancer Society, National Headquarters. 1599 Clifton', 'early, the chances of curing it are excellent. The five year\nsurvival rates for endometrial cancer by stage are: 90%,\nstage I; 60%, stage II; 40%, stage III; and 5%, stage IV .\nEndometrial cancer most often spreads to the lungs, liver,\nbones, brain, vagina, and certain lymph nodes.\nPrevention\nWomen (especially postmenopausal women) should\nreport any abnormal vaginal bleeding or discharge to the\ndoctor. Controlling obesity, blood pressure, and diabetes', 'Treatment of stage III endometrial cancer, stage IV endometrial cancer, and recurrent endometrial cancer may include the following:         -  Surgery (radical hysterectomy and removal of lymph nodes in the pelvis so they can be viewed under a microscope to check for cancer cells) followed by adjuvant chemotherapy and/or radiation therapy.    - Chemotherapy and internal and external radiation therapy for patients who cannot have surgery.    -  Hormone therapy for patients who']","The treatments for endometrial cancer include:

1. **Surgery**: This is the most common treatment and may involve:
   - Total hysterectomy: Removal of the uterus and cervix, which can be done vaginally or through a large abdominal incision.
   - Radical hysterectomy: Involves the removal of the uterus, cervix, and surrounding tissues, along with lymph nodes for examination.

2. **Chemotherapy**: This may be used for advanced or recurrent disease and is typically administered as pills. Side effects can include fatigue, fluid retention, and changes in appetite and weight.

3. **Radiation Therapy**: This can be used as adjuvant therapy after surgery or for patients who cannot undergo surgery. It may include both internal and external radiation.

4. **Hormone Therapy**: This is sometimes used for patients with advanced or recurrent disease.

5. **Clinical Trials**: Patients may also consider participating in clinical trials for new treatments.

It is essential to discuss these options with a healthcare provider to determine the best course of action based on individual circumstances.","Key Points
                    - There are different types of treatment for patients with endometrial cancer.    - Five types of standard treatment are used:          - Surgery     - Radiation therapy      - Chemotherapy     - Hormone therapy         - Targeted therapy    - New types of treatment are being tested in clinical trials.    - Patients may want to think about taking part in a clinical trial.    - Patients can enter clinical trials before, during, or after starting their cancer treatment.    - Follow-up tests may be needed.
                
                
                    There are different types of treatment for patients with endometrial cancer.
                    Different types of treatment are available for patients with endometrial cancer. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
                
                
                    Five types of standard treatment are used:
                    Surgery     Surgery (removing the cancer in an operation) is the most common treatment for endometrial cancer. The following surgical procedures may be used:             -  Total hysterectomy: Surgery to remove the uterus, including the cervix. If the uterus and cervix are taken out through the vagina, the operation is called a vaginal hysterectomy. If the uterus and cervix are taken out through a large incision (cut) in the abdomen, the operation is called a total abdominal hysterectomy. If the uterus and cervix are taken out through a small incision (cut) in the abdomen using a laparoscope, the operation is called a total laparoscopic hysterectomy.     -  Bilateral salpingo-oophorectomy: Surgery to remove both ovaries and both fallopian tubes.     -  Radical hysterectomy: Surgery to remove the uterus, cervix, and part of the vagina. The ovaries, fallopian tubes, or nearby lymph nodes may also be removed.     -  Lymph node dissection: A surgical procedure in which the lymph nodes are removed from the pelvic area and a sample of tissue is checked under a microscope for signs of cancer. This procedure is also called lymphadenectomy.           Even if the doctor removes all the cancer that can be seen at the time of the surgery, some patients may be given radiation therapy or hormone treatment after surgery to kill any cancer cells that are left. Treatment given after the surgery, to lower the risk that the cancer will come back, is called adjuvant therapy.        Radiation therapy     Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. There are two types of radiation therapy:            -  External radiation therapy uses a machine outside the body to send radiation toward the cancer.     -  Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer.           The way the radiation therapy is given depends on the type and stage of the cancer being treated. External and internal radiation therapy are used to treat endometrial cancer, and may also be used as palliative therapy to relieve symptoms and improve quality of life.       Chemotherapy     Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping the cells from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy).     The way the chemotherapy is given depends on the type and stage of the cancer being treated.       Hormone therapy      Hormone therapy is a cancer treatment that removes hormones or blocks their action and stops cancer cells from growing. Hormones are substances made by glands in the body and circulated in the bloodstream. Some hormones can cause certain cancers to grow. If tests show that the cancer cells have places where hormones can attach (receptors), drugs, surgery, or radiation therapy is used to reduce the production of hormones or block them from working.
                
                
                    Targeted therapy
                    Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells without harming normal cells. Monoclonal antibodies, mTOR inhibitors, and signal transduction inhibitors are three types of targeted therapy used to treat endometrial cancer.         - Monoclonal antibody therapy is a cancer treatment that uses antibodies made in the laboratory from a single type of immune system cell. These antibodies can identify substances on cancer cells or normal substances that may help cancer cells grow. The antibodies attach to the substances and kill the cancer cells, block their growth, or keep them from spreading. Monoclonal antibodies are given by infusion. They may be used alone or to carry drugs, toxins, or radioactive material directly to cancer cells. Bevacizumab is used to treat stage III, stage IV, and recurrent endometrial cancer.    - mTOR inhibitors block a protein called mTOR, which helps control cell division. mTOR inhibitors may keep cancer cells from growing and prevent the growth of new blood vessels that tumors need to grow. Everolimus and ridaforalimus are used to treat stage III, stage IV, and recurrent endometrial cancer.    - Signal transduction inhibitors block signals that are passed from one molecule to another inside a cell. Blocking these signals may kill cancer cells. Metformin is being studied to treat stage III, stage IV, and recurrent endometrial cancer.
                
                
                    New types of treatment are being tested in clinical trials.
                    Information about clinical trials is available from the NCI website.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
                
                
                    Follow-up tests may be needed.
                    Some of the tests that were done to diagnose the cancer or to find out the stage of the cancer may be repeated. Some tests will be repeated in order to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.   Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your condition has changed or if the cancer has recurred (come back). These tests are sometimes called follow-up tests or check-ups.
                
		        
		            Treatment Options by Stage
		            
		                
		                    Stage I and Stage II Endometrial Cancer
		                    Low-risk endometrial cancer (grade 1 or grade 2)    Treatment of low-risk stage I endometrial cancer and stage II endometrial cancer may include the following:         -  Surgery (total hysterectomy and bilateral salpingo-oophorectomy). Lymph nodes in the pelvis and abdomen may also be removed and viewed under a microscope to check for cancer cells.    - Surgery (total hysterectomy and bilateral salpingo-oophorectomy, with or without removal of lymph nodes in the pelvis and abdomen) followed by internal radiation therapy. In certain cases, external radiation therapy to the pelvis may be used in place of internal radiation therapy.    -  Radiation therapy alone for patients who cannot have surgery.    - A clinical trial of a new chemotherapy regimen.        If cancer has spread to the cervix, a radical hysterectomy with bilateral salpingo-oophorectomy may be done.    High-risk endometrial cancer (grade 3)    Treatment of high-risk stage I endometrial cancer and stage II endometrial cancer may include the following:         -  Surgery (radical hysterectomy and bilateral salpingo-oophorectomy). Lymph nodes in the pelvis and abdomen may also be removed and viewed under a microscope to check for cancer cells.    - Surgery (radical hysterectomy and bilateral salpingo-oophorectomy) followed by chemotherapy and sometimes radiation therapy.    - A clinical trial of a new chemotherapy regimen.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage I endometrial carcinoma and stage II endometrial carcinoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
		                
		                
		                    Stage III, Stage IV, and Recurrent Endometrial Cancer
		                    Treatment of stage III endometrial cancer, stage IV endometrial cancer, and recurrent endometrial cancer may include the following:         -  Surgery (radical hysterectomy and removal of lymph nodes in the pelvis so they can be viewed under a microscope to check for cancer cells) followed by adjuvant chemotherapy and/or radiation therapy.    - Chemotherapy and internal and external radiation therapy for patients who cannot have surgery.    -  Hormone therapy for patients who cannot have surgery or radiation therapy.    -  Targeted therapy with mTOR inhibitors (everolimus or ridaforolimus) or a monoclonal antibody (bevacizumab).    - A clinical trial of a new treatment regimen that may include combination chemotherapy, targeted therapy, such as an mTOR inhibitor (everolimus) or signal transduction inhibitor (metformin), and/or hormone therapy, for patients with advanced or recurrent endometrial cancer.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage III endometrial carcinoma, stage IV endometrial carcinoma and recurrent endometrial carcinoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.",0.85,0.9817165499354048,0.9999999999875,1.0
what research (or clinical trials) is being done for Endometrial Cancer ?,"['{\n  ""question"": ""what research (or clinical trials) is being done for Endometrial Cancer ?"",', 'slow the growth of endometrial cells. These drugs are\nusually available as pills. This therapy is usually reserved\nfor women with advanced or recurrent disease. Side\neffects include fatigue, fluid retention, and appetite and\nweight changes.\nAlternative treatment\nAlthough alternative and complementary therapies are\nused by many cancer patients, very few controlled studies\non the effectiveness of such therapies exist. Mind-body\ntechniques, such as prayer, biofeedback, visualization,', 'early, the chances of curing it are excellent. The five year\nsurvival rates for endometrial cancer by stage are: 90%,\nstage I; 60%, stage II; 40%, stage III; and 5%, stage IV .\nEndometrial cancer most often spreads to the lungs, liver,\nbones, brain, vagina, and certain lymph nodes.\nPrevention\nWomen (especially postmenopausal women) should\nreport any abnormal vaginal bleeding or discharge to the\ndoctor. Controlling obesity, blood pressure, and diabetes', 'and stage II endometrial carcinoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.\\n\\t\\t                \\n\\t\\t                \\n\\t\\t                    Stage III, Stage IV, and Recurrent Endometrial Cancer\\n\\t\\t', 'of developing a new type of cancer. Other trials are done with healthy volunteers who are not known to have any risk factors for cancer.    The purpose of some cancer prevention clinical trials is to find out whether actions people take can prevent cancer. These may include eating fruits and vegetables, exercising, quitting smoking, or taking certain medicines, vitamins, minerals, or food supplements.\\n                \\n                \\n                    New ways to prevent endometrial', 'Alternative Cancer Methods. Atlanta: American Cancer\nSociety, 2000.\nBurke, Thomas, Patricia Eifel, and Muggia Franco. Cancers\nof the Uterine Body. In Cancer: Principles & Practice of\nOncology, ed. Vincent DeVita, Samuel Hellman, and\nSteven Rosenberg. Philadelphia: Lippincott Williams &\nWilkins, 2001, 1573 86.\nLong, Harry. Carcinoma of the Endometrium. In Current\nTherapy in Cancer, ed. John Foley, Julie V ose, and James\nArmitage. Philadelphia: W. B. Saunders Company, 1999,\n16266.', 'or after starting their cancer treatment.    - Follow-up tests may be needed.\\n                \\n                \\n                    There are different types of treatment for patients with endometrial cancer.\\n                    Different types of treatment are available for patients with endometrial cancer. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current', 'the following PDQ summaries for more information about endometrial cancer:         -  Endometrial Cancer Treatment     -  Endometrial Cancer Prevention\\n                \\n                \\n                    In the United States, endometrial cancer is the most common invasive cancer of the female reproductive system.\\n                    Endometrial cancer is diagnosed most often in postmenopausal women at an average age of 60 years.   From 2004 to 2013, the number of new cases of endometrial']","Research and clinical trials for endometrial cancer focus on various aspects, including new treatment methods and prevention strategies. Some trials are testing new types of drugs that can slow the growth of endometrial cells, particularly for women with advanced or recurrent disease. These treatments are often available in pill form and may have side effects such as fatigue and weight changes.

Additionally, there are clinical trials aimed at cancer prevention, which investigate whether lifestyle changessuch as diet, exercise, and smoking cessationcan help reduce the risk of developing endometrial cancer. Patients are encouraged to discuss with their doctors about clinical trials that may be suitable for them, and general information about these trials can be found on the NCI website.

For more specific results, patients can refine their search by factors like trial location, treatment type, or drug name.","New types of treatment are being tested in clinical trials.
                    Information about clinical trials is available from the NCI website.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.",1.0,0.9398996726800721,0.9999999999875,1.0
What is (are) Small Cell Lung Cancer ?,"['small cell lung cancer.    - Certain factors affect prognosis (chance of recovery) and treatment options.    - For most patients with small cell lung cancer, current treatments do not cure the cancer.\\n                \\n                \\n                    Small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.\\n                    The lungs are a pair of cone-shaped breathing organs that are found in the chest. The lungs bring oxygen into the', '{\n  ""question"": ""What is (are) Small Cell Lung Cancer ?"",', '""ground_truth"": ""Signs of non-small cell lung cancer include a cough that doesn\'t go away and shortness of breath. Sometimes lung cancer does not cause any signs or symptoms. It may be found during a chest x-ray done for another condition. Signs and symptoms may be caused by lung cancer or by other conditions. Check with your doctor if you have any of the following:         - Chest discomfort or pain.    - A cough that doesnt go away or gets worse over time.     - Trouble breathing.     -', '{\n  ""question"": ""What is (are) Lung Cancer ?"",\n  ""ground_truth"": ""The body is made up of many types of cells. Normally, cells grow, divide, and produce more cells as needed to keep the body healthy and functioning properly. Sometimes, however, the process goes wrong -- cells become abnormal and form more cells in an uncontrolled way. These extra cells form a mass of tissue, called a growth or tumor. Tumors can be benign, meaning not cancerous, or malignant, meaning cancerous.""\n}', 'cell lung cancer grows quickly and often spreads to other tissues (metastasizes), most commonly to the adrenal glands (small hormone-producing glands located on top of each kidney), liver, brain, and bones. In more than half of cases, the small cell lung cancer has spread beyond the lung at the time of diagnosis. After diagnosis, most people with small cell lung cancer survive for about one year; less than seven percent survive 5 years.  Non-small cell lung cancer is divided into three main', 'cell lung cancer spreads to the brain, the cancer cells in the brain are actually lung cancer cells. The disease is metastatic lung cancer, not brain cancer.\\n                \\n                \\n                    The following stages are used for non-small cell lung cancer:\\n                    Occult (hidden) stage    In the occult (hidden) stage, cancer cannot be seen by imaging or bronchoscopy. Cancer cells are found in sputum (mucus coughed up from the lungs) or bronchial washing (a', '\\n\\t\\t            Treatment Options by Stage\\n\\t\\t            \\n\\t\\t                \\n\\t\\t                    Limited-Stage Small Cell Lung Cancer\\n\\t\\t                    Treatment of limited-stage small cell lung cancer may include the following:         -  Combination chemotherapy and radiation therapy to the chest. Radiation therapy to the brain may later be given to patients with complete responses.    - Combination chemotherapy alone for patients who cannot be given radiation therapy.', '""ground_truth"": ""Key Points\\n                    - Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.     - There are several types of non-small cell lung cancer.    - Smoking is the major risk factor for non-small cell lung cancer.    - Signs of non-small cell lung cancer include a cough that doesn\'t go away and shortness of breath.    - Tests that examine the lungs are used to detect (find), diagnose, and stage non-small cell lung']","Small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung. This type of lung cancer grows quickly and often spreads to other tissues (metastasizes), most commonly to the adrenal glands, liver, brain, and bones. In more than half of cases, small cell lung cancer has spread beyond the lung at the time of diagnosis. Most people with small cell lung cancer survive for about one year after diagnosis, with less than seven percent surviving five years.","Key Points
                    - Small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.    - There are two main types of small cell lung cancer.     - Smoking is the major risk factor for small cell lung cancer.    - Signs and symptoms of small cell lung cancer include coughing, shortness of breath, and chest pain.    - Tests and procedures that examine the lungs are used to detect (find), diagnose, and stage small cell lung cancer.    - Certain factors affect prognosis (chance of recovery) and treatment options.    - For most patients with small cell lung cancer, current treatments do not cure the cancer.
                
                
                    Small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.
                    The lungs are a pair of cone-shaped breathing organs that are found in the chest. The lungs bring oxygen into the body when you breathe in and take out carbon dioxide when you breathe out. Each lung has sections called lobes. The left lung has two lobes. The right lung, which is slightly larger, has three. A thin membrane called the pleura surrounds the lungs. Two tubes called bronchi lead from the trachea (windpipe) to the right and left lungs. The bronchi are sometimes also affected by lung cancer. Small tubes called bronchioles and tiny air sacs called alveoli make up the inside of the lungs.     There are two types of lung cancer: small cell lung cancer and non-small cell lung cancer.    This summary is about small cell lung cancer and its treatment. See the following PDQ summaries for more information about lung cancer:          -  Non-Small Cell Lung Cancer Treatment     -  Unusual Cancers of Childhood Treatment     -  Lung Cancer Prevention     -  Lung Cancer Screening
                
                
                    There are two main types of small cell lung cancer.
                    These two types include many different types of cells. The cancer cells of each type grow and spread in different ways. The types of small cell lung cancer are named for the kinds of cells found in the cancer and how the cells look when viewed under a microscope:         - Small cell carcinoma (oat cell cancer).     - Combined small cell carcinoma.
                
                
                    For most patients with small cell lung cancer, current treatments do not cure the cancer.
                    If lung cancer is found, patients should think about taking part in one of the many clinical trials being done to improve treatment. Clinical trials are taking place in most parts of the country for patients with all stages of small cell lung cancer. Information about ongoing clinical trials is available from the NCI website.",1.0,0.9166711678875265,0.9999999999875,0.5
Who is at risk for Small Cell Lung Cancer? ?,"['{\n  ""question"": ""Who is at risk for Small Cell Lung Cancer? ?"",', '""ground_truth"": ""Signs and symptoms of small cell lung cancer include coughing, shortness of breath, and chest pain. These and other signs and symptoms may be caused by small cell lung cancer or by other conditions. Check with your doctor if you have any of the following:         - Chest discomfort or pain.    - A cough that doesnt go away or gets worse over time.     - Trouble breathing.    - Wheezing.    -  Blood in sputum (mucus coughed up from the lungs).     - Hoarseness.    - Trouble', '""ground_truth"": ""Smoking is the major risk factor for non-small cell lung cancer. Anything that increases your chance of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn\'t mean that you will not get cancer. Talk to your doctor if you think you may be at risk for lung cancer.    Risk factors for lung cancer include the following:            -  Smoking cigarettes, pipes, or cigars, now or in the past. This is', 'the tumor cells are large when viewed under a microscope. The 5-year survival rate for people with non-small cell lung cancer is usually between 11 and 17 percent; it can be lower or higher depending on the subtype and stage of the cancer.""', 'risk of cancer, not the disease itself. Not all people who inherit mutations in these genes will develop lung cancer.""', '""ground_truth"": ""Key Points\\n                    - Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.     - There are several types of non-small cell lung cancer.    - Smoking is the major risk factor for non-small cell lung cancer.    - Signs of non-small cell lung cancer include a cough that doesn\'t go away and shortness of breath.    - Tests that examine the lungs are used to detect (find), diagnose, and stage non-small cell lung', '""ground_truth"": ""Lung cancer is one of the most common cancers in the world. It is a leading cause of cancer death in men and women in the United States. Cigarette smoking causes most lung cancers. The more cigarettes you smoke per day and the earlier you started smoking, the greater your risk of lung cancer. High levels of pollution, radiation and asbestos exposure may also increase risk.     Common symptoms of lung cancer include       - A cough that doesn\'t go away and gets worse over time', 'combined with other risk factors, the risk of lung cancer is increased.""']","Sorry, I can only answer medical-related questions.","Smoking is the major risk factor for small cell lung cancer. Anything that increases your chance of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. Talk to your doctor if you think you may be at risk for lung cancer.    Risk factors for lung cancer include the following:            -  Smoking cigarettes, pipes, or cigars, now or in the past. This is the most important risk factor for lung cancer. The earlier in life a person starts smoking, the more often a person smokes, and the more years a person smokes, the greater the risk of lung cancer.      -  Being exposed to secondhand smoke.     - Being exposed to radiation from any of the following:                  -  Radiation therapy to the breast or chest.       -  Radon in the home or workplace.       -  Imaging tests such as CT scans.       - Atomic bomb radiation.                 -  Being exposed to asbestos, chromium, nickel, beryllium, arsenic, soot, or tar in the workplace.     -  Living where there is air pollution.     -  Having a family history of lung cancer.     -  Being infected with the human immunodeficiency virus (HIV).     -  Taking beta carotene supplements and being a heavy smoker.           Older age is the main risk factor for most cancers. The chance of getting cancer increases as you get older.     When smoking is combined with other risk factors, the risk of lung cancer is increased.",0.0,0.0,0.9999999999875,1.0
What are the symptoms of Small Cell Lung Cancer ?,"['""ground_truth"": ""Signs and symptoms of small cell lung cancer include coughing, shortness of breath, and chest pain. These and other signs and symptoms may be caused by small cell lung cancer or by other conditions. Check with your doctor if you have any of the following:         - Chest discomfort or pain.    - A cough that doesnt go away or gets worse over time.     - Trouble breathing.    - Wheezing.    -  Blood in sputum (mucus coughed up from the lungs).     - Hoarseness.    - Trouble', '{\n  ""question"": ""What are the symptoms of Lung Cancer ?"",', 'worse over time    - Constant chest pain    - Coughing up blood    - Shortness of breath, wheezing, or hoarseness    - Repeated problems with pneumonia or bronchitis    - Swelling of the neck and face    - Loss of appetite or weight loss    - Fatigue       Doctors diagnose lung cancer using a physical exam, imaging, and lab tests. Treatment depends on the type, stage, and how advanced it is. Treatments include surgery, chemotherapy, radiation therapy, and targeted therapy. Targeted therapy uses', 'Other symptoms of lung cancer include frequent lung infections, fatigue (tiredness), and weight loss without a known cause.\\n                \\nSymptoms of mesothelioma include shortness of breath and chest pain due to pleural effusion.""', '""ground_truth"": ""Common Signs and Symptoms When lung cancer first develops, there may be no symptoms at all. But if the cancer grows, it can cause changes that people should watch for. Common signs and symptoms of lung cancer include: - a cough that doesn\'t go away and gets worse over time  - constant chest pain  - coughing up blood  - shortness of breath, wheezing, or hoarseness  - repeated problems with pneumonia or bronchitis  - swelling of the neck and face  - loss of appetite or weight', '""ground_truth"": ""Key Points\\n                    - Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.     - There are several types of non-small cell lung cancer.    - Smoking is the major risk factor for non-small cell lung cancer.    - Signs of non-small cell lung cancer include a cough that doesn\'t go away and shortness of breath.    - Tests that examine the lungs are used to detect (find), diagnose, and stage non-small cell lung', 'cell lung cancer grows quickly and often spreads to other tissues (metastasizes), most commonly to the adrenal glands (small hormone-producing glands located on top of each kidney), liver, brain, and bones. In more than half of cases, the small cell lung cancer has spread beyond the lung at the time of diagnosis. After diagnosis, most people with small cell lung cancer survive for about one year; less than seven percent survive 5 years.  Non-small cell lung cancer is divided into three main', '""ground_truth"": ""Lung adenocarcinoma is a cancer that occurs due to abnormal and uncontrolled cell growth in the lungs. It is a subtype of non-small cell lung cancer that is often diagnosed in an outer area of the lung. Early lung cancers may not be associated with any signs and symptoms. As the condition progresses, affected people can experience chest pain, a persistent cough, fatigue, coughing up blood, loss of appetite, unexplained weight loss, shortness of breath, and/or wheezing. The']","Signs and symptoms of small cell lung cancer include coughing, shortness of breath, and chest pain. Other symptoms may include a cough that doesn't go away or gets worse over time, trouble breathing, wheezing, blood in sputum (mucus coughed up from the lungs), hoarseness, and constant chest pain. If you experience any of these symptoms, it's important to check with your doctor.","Signs and symptoms of small cell lung cancer include coughing, shortness of breath, and chest pain. These and other signs and symptoms may be caused by small cell lung cancer or by other conditions. Check with your doctor if you have any of the following:         - Chest discomfort or pain.    - A cough that doesnt go away or gets worse over time.     - Trouble breathing.    - Wheezing.    -  Blood in sputum (mucus coughed up from the lungs).     - Hoarseness.    - Trouble swallowing.    - Loss of appetite.    - Weight loss for no known reason.    - Feeling very tired.     - Swelling in the face and/or veins in the neck.",1.0,0.9710176772857837,0.691666666649375,0.8461538461538461
How to diagnose Small Cell Lung Cancer ?,"['""ground_truth"": ""Signs and symptoms of small cell lung cancer include coughing, shortness of breath, and chest pain. These and other signs and symptoms may be caused by small cell lung cancer or by other conditions. Check with your doctor if you have any of the following:         - Chest discomfort or pain.    - A cough that doesnt go away or gets worse over time.     - Trouble breathing.    - Wheezing.    -  Blood in sputum (mucus coughed up from the lungs).     - Hoarseness.    - Trouble', 'patients with stage II non-small cell lung cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.\\n\\t\\t                \\n\\t\\t                \\n\\t\\t                    Stage IIIA Non-Small Cell Lung Cancer\\n\\t\\t', '{\n  ""question"": ""How to diagnose Small Cell Lung Cancer ?"",', '\\nThe only way to confirm a diagnosis of lung cancer or mesothelioma is for a pathologist to check samples of your lung cells or tissues. A pathologist is a doctor who identifies diseases by studying cells and tissues under a microscope.\\n                \\nDoctors have many ways to collect tissue samples. One way is through bronchoscopy (bron-KOS-ko-pee). For this procedure, your doctor will pass a thin, flexible tube through your nose (or sometimes your mouth), down your throat,', 'worse over time    - Constant chest pain    - Coughing up blood    - Shortness of breath, wheezing, or hoarseness    - Repeated problems with pneumonia or bronchitis    - Swelling of the neck and face    - Loss of appetite or weight loss    - Fatigue       Doctors diagnose lung cancer using a physical exam, imaging, and lab tests. Treatment depends on the type, stage, and how advanced it is. Treatments include surgery, chemotherapy, radiation therapy, and targeted therapy. Targeted therapy uses', '""ground_truth"": ""Key Points\\n                    - Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.     - There are several types of non-small cell lung cancer.    - Smoking is the major risk factor for non-small cell lung cancer.    - Signs of non-small cell lung cancer include a cough that doesn\'t go away and shortness of breath.    - Tests that examine the lungs are used to detect (find), diagnose, and stage non-small cell lung', '- National Cancer Institute: Small Cell Lung Cancer Treatment   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care""', '""ground_truth"": ""Tests and procedures that examine the lungs are used to detect (find), diagnose, and stage small cell lung cancer. The following tests and procedures may be used:         -   Physical exam and history : An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patients health habits, including smoking, and past jobs, illnesses, and treatments will also be taken.    -']","The only way to confirm a diagnosis of small cell lung cancer is for a pathologist to check samples of your lung cells or tissues. This is done by studying the cells and tissues under a microscope. Doctors use various methods to collect tissue samples, such as bronchoscopy, where a thin, flexible tube is passed through the nose or mouth, down the throat, and into the lungs. Additionally, doctors may perform a physical exam, imaging tests, and lab tests to aid in the diagnosis.","Tests and procedures that examine the lungs are used to detect (find), diagnose, and stage small cell lung cancer. The following tests and procedures may be used:         -   Physical exam and history : An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patients health habits, including smoking, and past jobs, illnesses, and treatments will also be taken.    -   Laboratory tests : Medical procedures that test samples of tissue, blood, urine, or other substances in the body. These tests help to diagnose disease, plan and check treatment, or monitor the disease over time.    -   Chest x-ray : An x-ray of the organs and bones inside the chest. An x-ray is a type of energy beam that can go through the body and onto film, making a picture of areas inside the body.    -   CT scan (CAT scan) of the brain, chest, and abdomen : A procedure that makes a series of detailed pictures of areas inside the body, taken from different angles. The pictures are made by a computer linked to an x-ray machine. A dye may be injected into a vein or swallowed to help the organs or tissues show up more clearly. This procedure is also called computed tomography, computerized tomography, or computerized axial tomography.     -   Sputum cytology : A microscope is used to check for cancer cells in the sputum (mucus coughed up from the lungs).     -   Biopsy : The removal of cells or tissues so they can be viewed under a microscope by a pathologist to check for signs of cancer. The different ways a biopsy can be done include the following:                -  Fine-needle aspiration (FNA) biopsy of the lung: The removal of tissue or fluid from the lung, using a thin needle. A CT scan, ultrasound, or other imaging procedure is used to find the abnormal tissue or fluid in the lung. A small incision may be made in the skin where the biopsy needle is inserted into the abnormal tissue or fluid. A sample is removed with the needle and sent to the laboratory. A pathologist then views the sample under a microscope to look for cancer cells. A chest x-ray is done after the procedure to make sure no air is leaking from the lung into the chest.      -  Bronchoscopy : A procedure to look inside the trachea and large airways in the lung for abnormal areas. A bronchoscope is inserted through the nose or mouth into the trachea and lungs. A bronchoscope is a thin, tube-like instrument with a light and a lens for viewing. It may also have a tool to remove tissue samples, which are checked under a microscope for signs of cancer.       -  Thoracoscopy : A surgical procedure to look at the organs inside the chest to check for abnormal areas. An incision (cut) is made between two ribs, and a thoracoscope is inserted into the chest. A thoracoscope is a thin, tube-like instrument with a light and a lens for viewing. It may also have a tool to remove tissue or lymph node samples, which are checked under a microscope for signs of cancer. In some cases, this procedure is used to remove part of the esophagus or lung. If certain tissues, organs, or lymph nodes cant be reached, a thoracotomy may be done. In this procedure, a larger incision is made between the ribs and the chest is opened.      -  Thoracentesis : The removal of fluid from the space between the lining of the chest and the lung, using a needle. A pathologist views the fluid under a microscope to look for cancer cells.      -  Mediastinoscopy : A surgical procedure to look at the organs, tissues, and lymph nodes between the lungs for abnormal areas. An incision (cut) is made at the top of the breastbone and a mediastinoscope is inserted into the chest. A mediastinoscope is a thin, tube-like instrument with a light and a lens for viewing. It may also have a tool to remove tissue or lymph node samples, which are checked under a microscope for signs of cancer.             -   Light and electron microscopy : A laboratory test in which cells in a sample of tissue are viewed under regular and high-powered microscopes to look for certain changes in the cells.    -   Immunohistochemistry : A test that uses antibodies to check for certain antigens in a sample of tissue. The antibody is usually linked to a radioactive substance or a dye that causes the tissue to light up under a microscope. This type of test may be used to tell the difference between different types of cancer.",1.0,0.9614344772987531,0.9999999999875,0.8125
What are the stages of Small Cell Lung Cancer ?,"['{\n  ""question"": ""What are the stages of Small Cell Lung Cancer ?"",', 'cell lung cancer grows quickly and often spreads to other tissues (metastasizes), most commonly to the adrenal glands (small hormone-producing glands located on top of each kidney), liver, brain, and bones. In more than half of cases, the small cell lung cancer has spread beyond the lung at the time of diagnosis. After diagnosis, most people with small cell lung cancer survive for about one year; less than seven percent survive 5 years.  Non-small cell lung cancer is divided into three main', 'Treatment Options by Stage\\n\\t\\t            \\n\\t\\t                \\n\\t\\t                    Occult Non-Small Cell Lung Cancer\\n\\t\\t                    Treatment of occult non-small cell lung cancer depends on the stage of the disease. Occult tumors are often found at an early stage (the tumor is in the lung only) and sometimes can be cured by surgery.   Check the list of NCI-supported cancer clinical trials that are now accepting patients with occult non-small cell lung cancer. For', '""ground_truth"": ""Key Points\\n                    - Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.     - There are several types of non-small cell lung cancer.    - Smoking is the major risk factor for non-small cell lung cancer.    - Signs of non-small cell lung cancer include a cough that doesn\'t go away and shortness of breath.    - Tests that examine the lungs are used to detect (find), diagnose, and stage non-small cell lung', 'Lung Cancer\\n                \\n                \\n                    After small cell lung cancer has been diagnosed, tests are done to find out if cancer cells have spread within the chest or to other parts of the body.\\n                    The process used to find out if cancer has spread within the chest or to other parts of the body is called staging. The information gathered from the staging process determines the stage of the disease. It is important to know the stage in order to plan', 'the blood, travels through the blood vessels, and forms a tumor (metastatic tumor) in another part of the body.        The metastatic tumor is the same type of cancer as the primary tumor. For example, if small cell lung cancer spreads to the brain, the cancer cells in the brain are actually lung cancer cells. The disease is metastatic small cell lung cancer, not brain cancer.\\n                \\n                \\n                    The following stages are used for small cell lung cancer:\\n', '""ground_truth"": ""Signs and symptoms of small cell lung cancer include coughing, shortness of breath, and chest pain. These and other signs and symptoms may be caused by small cell lung cancer or by other conditions. Check with your doctor if you have any of the following:         - Chest discomfort or pain.    - A cough that doesnt go away or gets worse over time.     - Trouble breathing.    - Wheezing.    -  Blood in sputum (mucus coughed up from the lungs).     - Hoarseness.    - Trouble', 'the tumor cells are large when viewed under a microscope. The 5-year survival rate for people with non-small cell lung cancer is usually between 11 and 17 percent; it can be lower or higher depending on the subtype and stage of the cancer.""']","The following stages are used for small cell lung cancer:

1. **Limited Stage**: The cancer is confined to one lung and may have spread to nearby lymph nodes.
2. **Extensive Stage**: The cancer has spread beyond one lung to other parts of the chest or to other organs in the body.

Staging is important to determine the extent of the disease and to plan appropriate treatment options.","Key Points
                    - After small cell lung cancer has been diagnosed, tests are done to find out if cancer cells have spread within the chest or to other parts of the body.     - There are three ways that cancer spreads in the body.    - Cancer may spread from where it began to other parts of the body.    - The following stages are used for small cell lung cancer:          - Limited-Stage Small Cell Lung Cancer     - Extensive-Stage Small Cell Lung Cancer
                
                
                    After small cell lung cancer has been diagnosed, tests are done to find out if cancer cells have spread within the chest or to other parts of the body.
                    The process used to find out if cancer has spread within the chest or to other parts of the body is called staging. The information gathered from the staging process determines the stage of the disease. It is important to know the stage in order to plan treatment. Some of the tests used to diagnose small cell lung cancer are also used to stage the disease. (See the General Information section.)    Other tests and procedures that may be used in the staging process include the following:         -   MRI (magnetic resonance imaging) of the brain: A procedure that uses a magnet, radio waves, and a computer to make a series of detailed pictures of areas inside the body. This procedure is also called nuclear magnetic resonance imaging (NMRI).    -   CT scan (CAT scan): A procedure that makes a series of detailed pictures of areas inside the body, such as the brain, chest or upper abdomen, taken from different angles. The pictures are made by a computer linked to an x-ray machine. A dye may be injected into a vein or swallowed to help the organs or tissues show up more clearly. This procedure is also called computed tomography, computerized tomography, or computerized axial tomography.    -   PET scan (positron emission tomography scan): A procedure to find malignant tumor cells in the body. A small amount of radioactive glucose (sugar) is injected into a vein. The PET scanner rotates around the body and makes a picture of where glucose is being used in the body. Malignant tumor cells show up brighter in the picture because they are more active and take up more glucose than normal cells do. A PET scan and CT scan may be done at the same time. This is called a PET-CT.    -   Bone scan : A procedure to check if there are rapidly dividing cells, such as cancer cells, in the bone. A very small amount of radioactive material is injected into a vein and travels through the bloodstream. The radioactive material collects in the bones and is detected by a scanner.
                
                
                    There are three ways that cancer spreads in the body.
                    Cancer can spread through tissue, the lymph system, and the blood:         - Tissue. The cancer spreads from where it began by growing into nearby areas.     - Lymph system. The cancer spreads from where it began by getting into the lymph system. The cancer travels through the lymph vessels to other parts of the body.     - Blood. The cancer spreads from where it began by getting into the blood. The cancer travels through the blood vessels to other parts of the body.
                
                
                    Cancer may spread from where it began to other parts of the body.
                    When cancer spreads to another part of the body, it is called metastasis. Cancer cells break away from where they began (the primary tumor) and travel through the lymph system or blood.         - Lymph system. The cancer gets into the lymph system, travels through the lymph vessels, and forms a tumor (metastatic tumor) in another part of the body.    - Blood. The cancer gets into the blood, travels through the blood vessels, and forms a tumor (metastatic tumor) in another part of the body.        The metastatic tumor is the same type of cancer as the primary tumor. For example, if small cell lung cancer spreads to the brain, the cancer cells in the brain are actually lung cancer cells. The disease is metastatic small cell lung cancer, not brain cancer.
                
                
                    The following stages are used for small cell lung cancer:
                    Limited-Stage Small Cell Lung Cancer    In limited-stage, cancer is in the lung where it started and may have spread to the area between the lungs or to the lymph nodes above the collarbone.        Extensive-Stage Small Cell Lung Cancer    In extensive-stage, cancer has spread beyond the lung or the area between the lungs or the lymph nodes above the collarbone to other places in the body.",0.625,0.9855308117290033,0.9999999999875,1.0
What are the treatments for Small Cell Lung Cancer ?,"['{\n  ""question"": ""What are the treatments for Non-Small Cell Lung Cancer ?"",', 'cell lung cancer in several ways, and surgery is a common treatment. Cryosurgery, a treatment that freezes and destroys cancer tissue, may be used to control symptoms in the later stages of non-small cell lung cancer. Doctors may also use radiation therapy and chemotherapy to slow the progress of the disease and to manage symptoms.  See more information about treatments for non-small cell lung cancer. Treating Small Cell Lung Cancer Small cell lung cancer spreads quickly. In many cases, cancer', 'Treatment Options by Stage\\n\\t\\t            \\n\\t\\t                \\n\\t\\t                    Occult Non-Small Cell Lung Cancer\\n\\t\\t                    Treatment of occult non-small cell lung cancer depends on the stage of the disease. Occult tumors are often found at an early stage (the tumor is in the lung only) and sometimes can be cured by surgery.   Check the list of NCI-supported cancer clinical trials that are now accepting patients with occult non-small cell lung cancer. For', 'This may be done in certain rare cases of non-small cell lung cancer.\\n                \\n                \\n                    New types of treatment are being tested in clinical trials.\\n                    This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.     Chemoprevention     Chemoprevention is the use of drugs, vitamins, or other', 'non-small cell lung cancer that cannot be removed with surgery may include the following:         - Chemotherapy and radiation therapy given over the same period of time or one followed by the other.    -  External radiation therapy alone for patients who cannot be treated with combined therapy, or as palliative treatment to relieve symptoms and improve the quality of life.    -  Internal radiation therapy or laser surgery, as palliative treatment to relieve symptoms and improve the quality of', 'many cases, cancer cells have already spread to other parts of the body when the disease is diagnosed. In order to reach cancer cells throughout the body, doctors almost always use chemotherapy. Treatment for small cell lung cancer may also include radiation therapy aimed at the tumor in the lung or tumors in other parts of the body, such as in the brain. Surgery is part of the treatment plan for a small number of patients with small cell lung cancer. Some patients with small cell lung cancer', '\\n\\t\\t            Treatment Options by Stage\\n\\t\\t            \\n\\t\\t                \\n\\t\\t                    Limited-Stage Small Cell Lung Cancer\\n\\t\\t                    Treatment of limited-stage small cell lung cancer may include the following:         -  Combination chemotherapy and radiation therapy to the chest. Radiation therapy to the brain may later be given to patients with complete responses.    - Combination chemotherapy alone for patients who cannot be given radiation therapy.', 'following:         -  Surgery (wedge resection or segmental resection).     -  Photodynamic therapy for tumors in or near the bronchus.     - Electrocautery, cryosurgery, or laser surgery for tumors in or near the bronchus.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage 0 non-small cell lung cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or']","Treatment for small cell lung cancer may include the following options:

1. **Combination chemotherapy and radiation therapy**: This is often used for limited-stage small cell lung cancer, where radiation therapy is directed to the chest. Radiation therapy to the brain may also be given later to patients who have complete responses.

2. **Combination chemotherapy alone**: This is an option for patients who cannot receive radiation therapy.

3. **Surgery**: While surgery is part of the treatment plan for a small number of patients, it may include wedge resection or segmental resection.

4. **Radiation therapy**: This may be aimed at the tumor in the lung or at tumors in other parts of the body, such as the brain.

These treatments are aimed at managing the disease and improving the quality of life for patients.","Key Points
                    - There are different types of treatment for patients with small cell lung cancer.     - Five types of standard treatment are used:         - Surgery      - Chemotherapy      - Radiation therapy      - Laser therapy     - Endoscopic stent placement        - New types of treatment are being tested in clinical trials.     - Patients may want to think about taking part in a clinical trial.    - Patients can enter clinical trials before, during, or after starting their cancer treatment.    - Follow-up tests may be needed.
                
                
                    There are different types of treatment for patients with small cell lung cancer.
                    Different types of treatment are available for patients with small cell lung cancer. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
                
                
                    Five types of standard treatment are used:
                    Surgery      Surgery may be used if the cancer is found in one lung and in nearby lymph nodes only. Because this type of lung cancer is usually found in both lungs, surgery alone is not often used. During surgery, the doctor will also remove lymph nodes to find out if they have cancer in them. Sometimes, surgery may be used to remove a sample of lung tissue to find out the exact type of lung cancer.     Even if the doctor removes all the cancer that can be seen at the time of the operation, some patients may be given chemotherapy or radiation therapy after surgery to kill any cancer cells that are left. Treatment given after the surgery, to lower the risk that the cancer will come back, is called adjuvant therapy.       Chemotherapy     Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy). The way the chemotherapy is given depends on the type and stage of the cancer being treated.    See Drugs Approved for Small Cell Lung Cancer for more information.       Radiation therapy     Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. There are two types of radiation therapy:            -  External radiation therapy uses a machine outside the body to send radiation toward the cancer.     -  Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer.           The way the radiation therapy is given depends on the type and stage of the cancer being treated. External radiation therapy is used to treat small cell lung cancer, and may also be used as palliative therapy to relieve symptoms and improve quality of life. Radiation therapy to the brain to lessen the risk that cancer will spread to the brain may also be given.       Laser therapy     Laser therapy is a cancer treatment that uses a laser beam (a narrow beam of intense light) to kill cancer cells.       Endoscopic stent placement     An endoscope is a thin, tube-like instrument used to look at tissues inside the body. An endoscope has a light and a lens for viewing and may be used to place a stent in a body structure to keep the structure open. An endoscopic stent can be used to open an airway blocked by abnormal tissue.
                
                
                    New types of treatment are being tested in clinical trials.
                    Information about clinical trials is available from the NCI website.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
                
                
                    Follow-up tests may be needed.
                    Some of the tests that were done to diagnose the cancer or to find out the stage of the cancer may be repeated. Some tests will be repeated in order to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.   Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your condition has changed or if the cancer has recurred (come back). These tests are sometimes called follow-up tests or check-ups.
                
		        
		            Treatment Options by Stage
		            
		                
		                    Limited-Stage Small Cell Lung Cancer
		                    Treatment of limited-stage small cell lung cancer may include the following:         -  Combination chemotherapy and radiation therapy to the chest. Radiation therapy to the brain may later be given to patients with complete responses.    - Combination chemotherapy alone for patients who cannot be given radiation therapy.    -  Surgery followed by chemotherapy.    - Surgery followed by chemotherapy and radiation therapy.    - Radiation therapy to the brain may be given to patients who have had a complete response, to prevent the spread of cancer to the brain.    -  Clinical trials of new chemotherapy, surgery, and radiation treatments.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with limited stage small cell lung cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
		                
		                
		                    Extensive-Stage Small Cell Lung Cancer
		                    Treatment of extensive-stage small cell lung cancer may include the following:         -  Combination chemotherapy.     -  Radiation therapy to the brain, spine, bone, or other parts of the body where the cancer has spread, as palliative therapy to relieve symptoms and improve quality of life.    - Radiation therapy to the chest may be given to patients who respond to chemotherapy.    - Radiation therapy to the brain may be given to patients who have had a complete response, to prevent the spread of cancer to the brain.    -  Clinical trials of new chemotherapy treatments.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with extensive stage small cell lung cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.",1.0,0.9681380762340547,0.9999999999875,1.0
what research (or clinical trials) is being done for Small Cell Lung Cancer ?,"['with all stages of non-small cell lung cancer. Information about ongoing clinical trials is available from the NCI website.""', '{\n  ""question"": ""what research (or clinical trials) is being done for Small Cell Lung Cancer ?"",', '""ground_truth"": ""Key Points\\n                    - There are different types of treatment for patients with small cell lung cancer.     - Five types of standard treatment are used:         - Surgery      - Chemotherapy      - Radiation therapy      - Laser therapy     - Endoscopic stent placement        - New types of treatment are being tested in clinical trials.     - Patients may want to think about taking part in a clinical trial.    - Patients can enter clinical trials before, during, or', 'This may be done in certain rare cases of non-small cell lung cancer.\\n                \\n                \\n                    New types of treatment are being tested in clinical trials.\\n                    This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.     Chemoprevention     Chemoprevention is the use of drugs, vitamins, or other', 'patients with small cell lung cancer, current treatments do not cure the cancer.\\n                    If lung cancer is found, patients should think about taking part in one of the many clinical trials being done to improve treatment. Clinical trials are taking place in most parts of the country for patients with all stages of small cell lung cancer. Information about ongoing clinical trials is available from the NCI website.""', '{\n  ""question"": ""What are the treatments for Lung Cancer ?"",\n  ""ground_truth"": ""Small cell lung cancer spreads quickly. In many cases, cancer cells have already spread to other parts of the body when the disease is diagnosed, so chemotherapy is usually the best choice. See more on treatments for small cell lung cancer.""\n}', 'are interested in taking part in a clinical trial should talk with their doctor. The U.S. National Institutes of Health, through its National Library of Medicine and other Institutes, maintains a database of clinical trials at ClinicalTrials.gov. Click here to see a list of the current clinical trials on lung cancer. A separate window will open. Click the \\""x\\"" in the upper right hand corner of the \\""Clinical Trials\\"" window to return here.""', 'results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.\\n\\t\\t                \\n\\t\\t                \\n\\t\\t                    Extensive-Stage Small Cell Lung Cancer\\n\\t\\t                    Treatment of extensive-stage small cell lung cancer may include the']","New types of treatment for small cell lung cancer are being tested in clinical trials. Patients may want to consider participating in these trials, as they can enter before, during, or after standard treatments. Current treatments do not cure small cell lung cancer, and clinical trials are ongoing in many parts of the country for patients with all stages of the disease. Information about these clinical trials can be found on the NCI website.","New types of treatment are being tested in clinical trials.
                    Information about clinical trials is available from the NCI website.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.",1.0,0.8971844036700659,0.9617346938638119,0.6875
What is (are) Plasma Cell Neoplasms (Including Multiple Myeloma) ?,"['{\n  ""question"": ""What is (are) Plasma Cell Neoplasms (Including Multiple Myeloma) ?"",', 'lymphoma, or chronic lymphocytic leukemia.       Plasmacytoma    In this type of plasma cell neoplasm, the abnormal plasma cells (myeloma cells) are in one place and form one tumor, called a plasmacytoma. Sometimes plasmacytoma can be cured. There are two types of plasmacytoma.            - In isolated plasmacytoma of bone, one plasma cell tumor is found in the bone, less than 10% of the bone marrow is made up of plasma cells, and there are no other signs of cancer. Plasmacytoma of the bone', ""problems caused by multiple myeloma and other plasma cell neoplasms.     Supportive care may include the following:          -  Plasmapheresis: If the blood becomes thick with extra antibody proteins and interferes with circulation, plasmapheresis is done to remove extra plasma and antibody proteins from the blood. In this procedure blood is removed from the patient and sent through a machine that separates the plasma (the liquid part of the blood) from the blood cells. The patient's plasma"", 'neoplasms have features of both myelodysplastic syndromes and myeloproliferative neoplasms.\\n                    In myelodysplastic diseases, the blood stem cells do not mature into healthy red blood cells, white blood cells, or platelets. The immature blood cells, called blasts, do not work the way they should and die in the bone marrow or soon after they enter the blood. As a result, there are fewer healthy red blood cells, white blood cells, and platelets.   In myeloproliferative diseases, a', '""ground_truth"": ""Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. These cells are part of your immune system, which helps protect the body from germs and other harmful substances. In time, myeloma cells collect in the bone marrow and in the solid parts of bones.    No one knows the exact causes of multiple myeloma, but it is more common in older people and African Americans. It can run in families. Common symptoms may include       - Bone pain, often in', 'cancer:         -  Lymphoplasmacytic lymphoma. (See Adult Non-Hodgkin Lymphoma Treatment for more information.)    -  Plasmacytoma.    -  Multiple myeloma.\\n                \\n                \\n                    There are several types of plasma cell neoplasms.\\n                    Plasma cell neoplasms include the following:     Monoclonal gammopathy of undetermined significance (MGUS)    In this type of plasma cell neoplasm, less than 10% of the bone marrow is made up of abnormal plasma', '""ground_truth"": ""Plasma cell leukemia (PCL) is a rare and aggressive form of multiple myeloma that involves high levels of plasma cells circulating in the peripheral blood. The signs and symptoms of PCL include aggressive clinical features, such as extramedullary disease, bone marrow failure, advanced stage disease and expression of distinct immunophenotypic markers. Different types of treatments are available for patients with PCL. Some treatments are standard (the currently used treatment),', 'The type of myeloproliferative neoplasm is based on whether too many red blood cells, white blood cells, or platelets are being made. Sometimes the body will make too many of more than one type of blood cell, but usually one type of blood cell is affected more than the others are. Chronic myeloproliferative neoplasms include the following 6 types:         -  Chronic myelogenous leukemia.    -  Polycythemia vera.    -  Primary myelofibrosis (also called chronic idiopathic']","Plasma cell neoplasms are a group of disorders characterized by the abnormal proliferation of plasma cells, which are a type of white blood cell involved in the immune response. The most common type of plasma cell neoplasm is multiple myeloma, a cancer that begins in plasma cells and leads to their accumulation in the bone marrow and solid parts of bones. 

There are several types of plasma cell neoplasms, including:

1. **Multiple Myeloma**: This is a cancer that results in the accumulation of myeloma cells in the bone marrow, leading to various symptoms such as bone pain, anemia, and increased risk of infections.

2. **Plasmacytoma**: This occurs when abnormal plasma cells form a single tumor, which can be either isolated to the bone or extramedullary (outside the bone). Isolated plasmacytoma of bone has specific characteristics, including less than 10% of the bone marrow being made up of plasma cells.

3. **Monoclonal Gammopathy of Undetermined Significance (MGUS)**: In this condition, there are abnormal plasma cells in the bone marrow, but they do not cause symptoms or require treatment.

4. **Plasma Cell Leukemia (PCL)**: This is a rare and aggressive form of multiple myeloma characterized by high levels of plasma cells in the peripheral blood and can present with severe clinical features.

These neoplasms can lead to various complications, and treatment options may vary depending on the specific type and stage of the disease.","Key Points
                    - Plasma cell neoplasms are diseases in which the body makes too many plasma cells.    - Plasma cell neoplasms can be benign (not cancer) or malignant (cancer).    - There are several types of plasma cell neoplasms.          - Monoclonal gammopathy of undetermined significance (MGUS)     - Plasmacytoma     - Multiple myeloma        - Multiple myeloma and other plasma cell neoplasms may cause a condition called amyloidosis.    - Age can affect the risk of plasma cell neoplasms.    - Tests that examine the blood, bone marrow, and urine are used to detect (find) and diagnose multiple myeloma and other plasma cell neoplasms.    - Certain factors affect prognosis (chance of recovery) and treatment options.
                
                
                    Plasma cell neoplasms are diseases in which the body makes too many plasma cells.
                    Plasma cells develop from B lymphocytes (B cells), a type of white blood cell that is made in the bone marrow. Normally, when bacteria or viruses enter the body, some of the B cells will change into plasma cells. The plasma cells make antibodies to fight bacteria and viruses, to stop infection and disease.     Plasma cell neoplasms are diseases in which abnormal plasma cells or myeloma cells form tumors in the bones or soft tissues of the body. The plasma cells also make an antibody protein, called M protein, that is not needed by the body and does not help fight infection. These antibody proteins build up in the bone marrow and can cause the blood to thicken or can damage the kidneys.
                
                
                    Plasma cell neoplasms can be benign (not cancer) or malignant (cancer).
                    Monoclonal gammopathy of undetermined significance (MGUS) is not cancer but can become cancer. The following types of plasma cell neoplasms are cancer:         -  Lymphoplasmacytic lymphoma. (See Adult Non-Hodgkin Lymphoma Treatment for more information.)    -  Plasmacytoma.    -  Multiple myeloma.
                
                
                    There are several types of plasma cell neoplasms.
                    Plasma cell neoplasms include the following:     Monoclonal gammopathy of undetermined significance (MGUS)    In this type of plasma cell neoplasm, less than 10% of the bone marrow is made up of abnormal plasma cells and there is no cancer. The abnormal plasma cells make M protein, which is sometimes found during a routine blood or urine test. In most patients, the amount of M protein stays the same and there are no signs, symptoms, or health problems.     In some patients, MGUS may later become a more serious condition, such as amyloidosis, or cause problems with the kidneys, heart, or nerves. MGUS can also become cancer, such as multiple myeloma, lymphoplasmacytic lymphoma, or chronic lymphocytic leukemia.       Plasmacytoma    In this type of plasma cell neoplasm, the abnormal plasma cells (myeloma cells) are in one place and form one tumor, called a plasmacytoma. Sometimes plasmacytoma can be cured. There are two types of plasmacytoma.            - In isolated plasmacytoma of bone, one plasma cell tumor is found in the bone, less than 10% of the bone marrow is made up of plasma cells, and there are no other signs of cancer. Plasmacytoma of the bone often becomes multiple myeloma.     - In extramedullary plasmacytoma, one plasma cell tumor is found in soft tissue but not in the bone or the bone marrow. Extramedullary plasmacytomas commonly form in tissues of the throat, tonsil, and paranasal sinuses.            Signs and symptoms depend on where the tumor is.            - In bone, the plasmacytoma may cause pain or broken bones.      - In soft tissue, the tumor may press on nearby areas and cause pain or other problems. For example, a plasmacytoma in the throat can make it hard to swallow.               Multiple myeloma    In multiple myeloma, abnormal plasma cells (myeloma cells) build up in the bone marrow and form tumors in many bones of the body. These tumors may keep the bone marrow from making enough healthy blood cells. Normally, the bone marrow makes stem cells (immature cells) that become three types of mature blood cells:            -  Red blood cells that carry oxygen and other substances to all tissues of the body.      -  White blood cells that fight infection and disease.      -  Platelets that form blood clots to help prevent bleeding.            As the number of myeloma cells increases, fewer red blood cells, white blood cells, and platelets are made. The myeloma cells also damage and weaken the bone.     Sometimes multiple myeloma does not cause any signs or symptoms. This is called smoldering multiple myeloma. It may be found when a blood or urine test is done for another condition. Signs and symptoms may be caused by multiple myeloma or other conditions. Check with your doctor if you have any of the following:            - Bone pain, especially in the back or ribs.     - Bones that break easily.     -  Fever for no known reason or frequent infections.     - Easy bruising or bleeding.     - Trouble breathing.     - Weakness of the arms or legs.     - Feeling very tired.           A tumor can damage the bone and cause hypercalcemia (too much calcium in the blood). This can affect many organs in the body, including the kidneys, nerves, heart, muscles, and digestive tract, and cause serious health problems.    Hypercalcemia may cause the following signs and symptoms:             - Loss of appetite.     -  Nausea or vomiting.     - Feeling thirsty.     - Frequent urination.     -  Constipation.     - Feeling very tired.     - Muscle weakness.      - Restlessness.     -  Confusion or trouble thinking.
                
                
                    Multiple myeloma and other plasma cell neoplasms may cause a condition called amyloidosis.
                    In rare cases, multiple myeloma can cause peripheral nerves (nerves that are not in the brain or spinal cord) and organs to fail. This may be caused by a condition called amyloidosis. Antibody proteins build up and stick together in peripheral nerves and organs, such as the kidney and heart. This can cause the nerves and organs to become stiff and unable to work the way they should.    Amyloidosis may cause the following signs and symptoms:         - Feeling very tired.    - Purple spots on the skin.    - Enlarged tongue.    -  Diarrhea.    - Swelling caused by fluid in your body's tissues.    - Tingling or numbness in your legs and feet.",0.75,0.894422166873468,0.9999999999875,1.0
Who is at risk for Plasma Cell Neoplasms (Including Multiple Myeloma)? ?,"['{\n  ""question"": ""Who is at risk for Plasma Cell Neoplasms (Including Multiple Myeloma)? ?"",', 'plasma cells also makes it more difficult for the bone marrow to make healthy blood cells and platelets. The plasma cells produced in multiple myeloma produce abnormal antibodies that the immune system is unable to use. These abnormal antibodies build up in the body and cause a variety of problems. Factors that are associated with an increased risk of developing multiple myeloma include increasing age, male sex, African American race, radiation exposure, a family history of the condition,', 'Myelodysplastic syndromes are rare. People at higher risk are over 60, have had chemotherapy or radiation therapy, or have been exposed to certain chemicals. Treatment options include transfusions, drug therapy, chemotherapy, and blood or bone marrow stem cell transplants.    NIH: National Cancer Institute""', 'risk factors: http://www.mayoclinic.com/health/multiple-myeloma/DS00415/DSECTION=risk-factors Monoclonal gammopathy of undetermined significance risk factors: http://www.mayoclinic.com/health/multiple-myeloma/DS00415/DSECTION=risk-factors""', '""ground_truth"": ""Age can affect the risk of plasma cell neoplasms. Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn\'t mean that you will not get cancer. Talk with your doctor if you think you may be at risk.    Plasma cell neoplasms are most common in people who are middle aged or older. For multiple myeloma and plasmacytoma, other risk factors include the following:', ""problems caused by multiple myeloma and other plasma cell neoplasms.     Supportive care may include the following:          -  Plasmapheresis: If the blood becomes thick with extra antibody proteins and interferes with circulation, plasmapheresis is done to remove extra plasma and antibody proteins from the blood. In this procedure blood is removed from the patient and sent through a machine that separates the plasma (the liquid part of the blood) from the blood cells. The patient's plasma"", '""ground_truth"": ""Multiple myeloma is a form of cancer that occurs due to abnormal and uncontrolled growth of plasma cells in the bone marrow. Some people with multiple myeloma, especially those with early stages of the condition, have no concerning signs or symptoms. When present, the most common symptom is anemia, which can be associated with fatigue and shortness of breath. Other features of the condition may include multiple infections; abnormal bleeding; bone pain; weak and/or easily', '{\n  ""question"": ""What are the treatments for Plasma Cell Neoplasms (Including Multiple Myeloma) ?"",']","Individuals at risk for Plasma Cell Neoplasms, including Multiple Myeloma, typically include those who are middle-aged or older. Other risk factors include:

- Increasing age
- Male sex
- African American race
- Radiation exposure
- A family history of the condition
- Previous chemotherapy or radiation therapy
- Exposure to certain chemicals

Having one or more of these risk factors does not guarantee that a person will develop the condition, but it may increase their risk. It's important to discuss any concerns with a healthcare provider.","Age can affect the risk of plasma cell neoplasms. Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. Talk with your doctor if you think you may be at risk.    Plasma cell neoplasms are most common in people who are middle aged or older. For multiple myeloma and plasmacytoma, other risk factors include the following:          - Being black.    - Being male.    - Having a personal history of MGUS or plasmacytoma.    - Being exposed to radiation or certain chemicals.",1.0,0.0,0.99999999998,0.8888888888888888
How to diagnose Plasma Cell Neoplasms (Including Multiple Myeloma) ?,"['{\n  ""question"": ""How to diagnose Plasma Cell Neoplasms (Including Multiple Myeloma) ?"",', '""ground_truth"": ""What are the signs and symptoms of Multiple myeloma? In some cases, multiple myeloma is not associated with any signs and symptoms. When present, the most common symptom is anemia (low red blood cell count), which can be associated with fatigue, shortness of breath, and dizziness. Other features of the condition may include: Bone pain Nausea Constipation Loss of appetite Frequent infections Weight loss Excessive thirst Weakness and/or numbness in the arms and legs Confusion', ""problems caused by multiple myeloma and other plasma cell neoplasms.     Supportive care may include the following:          -  Plasmapheresis: If the blood becomes thick with extra antibody proteins and interferes with circulation, plasmapheresis is done to remove extra plasma and antibody proteins from the blood. In this procedure blood is removed from the patient and sent through a machine that separates the plasma (the liquid part of the blood) from the blood cells. The patient's plasma"", 'of the bone often becomes multiple myeloma.     - In extramedullary plasmacytoma, one plasma cell tumor is found in soft tissue but not in the bone or the bone marrow. Extramedullary plasmacytomas commonly form in tissues of the throat, tonsil, and paranasal sinuses.            Signs and symptoms depend on where the tumor is.            - In bone, the plasmacytoma may cause pain or broken bones.      - In soft tissue, the tumor may press on nearby areas and cause pain or other problems. For', '""ground_truth"": ""Tests that examine the blood, bone marrow, and urine are used to detect (find) and diagnose multiple myeloma and other plasma cell neoplasms. The following tests and procedures may be used:         -   Physical exam and history : An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patients health habits and past illnesses and treatments will also be taken.    -', 'cancer:         -  Lymphoplasmacytic lymphoma. (See Adult Non-Hodgkin Lymphoma Treatment for more information.)    -  Plasmacytoma.    -  Multiple myeloma.\\n                \\n                \\n                    There are several types of plasma cell neoplasms.\\n                    Plasma cell neoplasms include the following:     Monoclonal gammopathy of undetermined significance (MGUS)    In this type of plasma cell neoplasm, less than 10% of the bone marrow is made up of abnormal plasma', '""ground_truth"": ""How is multiple myeloma diagnosed? A diagnosis of multiple myeloma may be suspected based on the presence of characteristic signs and symptoms. Additional testing can then be ordered to confirm the diagnosis. This may include: Specialized blood tests including immunoglobulin studies, complete blood count with differential, and blood chemistry studies Urine tests such as immunoglobulin studies and a twenty-four-hour urine test Bone marrow aspiration and biopsy Imaging studies', '""ground_truth"": ""What causes multiple myeloma? Although the exact underlying cause of multiple myeloma is poorly understood, the specific symptoms of the condition result from abnormal and excessive growth of plasma cells in the bone marrow. Plasma cells help the body fight infection by producing proteins called antibodies. In people with multiple myeloma, excess plasma cells form tumors in the bone, causing bones to become weak and easily broken. The abnormal growth of plasma cells also']","To diagnose Plasma Cell Neoplasms, including Multiple Myeloma, the following tests and procedures may be used:

1. **Physical Exam and History**: An examination of the body to check for general signs of health and any unusual findings, along with a review of the patient's health habits and past illnesses.

2. **Specialized Blood Tests**: These include immunoglobulin studies, complete blood count with differential, and blood chemistry studies.

3. **Urine Tests**: This may involve immunoglobulin studies and a twenty-four-hour urine test.

4. **Bone Marrow Aspiration and Biopsy**: This procedure helps to examine the bone marrow for abnormal plasma cells.

5. **Imaging Studies**: These are used to assess any damage to the bones or other areas affected by the neoplasm.

These tests help confirm the diagnosis of multiple myeloma and other plasma cell neoplasms.","Tests that examine the blood, bone marrow, and urine are used to detect (find) and diagnose multiple myeloma and other plasma cell neoplasms. The following tests and procedures may be used:         -   Physical exam and history : An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patients health habits and past illnesses and treatments will also be taken.    -  Blood and urine immunoglobulin studies: A procedure in which a blood or urine sample is checked to measure the amounts of certain antibodies (immunoglobulins). For multiple myeloma, beta-2-microglobulin, M protein, free light chains, and other proteins made by the myeloma cells are measured. A higher-than-normal amount of these substances can be a sign of disease.    -   Bone marrow aspiration and biopsy : The removal of bone marrow, blood, and a small piece of bone by inserting a hollow needle into the hipbone or breastbone. A pathologist views the bone marrow, blood, and bone under a microscope to look for abnormal cells. The following test may be done on the sample of tissue removed during the bone marrow aspiration and biopsy:                -  Cytogenetic analysis : A test in which cells in a sample of bone marrow are viewed under a microscope to look for certain changes in the chromosomes. Other tests, such as fluorescence in situ hybridization (FISH) and flow cytometry, may also be done to look for certain changes in the chromosomes.             -   Skeletal bone survey: In a skeletal bone survey, x-rays of all the bones in the body are taken. The x-rays are used to find areas where the bone is damaged. An x-ray is a type of energy beam that can go through the body and onto film, making a picture of areas inside the body.     -   Complete blood count (CBC) with differential : A procedure in which a sample of blood is drawn and checked for the following:               - The number of red blood cells and platelets.      - The number and type of white blood cells.      - The amount of hemoglobin (the protein that carries oxygen) in the red blood cells.      -  The portion of the blood sample made up of red blood cells.               -   Blood chemistry studies : A procedure in which a blood sample is checked to measure the amounts of certain substances, such as calcium or albumin, released into the blood by organs and tissues in the body. An unusual (higher or lower than normal) amount of a substance can be a sign of disease.    -  Twenty-four-hour urine test: A test in which urine is collected for 24 hours to measure the amounts of certain substances. An unusual (higher or lower than normal) amount of a substance can be a sign of disease in the organ or tissue that makes it. A higher than normal amount of protein may be a sign of multiple myeloma.     -   MRI (magnetic resonance imaging): A procedure that uses a magnet, radio waves, and a computer to make a series of detailed pictures of areas inside the body. This procedure is also called nuclear magnetic resonance imaging (NMRI). An MRI of the spine and pelvis may be used to find areas where the bone is damaged.    -   CT scan (CAT scan): A procedure that makes a series of detailed pictures of areas inside the body, such as the spine, taken from different angles. The pictures are made by a computer linked to an x-ray machine. A dye may be injected into a vein or swallowed to help the organs or tissues show up more clearly. This procedure is also called computed tomography, computerized tomography, or computerized axial tomography.     -   PET-CT scan : A procedure that combines the pictures from a positron emission tomography (PET) scan and a computed tomography (CT) scan. The PET and CT scans are done at the same time with the same machine. The combined scans give more detailed pictures of areas inside the body, such as the spine, than either scan gives by itself.",1.0,0.9520203997702424,0.9999999999875,1.0
What is the outlook for Plasma Cell Neoplasms (Including Multiple Myeloma) ?,"['{\n  ""question"": ""What is the outlook for Plasma Cell Neoplasms (Including Multiple Myeloma) ?"",', 'plasma cells also makes it more difficult for the bone marrow to make healthy blood cells and platelets. The plasma cells produced in multiple myeloma produce abnormal antibodies that the immune system is unable to use. These abnormal antibodies build up in the body and cause a variety of problems. Factors that are associated with an increased risk of developing multiple myeloma include increasing age, male sex, African American race, radiation exposure, a family history of the condition,', 'The National Cancer Institute offers information regarding the management of multiple myeloma, including more specific information regarding the treatments outlined above. Please click on the link to access this resource.""', ""problems caused by multiple myeloma and other plasma cell neoplasms.     Supportive care may include the following:          -  Plasmapheresis: If the blood becomes thick with extra antibody proteins and interferes with circulation, plasmapheresis is done to remove extra plasma and antibody proteins from the blood. In this procedure blood is removed from the patient and sent through a machine that separates the plasma (the liquid part of the blood) from the blood cells. The patient's plasma"", 'lymphoma, or chronic lymphocytic leukemia.       Plasmacytoma    In this type of plasma cell neoplasm, the abnormal plasma cells (myeloma cells) are in one place and form one tumor, called a plasmacytoma. Sometimes plasmacytoma can be cured. There are two types of plasmacytoma.            - In isolated plasmacytoma of bone, one plasma cell tumor is found in the bone, less than 10% of the bone marrow is made up of plasma cells, and there are no other signs of cancer. Plasmacytoma of the bone', 'of multiple myeloma and other plasma cell neoplasms.    See Drugs Approved for Multiple Myeloma and Other Plasma Cell Neoplasms for more information.       High-dose chemotherapy with stem cell transplant    This treatment is a way of giving high doses of chemotherapy and replacing blood -forming cells destroyed by the cancer treatment. Stem cells (immature blood cells) are removed from the blood or bone marrow of the patient (autologous transplant) or a donor (allogeneic transplant) and are', '- Age can affect the risk of plasma cell neoplasms.    - Tests that examine the blood, bone marrow, and urine are used to detect (find) and diagnose multiple myeloma and other plasma cell neoplasms.    - Certain factors affect prognosis (chance of recovery) and treatment options.\\n                \\n                \\n                    Plasma cell neoplasms are diseases in which the body makes too many plasma cells.\\n                    Plasma cells develop from B lymphocytes (B cells), a', 'I multiple myeloma     - Stage II multiple myeloma     - Stage III multiple myeloma\\n                \\n                \\n                    There are no standard staging systems for monoclonal gammopathy of undetermined significance (MGUS), macroglobulinemia, and plasmacytoma.\\n                    \\n                \\n                \\n                    After multiple myeloma has been diagnosed, tests are done to find out the amount of cancer in the body.\\n                    The process used']","The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, can vary based on several factors such as the stage of the disease, the patient's age, and overall health. Multiple Myeloma is a complex condition where abnormal plasma cells produce harmful antibodies that can lead to various health issues. 

Treatment options, including high-dose chemotherapy with stem cell transplant and supportive care like plasmapheresis, can improve outcomes. Prognosis is influenced by the amount of cancer in the body and individual patient factors. For more detailed information on management and treatment options, resources from the National Cancer Institute can be helpful.","Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) depends on the following:         - The type of plasma cell neoplasm.    - The stage of the disease.    - Whether a certain immunoglobulin (antibody) is present.    - Whether there are certain genetic changes.    - Whether the kidney is damaged.    - Whether the cancer responds to initial treatment or recurs (comes back).        Treatment options depend on the following:         - The type of plasma cell neoplasm.    - The age and general health of the patient.    - Whether there are signs, symptoms, or health problems, such as kidney failure or infection, related to the disease.    - Whether the cancer responds to initial treatment or recurs (comes back).",1.0,0.0,0.14285714284285714,1.0
What are the stages of Plasma Cell Neoplasms (Including Multiple Myeloma) ?,"['{\n  ""question"": ""What are the stages of Plasma Cell Neoplasms (Including Multiple Myeloma) ?"",', 'depend on the following:         - The type of plasma cell neoplasm.    - The age and general health of the patient.    - Whether there are signs, symptoms, or health problems, such as kidney failure or infection, related to the disease.    - Whether the cancer responds to initial treatment or recurs (comes back).""', ""problems caused by multiple myeloma and other plasma cell neoplasms.     Supportive care may include the following:          -  Plasmapheresis: If the blood becomes thick with extra antibody proteins and interferes with circulation, plasmapheresis is done to remove extra plasma and antibody proteins from the blood. In this procedure blood is removed from the patient and sent through a machine that separates the plasma (the liquid part of the blood) from the blood cells. The patient's plasma"", '""ground_truth"": ""Key Points\\n                    - There is no standard staging system for chronic myeloproliferative neoplasms.\\n                \\n                \\n                    There is no standard staging system for chronic myeloproliferative neoplasms.\\n                    Staging is the process used to find out how far the cancer has spread. There is no standard staging system for chronic myeloproliferative neoplasms. Treatment is based on the type of myeloproliferative neoplasm', 'lymphoma, or chronic lymphocytic leukemia.       Plasmacytoma    In this type of plasma cell neoplasm, the abnormal plasma cells (myeloma cells) are in one place and form one tumor, called a plasmacytoma. Sometimes plasmacytoma can be cured. There are two types of plasmacytoma.            - In isolated plasmacytoma of bone, one plasma cell tumor is found in the bone, less than 10% of the bone marrow is made up of plasma cells, and there are no other signs of cancer. Plasmacytoma of the bone', 'neoplasms have features of both myelodysplastic syndromes and myeloproliferative neoplasms.\\n                    In myelodysplastic diseases, the blood stem cells do not mature into healthy red blood cells, white blood cells, or platelets. The immature blood cells, called blasts, do not work the way they should and die in the bone marrow or soon after they enter the blood. As a result, there are fewer healthy red blood cells, white blood cells, and platelets.   In myeloproliferative diseases, a', '""ground_truth"": ""Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. These cells are part of your immune system, which helps protect the body from germs and other harmful substances. In time, myeloma cells collect in the bone marrow and in the solid parts of bones.    No one knows the exact causes of multiple myeloma, but it is more common in older people and African Americans. It can run in families. Common symptoms may include       - Bone pain, often in', 'cancer:         -  Lymphoplasmacytic lymphoma. (See Adult Non-Hodgkin Lymphoma Treatment for more information.)    -  Plasmacytoma.    -  Multiple myeloma.\\n                \\n                \\n                    There are several types of plasma cell neoplasms.\\n                    Plasma cell neoplasms include the following:     Monoclonal gammopathy of undetermined significance (MGUS)    In this type of plasma cell neoplasm, less than 10% of the bone marrow is made up of abnormal plasma']","The stages of Plasma Cell Neoplasms, including Multiple Myeloma, depend on several factors such as the type of plasma cell neoplasm, the age and general health of the patient, the presence of any related health problems (like kidney failure or infection), and the response to initial treatment or recurrence of the disease. There is no standard staging system for these conditions, and treatment is tailored based on these individual factors.","Key Points
                    - There are no standard staging systems for monoclonal gammopathy of undetermined significance (MGUS), macroglobulinemia, and plasmacytoma.    - After multiple myeloma has been diagnosed, tests are done to find out the amount of cancer in the body.    - The stage of multiple myeloma is based on the levels of beta-2-microglobulin and albumin in the blood.    - The following stages are used for multiple myeloma:         - Stage I multiple myeloma     - Stage II multiple myeloma     - Stage III multiple myeloma
                
                
                    There are no standard staging systems for monoclonal gammopathy of undetermined significance (MGUS), macroglobulinemia, and plasmacytoma.
                    
                
                
                    After multiple myeloma has been diagnosed, tests are done to find out the amount of cancer in the body.
                    The process used to find out the amount of cancer in the body is called staging. It is important to know the stage in order to plan treatment. The following tests and procedures may be used in the staging process:          -   Skeletal bone survey: In a skeletal bone survey, x-rays of all the bones in the body are taken. The x-rays are used to find areas where the bone is damaged. An x-ray is a type of energy beam that can go through the body and onto film, making a picture of areas inside the body.     -   MRI (magnetic resonance imaging): A procedure that uses a magnet, radio waves, and a computer to make a series of detailed pictures of areas inside the body, such as the bone marrow. This procedure is also called nuclear magnetic resonance imaging (NMRI).     -  Bone densitometry: A procedure that uses a special type of x-ray to measure bone density.
                
                
                    The stage of multiple myeloma is based on the levels of beta-2-microglobulin and albumin in the blood.
                    Beta-2-microglobulin and albumin are found in the blood. Beta-2-microglobulin is a protein found on plasma cells. Albumin makes up the biggest part of the blood plasma. It keeps fluid from leaking out of blood vessels. It also brings nutrients to tissues, and carries hormones, vitamins, drugs, and other substances, such as calcium, all through the body. In the blood of patients with multiple myeloma, the amount of beta-2-microglobulin is increased and the amount of albumin is decreased.
                
                
                    The following stages are used for multiple myeloma:
                    Stage I multiple myeloma    In stage I multiple myeloma, the blood levels are as follows:             -  beta-2-microglobulin level is lower than 3.5 mg/L; and     -  albumin level is 3.5 g/dL or higher.              Stage II multiple myeloma    In stage II multiple myeloma, the blood levels are in between the levels for stage I and stage III.       Stage III multiple myeloma    In stage III multiple myeloma, the blood level of beta-2-microglobulin is 5.5 mg/L or higher and the patient also has one of the following:            - high levels of lactate dehydrogenase (LDH); or     - certain changes in the chromosomes.",0.75,0.0,0.9999999999875,0.2857142857142857
What are the treatments for Plasma Cell Neoplasms (Including Multiple Myeloma) ?,"['{\n  ""question"": ""What are the treatments for Plasma Cell Neoplasms (Including Multiple Myeloma) ?"",', ""problems caused by multiple myeloma and other plasma cell neoplasms.     Supportive care may include the following:          -  Plasmapheresis: If the blood becomes thick with extra antibody proteins and interferes with circulation, plasmapheresis is done to remove extra plasma and antibody proteins from the blood. In this procedure blood is removed from the patient and sent through a machine that separates the plasma (the liquid part of the blood) from the blood cells. The patient's plasma"", '""ground_truth"": ""How might multiple myeloma be treated? The treatment of multiple myeloma varies based on many factors including the age and general health of the affected person; the associated signs and symptoms; and the severity of the condition. In general, one or more of the following interventions may be used to treat multiple myeloma: Chemotherapy Corticosteroid medications Targeted therapy Stem cell transplant Biological therapy Radiation therapy Surgery Watchful waiting The National', 'treatment.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with chronic myelomonocytic leukemia. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.\\n\\t\\t\\t\\t\\t\\t\\t                \\n\\t\\t\\t\\t\\t\\t\\t', 'of therapies         - Supportive care is given to lessen the problems caused by the disease or its treatment.     - Patients may want to think about taking part in a clinical trial.    - Patients can enter clinical trials before, during, or after starting their cancer treatment.    - Follow-up tests may be needed.\\n                \\n                \\n                    There are different types of treatment for patients with plasma cell neoplasms.\\n                    Different types of', 'used treatment), and some are being tested in clinical trials. For detailed information on the available treatment options, please visit the following link. http://www.cancer.gov/cancertopics/pdq/treatment/myeloma/Patient/page4""', 'of multiple myeloma and other plasma cell neoplasms.    See Drugs Approved for Multiple Myeloma and Other Plasma Cell Neoplasms for more information.       High-dose chemotherapy with stem cell transplant    This treatment is a way of giving high doses of chemotherapy and replacing blood -forming cells destroyed by the cancer treatment. Stem cells (immature blood cells) are removed from the blood or bone marrow of the patient (autologous transplant) or a donor (allogeneic transplant) and are', '""ground_truth"": ""Key Points\\n                    - There are different types of treatment for patients with chronic myeloproliferative neoplasms.    - Eleven types of standard treatment are used:          - Watchful waiting     -  Phlebotomy      -  Platelet apheresis      - Transfusion therapy     -  Chemotherapy      -  Radiation therapy      - Other drug therapy     -  Surgery      - Biologic therapy      - Targeted therapy     - High-dose chemotherapy with stem cell transplant        -']","The treatment of Plasma Cell Neoplasms, including Multiple Myeloma, varies based on several factors such as the patient's age, general health, and the severity of the condition. The following treatments may be used:

1. Chemotherapy
2. Corticosteroid medications
3. Targeted therapy
4. Stem cell transplant
5. Biological therapy
6. Radiation therapy
7. Surgery
8. Watchful waiting
9. Plasmapheresis (to remove extra plasma and antibody proteins if the blood becomes thick)
10. Supportive care to lessen problems caused by the disease or its treatment

Patients may also consider participating in clinical trials for new treatment options. Follow-up tests may be needed to monitor the condition.","Key Points
                    - There are different types of treatment for patients with plasma cell neoplasms.    - Eight types of treatment are used:         - Chemotherapy     - Other drug therapy     - Targeted therapy     - High-dose chemotherapy with stem cell transplant     - Biologic therapy     - Radiation therapy     - Surgery     - Watchful waiting        - New types of treatment are being tested in clinical trials.          - New combinations of therapies         - Supportive care is given to lessen the problems caused by the disease or its treatment.     - Patients may want to think about taking part in a clinical trial.    - Patients can enter clinical trials before, during, or after starting their cancer treatment.    - Follow-up tests may be needed.
                
                
                    There are different types of treatment for patients with plasma cell neoplasms.
                    Different types of treatments are available for patients with plasma cell neoplasms. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
                
                
                    Eight types of treatment are used:
                    Chemotherapy     Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy). The way the chemotherapy is given depends on the type and stage of the cancer being treated.    See Drugs Approved for Multiple Myeloma and Other Plasma Cell Neoplasms for more information.       Other drug therapy     Corticosteroids are steroids that have antitumor effects in multiple myeloma.        Targeted therapy     Targeted therapy is a treatment that uses drugs or other substances to identify and attack specific cancer cells without harming normal cells. Several types of targeted therapy may be used to treat multiple myeloma and other plasma cell neoplasms.     Proteasome inhibitor therapy is a type of targeted therapy that blocks the action of proteasomes in cancer cells and may prevent the growth of tumors. Bortezomib, carfilzomib, ixazomib, daratumumab, and elotuzumab are proteasome inhibitors used in the treatment of multiple myeloma and other plasma cell neoplasms.     Histone deacetylase (HDAC) inhibitor therapy is a type of targeted therapy that blocks enzymes needed for cell division and may stop the growth of cancer cells. Panobinostat is an HDAC inhibitor used in the treatment of multiple myeloma and other plasma cell neoplasms.    See Drugs Approved for Multiple Myeloma and Other Plasma Cell Neoplasms for more information.       High-dose chemotherapy with stem cell transplant    This treatment is a way of giving high doses of chemotherapy and replacing blood -forming cells destroyed by the cancer treatment. Stem cells (immature blood cells) are removed from the blood or bone marrow of the patient (autologous transplant) or a donor (allogeneic transplant) and are frozen and stored. After the chemotherapy is completed, the stored stem cells are thawed and given back to the patient through an infusion. These reinfused stem cells grow into (and restore) the body's blood cells.           Biologic therapy     Biologic therapy is a treatment that uses the patient's immune system to fight cancer. Substances made by the body or made in a laboratory are used to boost, direct, or restore the body's natural defenses against cancer. This type of cancer treatment is also called biotherapy or immunotherapy.     Immunomodulators are a type of biologic therapy. Thalidomide, lenalidomide, and pomalidomide are immunomodulators used to treat multiple myeloma and other plasma cell neoplasms.     Interferon is a type of biologic therapy. It affects the division of cancer cells and can slow tumor growth.     See Drugs Approved for Multiple Myeloma and Other Plasma Cell Neoplasms for more information.       Radiation therapy     Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. There are two types of radiation therapy:            -  External radiation therapy uses a machine outside the body to send radiation toward the cancer.     -  Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer.           The way the radiation therapy is given depends on the type and stage of the cancer being treated. External radiation therapy is used to treat plasma cell neoplasms.       Surgery     Surgery to remove the tumor may be done and is usually followed by radiation therapy. Treatment given after the surgery, to lower the risk that the cancer will come back, is called adjuvant therapy.       Watchful waiting     Watchful waiting is closely monitoring a patients condition without giving any treatment until signs or symptoms appear or change.
                
                
                    New types of treatment are being tested in clinical trials.
                    This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.     New combinations of therapies     Clinical trials are studying different combinations of biologic therapy, chemotherapy, steroid therapy, and drugs. New treatment regimens using thalidomide or lenalidomide are also being studied.
                
                
                    Supportive care is given to lessen the problems caused by the disease or its treatment.
                    This therapy controls problems or side effects caused by the disease or its treatment, and improves quality of life. Supportive care is given to treat problems caused by multiple myeloma and other plasma cell neoplasms.     Supportive care may include the following:          -  Plasmapheresis: If the blood becomes thick with extra antibody proteins and interferes with circulation, plasmapheresis is done to remove extra plasma and antibody proteins from the blood. In this procedure blood is removed from the patient and sent through a machine that separates the plasma (the liquid part of the blood) from the blood cells. The patient's plasma contains the unneeded antibodies and is not returned to the patient. The normal blood cells are returned to the bloodstream along with donated plasma or a plasma replacement. Plasmapheresis does not keep new antibodies from forming.     -  High-dose chemotherapy with stem cell transplant: If amyloidosis occurs, treatment may include high-dose chemotherapy followed by stem cell transplant using the patient's own stem cells.    -  Biologic therapy: Biologic therapy with thalidomide, lenalidomide, or pomalidomide is given to treat amyloidosis.    -  Targeted therapy: Targeted therapy with proteasome inhibitors is given to treat amyloidosis.    -  Radiation therapy: Radiation therapy is given for bone lesions of the spine.    -  Chemotherapy: Chemotherapy is given to reduce back pain from osteoporosis or compression fractures of the spine.    -  Bisphosphonate therapy: Bisphosphonate therapy is given to slow bone loss and reduce bone pain. See the following PDQ summaries for more information on bisphosphonates and problems related to their use:               - Cancer Pain      - Oral Complications of Chemotherapy and Head/Neck Radiation
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
                
                
                    Follow-up tests may be needed.
                    Some of the tests that were done to diagnose the cancer or to find out the stage of the cancer may be repeated. Some tests will be repeated in order to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.   Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your condition has changed or if the cancer has recurred (come back). These tests are sometimes called follow-up tests or check-ups.
                
		        
		            Treatment Options for Plasma Cell Neoplasms
		            
		                
		                    Monoclonal Gammopathy of Undetermined Significance
		                    Treatment of monoclonal gammopathy of undetermined significance (MGUS) is usually watchful waiting. Regular blood tests to check the level of M protein in the blood and physical exams to check for signs or symptoms of cancer will be done.   Check the list of NCI-supported cancer clinical trials that are now accepting patients with monoclonal gammopathy of undetermined significance. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
		                
		                
		                    Isolated Plasmacytoma of Bone
		                    Treatment of isolated plasmacytoma of bone is usually radiation therapy to the bone lesion.   Check the list of NCI-supported cancer clinical trials that are now accepting patients with isolated plasmacytoma of bone. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
		                
		                
		                    Extramedullary Plasmacytoma
		                    Treatment of extramedullary plasmacytoma may include the following:          -  Radiation therapy to the tumor and nearby lymph nodes.    -  Surgery, usually followed by radiation therapy.    -  Watchful waiting after initial treatment, followed by radiation therapy, surgery, or chemotherapy if the tumor grows or causes signs or symptoms.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with extramedullary plasmacytoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
		                
		                
		                    Multiple Myeloma
		                    Patients without signs or symptoms may not need treatment. When signs or symptoms appear, the treatment of multiple myeloma may be done in phases:         -   Induction therapy : This is the first phase of treatment. Its goal is to reduce the amount of disease, and may include one or more of the following:               -  Corticosteroid therapy.      -  Biologic therapy with lenalidomide, pomalidomide, or thalidomide therapy.      -  Targeted therapy with proteasome inhibitors (bortezomib, carfilzomib, ixazomib, daratumumab, and elotuzumab).      -  Chemotherapy.      -  Histone deacetylase inhibitor therapy with panobinostat.      - A clinical trial of different combinations of treatment.             -   Consolidation chemotherapy : This is the second phase of treatment. Treatment in the consolidation phase is to kill any remaining cancer cells. High-dose chemotherapy is followed by either:               - one autologous stem cell transplant, in which the patient's stem cells from the blood or bone marrow are used; or      - two autologous stem cell transplants followed by an autologous or allogeneic stem cell transplant, in which the patient receives stem cells from the blood or bone marrow of a donor; or      - one allogeneic stem cell transplant.             -   Maintenance therapy : After the initial treatment, maintenance therapy is often given to help keep the disease in remission for a longer time. Several types of treatment are being studied for this use, including the following:               - Chemotherapy.      -  Biologic therapy with interferon.      - Corticosteroid therapy.      - Lenalidomide therapy.      - Targeted therapy with a proteasome inhibitor (bortezomib).                 Check the list of NCI-supported cancer clinical trials that are now accepting patients with multiple myeloma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
		                
		                
		                    Refractory Multiple Myeloma
		                    Treatment of refractory multiple myeloma may include the following:         -  Watchful waiting for patients whose disease is stable.    - A different treatment than treatment already given, for patients whose tumor kept growing during treatment. (See Multiple Myeloma treatment options.)    - A clinical trial of a new therapy.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with refractory multiple myeloma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.",1.0,0.967391317057539,0.9999999999875,1.0
what research (or clinical trials) is being done for Plasma Cell Neoplasms (Including Multiple Myeloma) ?,"['{\n  ""question"": ""what research (or clinical trials) is being done for Plasma Cell Neoplasms (Including Multiple Myeloma) ?"",', 'trials is available from the NCI website.\\n\\t\\t\\t\\t\\t\\t\\t\\t                \\n\\t\\t\\t\\t\\t\\t\\t\\t                \\n\\t\\t\\t\\t\\t\\t\\t\\t                    Relapsed Chronic Myelogenous Leukemia\\n\\t\\t\\t\\t\\t\\t\\t\\t                    Treatment of relapsed chronic myelogenous leukemia may include the following:         -  Targeted therapy with a tyrosine kinase inhibitor.    -  Donor stem cell transplant.    -  Chemotherapy.     -  Donor lymphocyte infusion.    -  Biologic therapy (interferon).    - A', ""problems caused by multiple myeloma and other plasma cell neoplasms.     Supportive care may include the following:          -  Plasmapheresis: If the blood becomes thick with extra antibody proteins and interferes with circulation, plasmapheresis is done to remove extra plasma and antibody proteins from the blood. In this procedure blood is removed from the patient and sent through a machine that separates the plasma (the liquid part of the blood) from the blood cells. The patient's plasma"", 'The National Cancer Institute offers information regarding the management of multiple myeloma, including more specific information regarding the treatments outlined above. Please click on the link to access this resource.""', 'Different types of treatments are available for patients with plasma cell neoplasms. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may', 'of multiple myeloma and other plasma cell neoplasms.    See Drugs Approved for Multiple Myeloma and Other Plasma Cell Neoplasms for more information.       High-dose chemotherapy with stem cell transplant    This treatment is a way of giving high doses of chemotherapy and replacing blood -forming cells destroyed by the cancer treatment. Stem cells (immature blood cells) are removed from the blood or bone marrow of the patient (autologous transplant) or a donor (allogeneic transplant) and are', 'for you. General information about clinical trials is available from the NCI website.\\n\\t\\t\\t\\t\\t\\t\\t                \\n\\t\\t\\t\\t\\t\\t\\t                \\n\\t\\t\\t\\t\\t\\t\\t                    Myelodysplastic/ Myeloproliferative Neoplasm, Unclassifiable\\n\\t\\t\\t\\t\\t\\t\\t                    Because myelodysplastic /myeloproliferative neoplasm, unclassifiable (MDS/MPN-UC) is a rare disease, little is known about its treatment. Treatment may include the following:         -  Supportive care treatments to', '""ground_truth"": ""Key Points\\n                    - There are different types of treatment for patients with plasma cell neoplasms.    - Eight types of treatment are used:         - Chemotherapy     - Other drug therapy     - Targeted therapy     - High-dose chemotherapy with stem cell transplant     - Biologic therapy     - Radiation therapy     - Surgery     - Watchful waiting        - New types of treatment are being tested in clinical trials.          - New combinations of therapies']","There are different types of treatments being researched for plasma cell neoplasms, including multiple myeloma. Clinical trials are conducted to improve current treatments or to obtain information on new treatments. Some of the treatment options being tested include:

- Chemotherapy
- Other drug therapy
- Targeted therapy
- High-dose chemotherapy with stem cell transplant
- Biologic therapy
- Radiation therapy
- Surgery
- Watchful waiting

These clinical trials may involve new combinations of therapies, and when a new treatment shows better results than the standard treatment, it may become the new standard. For more detailed information about ongoing clinical trials, you can visit the National Cancer Institute (NCI) website.","New types of treatment are being tested in clinical trials.
                    This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.     New combinations of therapies     Clinical trials are studying different combinations of biologic therapy, chemotherapy, steroid therapy, and drugs. New treatment regimens using thalidomide or lenalidomide are also being studied.
                
                
                    Supportive care is given to lessen the problems caused by the disease or its treatment.
                    This therapy controls problems or side effects caused by the disease or its treatment, and improves quality of life. Supportive care is given to treat problems caused by multiple myeloma and other plasma cell neoplasms.     Supportive care may include the following:          -  Plasmapheresis: If the blood becomes thick with extra antibody proteins and interferes with circulation, plasmapheresis is done to remove extra plasma and antibody proteins from the blood. In this procedure blood is removed from the patient and sent through a machine that separates the plasma (the liquid part of the blood) from the blood cells. The patient's plasma contains the unneeded antibodies and is not returned to the patient. The normal blood cells are returned to the bloodstream along with donated plasma or a plasma replacement. Plasmapheresis does not keep new antibodies from forming.     -  High-dose chemotherapy with stem cell transplant: If amyloidosis occurs, treatment may include high-dose chemotherapy followed by stem cell transplant using the patient's own stem cells.    -  Biologic therapy: Biologic therapy with thalidomide, lenalidomide, or pomalidomide is given to treat amyloidosis.    -  Targeted therapy: Targeted therapy with proteasome inhibitors is given to treat amyloidosis.    -  Radiation therapy: Radiation therapy is given for bone lesions of the spine.    -  Chemotherapy: Chemotherapy is given to reduce back pain from osteoporosis or compression fractures of the spine.    -  Bisphosphonate therapy: Bisphosphonate therapy is given to slow bone loss and reduce bone pain. See the following PDQ summaries for more information on bisphosphonates and problems related to their use:               - Cancer Pain      - Oral Complications of Chemotherapy and Head/Neck Radiation
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.",1.0,0.9218804781381666,0.9999999999875,0.9523809523809523
